{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T07:09:27Z","timestamp":1793084967145,"version":"4.5.0"},"reference-count":550,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T00:00:00Z","timestamp":1781481600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T00:00:00Z","timestamp":1787616000000},"content-version":"vor","delay-in-days":71,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nutr Metab (Lond)"],"DOI":"10.1186\/s12986-026-01147-8","type":"journal-article","created":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T11:15:21Z","timestamp":1781522121000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["The nutrigenomic-epigenetic axis in cancer: from dietary bioactives to precision oncology"],"prefix":"10.1186","volume":"23","author":[{"given":"Fatemeh","family":"Boroomand","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Amin","family":"Karimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaheh","family":"Karimzadeh-Soureshjani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daryoush","family":"Kiani-Shamsabadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Farhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helia","family":"Mardani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7343-027X","authenticated-orcid":false,"given":"Ali","family":"Jafari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,15]]},"reference":[{"issue":"1","key":"1147_CR1","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1186\/s13045-024-01640-8","volume":"17","author":"Z Wu","year":"2024","unstructured":"Wu Z, Xia F, Lin R. Global burden of cancer and associated risk factors in 204 countries and territories, 1980\u20132021: a systematic analysis for the GBD 2021. J Hematol Oncol. 2024;17(1):119.","journal-title":"J Hematol Oncol"},{"issue":"1","key":"1147_CR2","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1093\/carcin\/bgp263","volume":"31","author":"MJ Thun","year":"2010","unstructured":"Thun MJ, DeLancey JO, Center MM, Jemal A, Ward EM. The global burden of cancer: priorities for prevention. Carcinogenesis. 2010;31(1):100\u201310.","journal-title":"Carcinogenesis"},{"issue":"3","key":"1147_CR3","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer. J Clin. 2024;74(3):229\u201363.","journal-title":"J Clin"},{"key":"1147_CR4","first-page":"395","volume-title":"Public Health, Lifestyle, and Chemoprevention","author":"M Romani","year":"2019","unstructured":"Romani M, Banelli B, Epigenetics. Public Health, Lifestyle, and Chemoprevention. Epigenetics of cancer prevention: Elsevier; 2019. pp. 395\u2013418."},{"issue":"1","key":"1147_CR5","doi-asserted-by":"publisher","first-page":"23","DOI":"10.4048\/jbc.2013.16.1.23","volume":"16","author":"S Mirza","year":"2013","unstructured":"Mirza S, Sharma G, Parshad R, Gupta SD, Pandya P, Ralhan R. Expression of DNA methyltransferases in breast cancer patients and to analyze the effect of natural compounds on DNA methyltransferases and associated proteins. J breast cancer. 2013;16(1):23\u201331.","journal-title":"J breast cancer"},{"key":"1147_CR6","doi-asserted-by":"crossref","unstructured":"Pradhan N, Kar S, Parbin S, Sengupta D, Deb M, Das L et al. Epigenetic dietary interventions for prevention of cancer. Epigenetics of cancer prevention: Elsevier; 2019. pp. 23\u201348.","DOI":"10.1016\/B978-0-12-812494-9.00002-0"},{"key":"1147_CR7","doi-asserted-by":"crossref","unstructured":"Gu M, Ren B, Fang Y, Ren J, Liu X, Wang X et al. Epigenetic regulation in cancer. MedComm (2020). 2024;5(2):e495.","DOI":"10.1002\/mco2.495"},{"issue":"1","key":"1147_CR8","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.mito.2009.09.006","volume":"10","author":"DC Wallace","year":"2010","unstructured":"Wallace DC, Fan W. Energetics, epigenetics, mitochondrial genetics. Mitochondrion. 2010;10(1):12\u201331.","journal-title":"Mitochondrion"},{"key":"1147_CR9","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1007\/s40495-014-0003-9","volume":"1","author":"KJ Royston","year":"2015","unstructured":"Royston KJ, Tollefsbol TO. The epigenetic impact of cruciferous vegetables on cancer prevention. Curr Pharmacol Rep. 2015;1:46\u201351.","journal-title":"Curr Pharmacol Rep"},{"issue":"6","key":"1147_CR10","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1080\/01635581.2013.805794","volume":"65","author":"G Supic","year":"2013","unstructured":"Supic G, Jagodic M, Magic Z. Epigenetics: a new link between nutrition and cancer. Nutr Cancer. 2013;65(6):781\u201392.","journal-title":"Nutr Cancer"},{"key":"1147_CR11","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/B978-0-12-380866-0.60003-4","volume":"70","author":"C Sawan","year":"2010","unstructured":"Sawan C, Herceg Z. Histone modifications and cancer. Adv Genet. 2010;70:57\u201385.","journal-title":"Adv Genet"},{"issue":"1","key":"1147_CR12","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s13072-024-00558-2","volume":"17","author":"A Chera","year":"2024","unstructured":"Chera A, Stancu-Cretu M, Zabet NR, Bucur O. Shedding light on DNA methylation and its clinical implications: the impact of long-read-based nanopore technology. Epigenetics Chromatin. 2024;17(1):39.","journal-title":"Epigenetics Chromatin"},{"issue":"4","key":"1147_CR13","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1042\/EBC20180038","volume":"63","author":"S Minchin","year":"2019","unstructured":"Minchin S, Lodge J. Understanding biochemistry: structure and function of nucleic acids. Essays Biochem. 2019;63(4):433\u201356.","journal-title":"Essays Biochem"},{"key":"1147_CR14","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.pharmthera.2017.02.011","volume":"173","author":"S Biswas","year":"2017","unstructured":"Biswas S, Rao CM. Epigenetics in cancer: fundamentals and beyond. Pharmacol Ther. 2017;173:118\u201334.","journal-title":"Pharmacol Ther"},{"issue":"1","key":"1147_CR15","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s13072-015-0016-6","volume":"8","author":"A Breiling","year":"2015","unstructured":"Breiling A, Lyko F. Epigenetic regulatory functions of DNA modifications: 5-methylcytosine and beyond. Epigenetics Chromatin. 2015;8(1):24.","journal-title":"Epigenetics Chromatin"},{"issue":"9","key":"1147_CR16","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1039\/D2NP00086E","volume":"40","author":"YH Lee","year":"2023","unstructured":"Lee YH, Ren D, Jeon B, Liu HW. S-Adenosylmethionine: more than just a methyl donor. Nat Prod Rep. 2023;40(9):1521\u201349.","journal-title":"Nat Prod Rep"},{"key":"1147_CR17","doi-asserted-by":"publisher","unstructured":"Bekdash RA. Methyl donors, epigenetic alterations, and brain health: understanding the connection. Int J Mol Sci.2023;24(3):2346. https:\/\/doi.org\/10.3390\/ijms24032346","DOI":"10.3390\/ijms24032346"},{"issue":"8","key":"1147_CR18","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1038\/cr.2015.72","volume":"25","author":"W Qin","year":"2015","unstructured":"Qin W, Wolf P, Liu N, Link S, Smets M, Mastra FL, et al. DNA methylation requires a DNMT1 ubiquitin interacting motif (UIM) and histone ubiquitination. Cell Res. 2015;25(8):911\u201329.","journal-title":"Cell Res"},{"issue":"3","key":"1147_CR19","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1042\/BST20200695","volume":"49","author":"A Angeloni","year":"2021","unstructured":"Angeloni A, Bogdanovic O. Sequence determinants, function, and evolution of CpG islands. Biochem Soc Trans. 2021;49(3):1109\u201319.","journal-title":"Biochem Soc Trans"},{"issue":"6","key":"1147_CR20","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1177\/1947601910393957","volume":"2","author":"B Jin","year":"2011","unstructured":"Jin B, Li Y, Robertson KD. DNA methylation: superior or subordinate in the epigenetic hierarchy? Genes Cancer. 2011;2(6):607\u201317.","journal-title":"Genes Cancer"},{"issue":"8","key":"1147_CR21","doi-asserted-by":"publisher","first-page":"194567","DOI":"10.1016\/j.bbagrm.2020.194567","volume":"1863","author":"AL Hughes","year":"2020","unstructured":"Hughes AL, Kelley JR, Klose RJ. Understanding the interplay between CpG island-associated gene promoters and H3K4 methylation. Biochim Biophys Acta Gene Regul Mech. 2020;1863(8):194567.","journal-title":"Biochim Biophys Acta Gene Regul Mech"},{"issue":"35","key":"1147_CR22","doi-asserted-by":"publisher","first-page":"5427","DOI":"10.1038\/sj.onc.1205600","volume":"21","author":"M Esteller","year":"2002","unstructured":"Esteller M. CpG island hypermethylation and tumor suppressor genes: a booming present, a brighter future. Oncogene. 2002;21(35):5427\u201340.","journal-title":"Oncogene"},{"key":"1147_CR23","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/978-3-319-43624-1_7","volume":"945","author":"R Lakshminarasimhan","year":"2016","unstructured":"Lakshminarasimhan R, Liang G. The Role of DNA Methylation in Cancer. Adv Exp Med Biol. 2016;945:151\u201372.","journal-title":"Adv Exp Med Biol"},{"issue":"3","key":"1147_CR24","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1093\/carcin\/21.3.461","volume":"21","author":"KD Robertson","year":"2000","unstructured":"Robertson KD, Jones A. DNA methylation: past, present and future directions. Carcinogenesis. 2000;21(3):461\u20137.","journal-title":"Carcinogenesis"},{"issue":"2","key":"1147_CR25","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.jnutbio.2008.12.003","volume":"21","author":"WP Tsang","year":"2010","unstructured":"Tsang WP, Kwok TT. Epigallocatechin gallate up-regulation of miR-16 and induction of apoptosis in human cancer cells. J Nutr Biochem. 2010;21(2):140\u20136.","journal-title":"J Nutr Biochem"},{"issue":"3","key":"1147_CR26","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.jnutbio.2010.02.008","volume":"22","author":"C Boesch-Saadatmandi","year":"2011","unstructured":"Boesch-Saadatmandi C, Loboda A, Wagner AE, Stachurska A, Jozkowicz A, Dulak J, et al. Effect of quercetin and its metabolites isorhamnetin and quercetin-3-glucuronide on inflammatory gene expression: role of miR-155. J Nutr Biochem. 2011;22(3):293\u20139.","journal-title":"J Nutr Biochem"},{"key":"1147_CR27","doi-asserted-by":"publisher","unstructured":"Santos-Buelga C. Polyphenols and human beings: from epidemiology to molecular targets. Molecules.2021;26(14):4218. https:\/\/doi.org\/10.3390\/molecules26144218","DOI":"10.3390\/molecules26144218"},{"issue":"6","key":"1147_CR28","doi-asserted-by":"publisher","first-page":"100241","DOI":"10.1016\/j.advnut.2024.100241","volume":"15","author":"GM Chodur","year":"2024","unstructured":"Chodur GM, Steinberg FM. Human MicroRNAs Modulated by Diet: A Scoping Review. Adv Nutr. 2024;15(6):100241.","journal-title":"Adv Nutr"},{"issue":"1","key":"1147_CR29","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1038\/s41392-024-02030-9","volume":"9","author":"Y Chen","year":"2024","unstructured":"Chen Y, Liang R, Li Y, Jiang L, Ma D, Luo Q, et al. Chromatin accessibility: biological functions, molecular mechanisms and therapeutic application. Signal Transduct Target Therapy. 2024;9(1):340.","journal-title":"Signal Transduct Target Therapy"},{"issue":"20","key":"1147_CR30","doi-asserted-by":"publisher","first-page":"2914","DOI":"10.1016\/j.febslet.2015.05.016","volume":"589","author":"AR Cutter","year":"2015","unstructured":"Cutter AR, Hayes JJ. A brief review of nucleosome structure. FEBS Lett. 2015;589(20):2914\u201322.","journal-title":"FEBS Lett"},{"key":"1147_CR31","doi-asserted-by":"crossref","unstructured":"Shankar E, Gupta K, Gupta S. Dietary and lifestyle factors in epigenetic regulation of cancer. Epigenetics of cancer prevention: Elsevier; 2019. pp. 361\u2009\u2013\u200994.","DOI":"10.1016\/B978-0-12-812494-9.00017-2"},{"issue":"4","key":"1147_CR32","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.gendis.2018.06.003","volume":"5","author":"M Fardi","year":"2018","unstructured":"Fardi M, Solali S, Hagh MF. Epigenetic mechanisms as a new approach in cancer treatment: An updated review. Genes Dis. 2018;5(4):304\u201311.","journal-title":"Genes Dis"},{"issue":"4","key":"1147_CR33","doi-asserted-by":"publisher","first-page":"503","DOI":"10.2217\/epi.11.71","volume":"3","author":"TM Hardy","year":"2011","unstructured":"Hardy TM, Tollefsbol TO. Epigenetic diet: impact on the epigenome and cancer. Epigenomics. 2011;3(4):503\u201318.","journal-title":"Epigenomics"},{"key":"1147_CR34","doi-asserted-by":"publisher","first-page":"107813","DOI":"10.1016\/j.phrs.2025.107813","volume":"217","author":"X Wang","year":"2025","unstructured":"Wang X, Luo H. The roles of histone acetylation key enzymes HAT, HDAC and BET proteins in neuropathic pain: Selection of drug targets. Pharmacol Res. 2025;217:107813.","journal-title":"Pharmacol Res"},{"issue":"4","key":"1147_CR35","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s00425-024-04518-8","volume":"260","author":"Z Zhang","year":"2024","unstructured":"Zhang Z, Zeng Y, Hou J, Li L. Advances in understanding the roles of plant HAT and HDAC in non-histone protein acetylation and deacetylation. Planta. 2024;260(4):93.","journal-title":"Planta"},{"issue":"4","key":"1147_CR36","doi-asserted-by":"publisher","first-page":"a018713","DOI":"10.1101\/cshperspect.a018713","volume":"6","author":"E Seto","year":"2014","unstructured":"Seto E, Yoshida M. Erasers of histone acetylation: the histone deacetylase enzymes. Cold Spring Harb Perspect Biol. 2014;6(4):a018713.","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"1147_CR37","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.tifs.2020.06.004","volume":"102","author":"B \u00d6zyal\u00e7in","year":"2020","unstructured":"\u00d6zyal\u00e7in B, Sanlier N. The effect of diet components on cancer with epigenetic mechanisms. Trends Food Sci Technol. 2020;102:138\u201345.","journal-title":"Trends Food Sci Technol"},{"issue":"1","key":"1147_CR38","doi-asserted-by":"publisher","first-page":"255","DOI":"10.2174\/138920112798868601","volume":"13","author":"T MCM de Kok","year":"2012","unstructured":"MCM de Kok T, GJ van Breda S, Briede J. Genomics-based identification of molecular mechanisms behind the cancer preventive action of phytochemicals: potential and challenges. Curr Pharm Biotechnol. 2012;13(1):255\u201364.","journal-title":"Curr Pharm Biotechnol"},{"issue":"7","key":"1147_CR39","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1203\/pdr.0b013e3180457684","volume":"61","author":"JC Chuang","year":"2007","unstructured":"Chuang JC, Jones PA. Epigenetics and microRNAs. Pediatr Res. 2007;61(7):24\u20139.","journal-title":"Pediatr Res"},{"issue":"1","key":"1147_CR40","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1146\/annurev.genet.032608.103928","volume":"43","author":"EI Campos","year":"2009","unstructured":"Campos EI, Reinberg D. Histones: annotating chromatin. Annu Rev Genet. 2009;43(1):559\u201399.","journal-title":"Annu Rev Genet"},{"issue":"6648","key":"1147_CR41","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/38444","volume":"389","author":"K Luger","year":"1997","unstructured":"Luger K, M\u00e4der AW, Richmond RK, Sargent DF, Richmond TJ. Crystal structure of the nucleosome core particle at 2.8 \u00c5 resolution. Nature. 1997;389(6648):251\u201360.","journal-title":"Nature"},{"issue":"3","key":"1147_CR42","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/cr.2011.22","volume":"21","author":"AJ Bannister","year":"2011","unstructured":"Bannister AJ, Kouzarides T. Regulation of chromatin by histone modifications. Cell Res. 2011;21(3):381\u201395.","journal-title":"Cell Res"},{"issue":"1","key":"1147_CR43","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s13578-023-00953-4","volume":"13","author":"D Jiang","year":"2023","unstructured":"Jiang D, Li T, Guo C, Tang T-S, Liu H. Small molecule modulators of chromatin remodeling: from neurodevelopment to neurodegeneration. Cell Bioscience. 2023;13(1):10.","journal-title":"Cell Bioscience"},{"key":"1147_CR44","doi-asserted-by":"publisher","first-page":"103811","DOI":"10.1016\/j.dnarep.2025.103811","volume":"146","author":"L He","year":"2025","unstructured":"He L, Moon J, Cai C, Hao Y, Lee H, Kim W, et al. The interplay between chromatin remodeling and DNA double-strand break repair: Implications for cancer biology and therapeutics. DNA Repair. 2025;146:103811.","journal-title":"DNA Repair"},{"key":"1147_CR45","doi-asserted-by":"publisher","unstructured":"Morrison O, Thakur J. Molecular complexes at euchromatin, heterochromatin and centromeric chromatin. Int J Mol Sci.2021;22(13):6922. https:\/\/doi.org\/10.3390\/ijms22136922","DOI":"10.3390\/ijms22136922"},{"key":"1147_CR46","doi-asserted-by":"publisher","unstructured":"Minami K, Semeigazin A, Nakazato K, Maeshima K. Euchromatin and heterochromatin: implications for DNAaccessibility and transcription. J Mol Biol. 2026;438(1):169270. https:\/\/doi.org\/10.1016\/j.jmb.2025.169270","DOI":"10.1016\/j.jmb.2025.169270"},{"key":"1147_CR47","first-page":"79","volume":"364","author":"D Fratantonio","year":"2021","unstructured":"Fratantonio D, Virgili F, Benassi B. Diet and epigenetics: dietary effects on DNA methylation, histone remodeling and mRNA stability. Compr foodomics. 2021;364:79.","journal-title":"Compr foodomics"},{"key":"1147_CR48","doi-asserted-by":"publisher","unstructured":"Schrezenmeier J, Huntly BJP. Epigenetic dysregulation in acute myeloid leukemia. Semin Hematol. 2025;62(3):177-186. https:\/\/doi.org\/10.1053\/j.seminhematol.2025.06.003","DOI":"10.1053\/j.seminhematol.2025.06.003"},{"issue":"4","key":"1147_CR49","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1101\/gad.184341.111","volume":"26","author":"JJ Trowbridge","year":"2012","unstructured":"Trowbridge JJ, Sinha AU, Zhu N, Li M, Armstrong SA, Orkin SH. Haploinsufficiency of Dnmt1 impairs leukemia stem cell function through derepression of bivalent chromatin domains. Genes Dev. 2012;26(4):344\u20139.","journal-title":"Genes Dev"},{"issue":"21","key":"1147_CR50","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1182\/blood.V118.21.409.409","volume":"118","author":"H-A Hou","year":"2011","unstructured":"Hou H-A, Kuo Y-Y, Liu C-Y, Chou W-C, Lee MC, Chen C-Y, et al. DNMT3A mutations in acute myeloid leukemia-stability during disease evolution and the clinical implication. Blood. 2011;118(21):409.","journal-title":"Blood"},{"issue":"6","key":"1147_CR51","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1038\/leu.2011.382","volume":"26","author":"A Renneville","year":"2012","unstructured":"Renneville A, Boissel N, Nibourel O, Berthon C, Helevaut N, Gardin C, et al. Prognostic significance of DNA methyltransferase 3A mutations in cytogenetically normal acute myeloid leukemia: a study by the Acute Leukemia French Association. Leukemia. 2012;26(6):1247\u201354.","journal-title":"Leukemia"},{"key":"1147_CR52","doi-asserted-by":"publisher","unstructured":"Shiba N, Taki T, Park MJ, Shimada A, Sotomatsu M, Adachi S, Tawa A, Horibe K, Tsuchida M, Hanada R, Tsukimoto I,Arakawa H, Hayashi Y. DNMT3A mutations are rare in childhood acute myeloid leukaemia, myelodysplasticsyndromes and juvenile myelomonocytic leukaemia. Br J Haematol. 2012;156(3):413-414. https:\/\/doi.org\/10.1111\/j.1365-2141.2011.08879.x","DOI":"10.1111\/j.1365-2141.2011.08879.x"},{"key":"1147_CR53","doi-asserted-by":"publisher","first-page":"4306","DOI":"10.1182\/blood-2023-181060","volume":"142","author":"RE Ries","year":"2023","unstructured":"Ries RE, Ma X, Tregnago C, Alonzo TA, Wang J, Hylkema T, et al. DNMT3A Mutants Are Enriched in NPMc\u2009+\u2009AML and Associated with Adverse Outcome in Childhood AML. Blood. 2023;142:4306.","journal-title":"Blood"},{"issue":"8","key":"1147_CR54","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.3324\/haematol.2018.197848","volume":"104","author":"J Bond","year":"2019","unstructured":"Bond J, Touzart A, Lepr\u00eatre S, Graux C, Bargetzi M, Lhermitte L, et al. DNMT3A mutation is associated with increased age and adverse outcome in adult T-cell acute lymphoblastic leukemia. Haematologica. 2019;104(8):1617\u201325.","journal-title":"Haematologica"},{"issue":"1","key":"1147_CR55","doi-asserted-by":"publisher","first-page":"86","DOI":"10.3324\/haematol.2020.271619","volume":"107","author":"T Milan","year":"2022","unstructured":"Milan T, Celton M, Lagac\u00e9 K, Roques \u00c9, Safa-Tahar-Henni S, Bresson E, et al. Epigenetic changes in human model KMT2A leukemias highlight early events during leukemogenesis. Haematologica. 2022;107(1):86\u201399.","journal-title":"Haematologica"},{"issue":"1","key":"1147_CR56","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/leu.2009.202","volume":"24","author":"S Goyama","year":"2010","unstructured":"Goyama S, Nitta E, Yoshino T, Kako S, Watanabe-Okochi N, Shimabe M, et al. EVI-1 interacts with histone methyltransferases SUV39H1 and G9a for transcriptional repression and bone marrow immortalization. Leukemia. 2010;24(1):81\u20138.","journal-title":"Leukemia"},{"issue":"4","key":"1147_CR57","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1038\/onc.2009.361","volume":"29","author":"A Lakshmikuttyamma","year":"2010","unstructured":"Lakshmikuttyamma A, Scott S, DeCoteau J, Geyer C. Reexpression of epigenetically silenced AML tumor suppressor genes by SUV39H1 inhibition. Oncogene. 2010;29(4):576\u201388.","journal-title":"Oncogene"},{"issue":"10","key":"1147_CR58","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1101\/gad.512009","volume":"23","author":"H Boukarabila","year":"2009","unstructured":"Boukarabila H, Saurin AJ, Batsch\u00e9 E, Mossadegh N, van Lohuizen M, Otte AP, et al. The PRC1 Polycomb group complex interacts with PLZF\/RARA to mediate leukemic transformation. Genes Dev. 2009;23(10):1195\u2013206.","journal-title":"Genes Dev"},{"issue":"4","key":"1147_CR59","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1038\/leu.2011.264","volume":"26","author":"T Waldron","year":"2012","unstructured":"Waldron T, De Dominici M, Soliera AR, Audia A, Iacobucci I, Lonetti A, et al. c-Myb and its target Bmi1 are required for p190BCR\/ABL leukemogenesis in mouse and human cells. Leukemia. 2012;26(4):644\u201353.","journal-title":"Leukemia"},{"issue":"2","key":"1147_CR60","first-page":"494","volume":"119","author":"A Sengupta","year":"2012","unstructured":"Sengupta A, Ficker AM, Dunn SK, Madhu M, Cancelas JA. Bmi1 reprograms CML B-lymphoid progenitors to become B-ALL\u2013initiating cells. Blood. J Am Soc Hematol. 2012;119(2):494\u2013502.","journal-title":"J Am Soc Hematol"},{"issue":"7","key":"1147_CR61","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1038\/ncb1608","volume":"9","author":"GG Wang","year":"2007","unstructured":"Wang GG, Cai L, Pasillas MP, Kamps MP. NUP98\u2013NSD1 links H3K36 methylation to Hox-A gene activation and leukaemogenesis. Nat Cell Biol. 2007;9(7):804\u201312.","journal-title":"Nat Cell Biol"},{"issue":"1","key":"1147_CR62","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1002\/hon.2018","volume":"31","author":"N Grzasko","year":"2013","unstructured":"Grzasko N, Hus M, Pluta A, Jurczyszyn A, Walter-Croneck A, Morawska M, et al. Additional genetic abnormalities significantly worsen poor prognosis associated with 1q21 amplification in multiple myeloma patients. Hematol Oncol. 2013;31(1):41\u20138.","journal-title":"Hematol Oncol"},{"issue":"1","key":"1147_CR63","first-page":"211","volume":"117","author":"E Martinez-Garcia","year":"2011","unstructured":"Martinez-Garcia E, Popovic R, Min D-J, Sweet SM, Thomas PM, Zamdborg L, et al. The MMSET histone methyl transferase switches global histone methylation and alters gene expression in t (4; 14) multiple myeloma cells. Blood J Am Soc Hematol. 2011;117(1):211\u201320.","journal-title":"Blood J Am Soc Hematol"},{"issue":"6","key":"1147_CR64","first-page":"3145","volume":"111","author":"J Marango","year":"2008","unstructured":"Marango J, Shimoyama M, Nishio H, Meyer JA, Min D-J, Sirulnik A, et al. The MMSET protein is a histone methyltransferase with characteristics of a transcriptional corepressor. Blood J Am Soc Hematol. 2008;111(6):3145\u201354.","journal-title":"Blood J Am Soc Hematol"},{"issue":"10","key":"1147_CR65","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.4161\/epi.6.10.17200","volume":"6","author":"A P\u00e9rez-Perarnau","year":"2011","unstructured":"P\u00e9rez-Perarnau A, Coll-Mulet L, Rubio-Pati\u00f1o C, Iglesias-Serret D, Cosialls AM, Gonz\u00e1lez-Giron\u00e8s DM, et al. Analysis of apoptosis regulatory genes altered by histone deacetylase inhibitors in chronic lymphocytic leukemia cells. Epigenetics. 2011;6(10):1228\u201335.","journal-title":"Epigenetics"},{"issue":"5\u20136","key":"1147_CR66","first-page":"325","volume":"81","author":"J Wang","year":"2012","unstructured":"Wang J, Kafeel M, Avezbakiyev B, Chen C, Sun Y, Rathnasabapathy C, et al. Histone deacetylase in chronic lymphocytic leukemia. Oncology. 2012;81(5\u20136):325\u20139.","journal-title":"Oncology"},{"issue":"5","key":"1147_CR67","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1002\/path.1661","volume":"204","author":"M S\u00e1nchez-Beato","year":"2004","unstructured":"S\u00e1nchez-Beato M, S\u00e1nchez E, Garc\u00eda JF, P\u00e9rez\u2010Rosado A, Montoya MC, Fraga M, et al. Abnormal PcG protein expression in Hodgkin\u2019s lymphoma. Relation with E2F6 and NF\u03baB transcription factors. J Pathology: J Pathological Soc Great Br Irel. 2004;204(5):528\u201337.","journal-title":"J Pathology: J Pathological Soc Great Br Irel"},{"issue":"6","key":"1147_CR68","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/j.ccr.2010.11.015","volume":"18","author":"ME Figueroa","year":"2010","unstructured":"Figueroa ME, Abdel-Wahab O, Lu C, Ward PS, Patel J, Shih A, et al. Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation. Cancer Cell. 2010;18(6):553\u201367.","journal-title":"Cancer Cell"},{"issue":"4","key":"1147_CR69","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1016\/j.bbrc.2006.12.166","volume":"353","author":"M Negishi","year":"2007","unstructured":"Negishi M, Saraya A, Miyagi S, Nagao K, Inagaki Y, Nishikawa M, et al. Bmi1 cooperates with Dnmt1-associated protein 1 in gene silencing. Biochem Biophys Res Commun. 2007;353(4):992\u20138.","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"1147_CR70","doi-asserted-by":"publisher","first-page":"e39","DOI":"10.1371\/journal.pcbi.0030039","volume":"3","author":"E Eden","year":"2007","unstructured":"Eden E, Lipson D, Yogev S, Yakhini Z. Discovering motifs in ranked lists of DNA sequences. PLoS Comput Biol. 2007;3(3):e39.","journal-title":"PLoS Comput Biol"},{"key":"1147_CR71","doi-asserted-by":"crossref","unstructured":"Kuzmichev A, Margueron R, Vaquero A, Preissner TS, Scher M, Kirmizis A et al. Composition and histone substrates of polycomb repressive group complexes change during cellular differentiation. Proceedings of the National Academy of Sciences. 2005;102(6):1859-64.","DOI":"10.1073\/pnas.0409875102"},{"issue":"5","key":"1147_CR72","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1101\/gr.131169.111","volume":"22","author":"H Easwaran","year":"2012","unstructured":"Easwaran H, Johnstone SE, Van Neste L, Ohm J, Mosbruger T, Wang Q, et al. A DNA hypermethylation module for the stem\/progenitor cell signature of cancer. Genome Res. 2012;22(5):837\u201349.","journal-title":"Genome Res"},{"issue":"11","key":"1147_CR73","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1038\/nrc2736","volume":"9","author":"AP Bracken","year":"2009","unstructured":"Bracken AP, Helin K. Polycomb group proteins: navigators of lineage pathways led astray in cancer. Nat Rev Cancer. 2009;9(11):773\u201384.","journal-title":"Nat Rev Cancer"},{"issue":"4","key":"1147_CR74","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1002\/jcb.22461","volume":"109","author":"XM Wang","year":"2010","unstructured":"Wang XM, Greiner TC, Bibikova M, Pike BL, Siegmund KD, Sinha UK, et al. Identification and functional relevance of de novo DNA methylation in cancerous B-cell populations. J Cell Biochem. 2010;109(4):818\u201327.","journal-title":"J Cell Biochem"},{"key":"1147_CR75","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1476-4598-9-44","volume":"9","author":"T Dunwell","year":"2010","unstructured":"Dunwell T, Hesson L, Rauch TA, Wang L, Clark RE, Dallol A, et al. A genome-wide screen identifies frequently methylated genes in haematological and epithelial cancers. Mol Cancer. 2010;9:1\u201312.","journal-title":"Mol Cancer"},{"issue":"21","key":"1147_CR76","doi-asserted-by":"publisher","first-page":"2670","DOI":"10.1200\/JCO.2011.38.9429","volume":"30","author":"HM Kantarjian","year":"2012","unstructured":"Kantarjian HM, Thomas XG, Dmoszynska A, Wierzbowska A, Mazur G, Mayer J, et al. Multicenter, randomized, open-label, phase III trial of decitabine versus patient choice, with physician advice, of either supportive care or low-dose cytarabine for the treatment of older patients with newly diagnosed acute myeloid leukemia. J Clin Oncol. 2012;30(21):2670\u20137.","journal-title":"J Clin Oncol"},{"issue":"10","key":"1147_CR77","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1111\/j.1349-7006.2012.02386.x","volume":"103","author":"Y Oki","year":"2012","unstructured":"Oki Y, Kondo Y, Yamamoto K, Ogura M, Kasai M, Kobayashi Y, et al. Phase I\/II study of decitabine in patients with myelodysplastic syndrome: A multi-center study in J apan. Cancer Sci. 2012;103(10):1839\u201347.","journal-title":"Cancer Sci"},{"issue":"25","key":"1147_CR78","first-page":"4945","volume":"120","author":"MA Sekeres","year":"2012","unstructured":"Sekeres MA, Tiu RV, Komrokji R, Lancet J, Advani AS, Afable M, et al. Phase 2 study of the lenalidomide and azacitidine combination in patients with higher-risk myelodysplastic syndromes. Blood J Am Soc Hematol. 2012;120(25):4945\u201351.","journal-title":"Blood J Am Soc Hematol"},{"issue":"11","key":"1147_CR79","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1517\/17460441.2012.722618","volume":"7","author":"X Thomas","year":"2012","unstructured":"Thomas X. DNA methyltransferase inhibitors in acute myeloid leukemia: discovery, design and first therapeutic experiences. Expert Opin Drug Discov. 2012;7(11):1039\u201351.","journal-title":"Expert Opin Drug Discov"},{"issue":"3","key":"1147_CR80","doi-asserted-by":"publisher","first-page":"910","DOI":"10.3892\/ijo.2012.1546","volume":"41","author":"DY Shin","year":"2012","unstructured":"Shin DY, Park Y-S, Yang K, Kim G-Y, Kim W-J, Han MH, et al. Decitabine, a DNA methyltransferase inhibitor, induces apoptosis in human leukemia cells through intracellular reactive oxygen species generation. Int J Oncol. 2012;41(3):910\u20138.","journal-title":"Int J Oncol"},{"issue":"2","key":"1147_CR81","doi-asserted-by":"publisher","first-page":"321","DOI":"10.3109\/10428194.2012.713477","volume":"54","author":"PL Greenberg","year":"2013","unstructured":"Greenberg PL, Garcia-Manero G, Moore M, Damon L, Roboz G, Hu K, et al. A randomized controlled trial of romiplostim in patients with low-or intermediate-risk myelodysplastic syndrome receiving decitabine. Leuk Lymphoma. 2013;54(2):321\u20138.","journal-title":"Leuk Lymphoma"},{"issue":"6","key":"1147_CR82","doi-asserted-by":"publisher","first-page":"2579","DOI":"10.1182\/blood-2006-07-027326","volume":"109","author":"CR Isham","year":"2007","unstructured":"Isham CR, Tibodeau JD, Jin W, Xu R, Timm MM, Bible KC. Chaetocin: a promising new antimyeloma agent with in vitro and in vivo activity mediated via imposition of oxidative stress. Blood. 2007;109(6):2579\u201388.","journal-title":"Blood"},{"issue":"8","key":"1147_CR83","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1016\/j.leukres.2012.02.026","volume":"36","author":"B Hackanson","year":"2012","unstructured":"Hackanson B, Rimmele L, Benki\u00dfer M, Abdelkarim M, Fliegauf M, Jung M, et al. HDAC6 as a target for antileukemic drugs in acute myeloid leukemia. Leuk Res. 2012;36(8):1055\u201362.","journal-title":"Leuk Res"},{"issue":"22","key":"1147_CR84","first-page":"5201","volume":"119","author":"T Bhatla","year":"2012","unstructured":"Bhatla T, Wang J, Morrison DJ, Raetz EA, Burke MJ, Brown P, et al. Epigenetic reprogramming reverses the relapse-specific gene expression signature and restores chemosensitivity in childhood B-lymphoblastic leukemia. Blood J Am Soc Hematol. 2012;119(22):5201\u201310.","journal-title":"Blood J Am Soc Hematol"},{"issue":"10","key":"1147_CR85","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.1158\/1535-7163.MCT-11-0873","volume":"11","author":"SJ Cooper","year":"2012","unstructured":"Cooper SJ, Von Roemeling CA, Kang KH, Marlow LA, Grebe SK, Menefee ME, et al. Reexpression of tumor suppressor, sFRP1, leads to antitumor synergy of combined HDAC and methyltransferase inhibitors in chemoresistant cancers. Mol Cancer Ther. 2012;11(10):2105\u201315.","journal-title":"Mol Cancer Ther"},{"issue":"39","key":"1147_CR86","doi-asserted-by":"publisher","first-page":"9882","DOI":"10.1021\/jf302527p","volume":"60","author":"B Kim","year":"2012","unstructured":"Kim B, Kim S-H, Jeong S-J, Sohn EJ, Jung JH, Lee MH, et al. Brazilin induces apoptosis and G2\/M arrest via inactivation of histone deacetylase in multiple myeloma U266 cells. J Agric Food Chem. 2012;60(39):9882\u20139.","journal-title":"J Agric Food Chem"},{"issue":"20","key":"1147_CR87","first-page":"5550","volume":"118","author":"E Leich","year":"2011","unstructured":"Leich E, Zamo A, Horn H, Haralambieva E, Puppe B, Gascoyne RD, et al. MicroRNA profiles of t (14; 18)\u2013negative follicular lymphoma support a late germinal center B-cell phenotype. Blood J Am Soc Hematol. 2011;118(20):5550\u20138.","journal-title":"Blood J Am Soc Hematol"},{"issue":"6","key":"1147_CR88","doi-asserted-by":"publisher","first-page":"2623","DOI":"10.1158\/0008-5472.CAN-08-3114","volume":"69","author":"JM Friedman","year":"2009","unstructured":"Friedman JM, Liang G, Liu C-C, Wolff EM, Tsai YC, Ye W, et al. The putative tumor suppressor microRNA-101 modulates the cancer epigenome by repressing the polycomb group protein EZH2. Cancer Res. 2009;69(6):2623\u20139.","journal-title":"Cancer Res"},{"issue":"1","key":"1147_CR89","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.molcel.2009.08.008","volume":"36","author":"AH Juan","year":"2009","unstructured":"Juan AH, Kumar RM, Marx JG, Young RA, Sartorelli V. Mir-214-dependent regulation of the polycomb protein Ezh2 in skeletal muscle and embryonic stem cells. Mol Cell. 2009;36(1):61\u201374.","journal-title":"Mol Cell"},{"issue":"3","key":"1147_CR90","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1016\/j.cell.2009.07.011","volume":"138","author":"Y Shimono","year":"2009","unstructured":"Shimono Y, Zabala M, Cho RW, Lobo N, Dalerba P, Qian D, et al. Downregulation of miRNA-200c links breast cancer stem cells with normal stem cells. Cell. 2009;138(3):592\u2013603.","journal-title":"Cell"},{"issue":"25","key":"1147_CR91","first-page":"6411","volume":"113","author":"R Garzon","year":"2009","unstructured":"Garzon R, Liu S, Fabbri M, Liu Z, Heaphy CE, Callegari E, et al. MicroRNA-29b induces global DNA hypomethylation and tumor suppressor gene reexpression in acute myeloid leukemia by targeting directly DNMT3A and 3B and indirectly DNMT1. Blood. J Am Soc Hematol. 2009;113(25):6411\u20138.","journal-title":"J Am Soc Hematol"},{"issue":"3","key":"1147_CR92","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.cdp.2007.05.001","volume":"31","author":"JW Hill","year":"2007","unstructured":"Hill JW, Evans MK. A novel R229Q OGG1 polymorphism results in a thermolabile enzyme that sensitizes KG-1 leukemia cells to DNA damaging agents. Cancer Detect Prev. 2007;31(3):237\u201343.","journal-title":"Cancer Detect Prev"},{"issue":"2","key":"1147_CR93","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/S0304-3835(01)00499-2","volume":"169","author":"M Hattori","year":"2001","unstructured":"Hattori M, Sakamoto H, Satoh K, Yamamoto T. DNA demethylase is expressed in ovarian cancers and the expression correlates with demethylation of CpG sites in the promoter region of c-erbB-2 and survivin genes. Cancer Lett. 2001;169(2):155\u201364.","journal-title":"Cancer Lett"},{"issue":"13","key":"1147_CR94","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1038\/onc.2009.462","volume":"29","author":"K Liddiard","year":"2010","unstructured":"Liddiard K, Hills R, Burnett AK, Darley RL, Tonks A. OGG1 is a novel prognostic indicator in acute myeloid leukaemia. Oncogene. 2010;29(13):2005\u201312.","journal-title":"Oncogene"},{"key":"1147_CR95","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1007\/s11033-010-0127-x","volume":"38","author":"M Stanczyk","year":"2011","unstructured":"Stanczyk M, Sliwinski T, Cuchra M, Zubowska M, Bielecka-Kowalska A, Kowalski M, et al. The association of polymorphisms in DNA base excision repair genes XRCC1, OGG1 and MUTYH with the risk of childhood acute lymphoblastic leukemia. Mol Biol Rep. 2011;38:445\u201351.","journal-title":"Mol Biol Rep"},{"issue":"1","key":"1147_CR96","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/s41392-023-01342-6","volume":"8","author":"A Zhao","year":"2023","unstructured":"Zhao A, Zhou H, Yang J, Li M, Niu T. Epigenetic regulation in hematopoiesis and its implications in the targeted therapy of hematologic malignancies. Signal Transduct Target Therapy. 2023;8(1):71.","journal-title":"Signal Transduct Target Therapy"},{"issue":"1","key":"1147_CR97","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/s41392-023-01341-7","volume":"8","author":"N Wang","year":"2023","unstructured":"Wang N, Ma T, Yu B. Targeting epigenetic regulators to overcome drug resistance in cancers. Signal Transduct Target Therapy. 2023;8(1):69.","journal-title":"Signal Transduct Target Therapy"},{"key":"1147_CR98","doi-asserted-by":"publisher","unstructured":"Nwabo Kamdje AH, Dongmo Fogang HP, Mimche PN. Role of epigenetic in cancer biology, in hematologicmalignancies and in anticancer therapy. Front Mol Med. 2024;4:1426454. https:\/\/doi.org\/10.3389\/fmmed.2024.1426454","DOI":"10.3389\/fmmed.2024.1426454"},{"issue":"14","key":"1147_CR99","doi-asserted-by":"publisher","first-page":"2917","DOI":"10.1128\/MCB.00133-12","volume":"32","author":"J-Y Kim","year":"2012","unstructured":"Kim J-Y, Kim K-B, Eom GH, Choe N, Kee HJ, Son H-J, et al. KDM3B is the H3K9 demethylase involved in transcriptional activation of lmo2 in leukemia. Mol Cell Biol. 2012;32(14):2917\u201333.","journal-title":"Mol Cell Biol"},{"issue":"5","key":"1147_CR100","first-page":"1208","volume":"119","author":"J Score","year":"2012","unstructured":"Score J, Hidalgo-Curtis C, Jones AV, Winkelmann N, Skinner A, Ward D, et al. Inactivation of polycomb repressive complex 2 components in myeloproliferative and myelodysplastic\/myeloproliferative neoplasms. Blood J Am Soc Hematol. 2012;119(5):1208\u201313.","journal-title":"Blood J Am Soc Hematol"},{"issue":"8","key":"1147_CR101","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1111\/j.1349-7006.2008.00865.x","volume":"99","author":"T Katsumoto","year":"2008","unstructured":"Katsumoto T, Yoshida N, Kitabayashi I. Roles of the histone acetyltransferase monocytic leukemia zinc finger protein in normal and malignant hematopoiesis. Cancer Sci. 2008;99(8):1523\u20137.","journal-title":"Cancer Sci"},{"issue":"4","key":"1147_CR102","first-page":"822","volume":"120","author":"K Wolyniec","year":"2012","unstructured":"Wolyniec K, Shortt J, de Stanchina E, Levav-Cohen Y, Alsheich-Bartok O, Louria-Hayon I, et al. E6AP ubiquitin ligase regulates PML-induced senescence in Myc-driven lymphomagenesis. Blood J Am Soc Hematol. 2012;120(4):822\u201332.","journal-title":"Blood J Am Soc Hematol"},{"issue":"2","key":"1147_CR103","doi-asserted-by":"publisher","first-page":"188","DOI":"10.4161\/epi.6.2.13528","volume":"6","author":"S Fabris","year":"2011","unstructured":"Fabris S, Bollati V, Agnelli L, Morabito F, Motta V, Cutrona G, et al. Biological and clinical relevance of quantitative global methylation of repetitive DNA sequences in chronic lymphocytic leukemia. Epigenetics. 2011;6(2):188\u201394.","journal-title":"Epigenetics"},{"issue":"8","key":"1147_CR104","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1093\/carcin\/bgp149","volume":"30","author":"V Bollati","year":"2009","unstructured":"Bollati V, Fabris S, Pegoraro V, Ronchetti D, Mosca L, Deliliers GL, et al. Differential repetitive DNA methylation in multiple myeloma molecular subgroups. Carcinogenesis. 2009;30(8):1330\u20135.","journal-title":"Carcinogenesis"},{"issue":"1","key":"1147_CR105","doi-asserted-by":"publisher","first-page":"644","DOI":"10.3390\/ijms24010644","volume":"24","author":"OS Al-Odat","year":"2022","unstructured":"Al-Odat OS, Guirguis DA, Schmalbach NK, Yao G, Budak-Alpdogan T, Jonnalagadda SC, et al. Autophagy and apoptosis: current challenges of treatment and drug resistance in multiple myeloma. Int J Mol Sci. 2022;24(1):644.","journal-title":"Int J Mol Sci"},{"key":"1147_CR106","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1476-4598-8-42","volume":"8","author":"LB Hesson","year":"2009","unstructured":"Hesson LB, Dunwell TL, Cooper WN, Catchpoole D, Brini AT, Chiaramonte R, et al. The novel RASSF6 and RASSF10 candidate tumour suppressor genes are frequently epigenetically inactivated in childhood leukaemias. Mol Cancer. 2009;8:1\u201310.","journal-title":"Mol Cancer"},{"key":"1147_CR107","doi-asserted-by":"publisher","unstructured":"Sato T, Issa JPJ, Kropf P. DNA hypomethylating drugs in cancer therapy. Cold Spring Harb Perspect Med.2017;7(5):a026948. https:\/\/doi.org\/10.1101\/cshperspect.a026948","DOI":"10.1101\/cshperspect.a026948"},{"issue":"10","key":"1147_CR108","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1517\/14728222.12.10.1301","volume":"12","author":"BR Keppler","year":"2008","unstructured":"Keppler BR, Archer TK. Chromatin-modifying enzymes as therapeutic targets\u2013Part 1. Expert Opin Ther Targets. 2008;12(10):1301\u201312.","journal-title":"Expert Opin Ther Targets"},{"issue":"1\u20133","key":"1147_CR109","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.ejphar.2010.03.051","volume":"637","author":"W-F Hua","year":"2010","unstructured":"Hua W-F, Fu Y-S, Liao Y-J, Xia W-J, Chen Y-C, Zeng Y-X, et al. Curcumin induces down-regulation of EZH2 expression through the MAPK pathway in MDA-MB-435 human breast cancer cells. Eur J Pharmacol. 2010;637(1\u20133):16\u201321.","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"1147_CR110","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.abb.2007.05.006","volume":"464","author":"DE Edmondson","year":"2007","unstructured":"Edmondson DE, Binda C, Mattevi A. Structural insights into the mechanism of amine oxidation by monoamine oxidases A and B. Arch Biochem Biophys. 2007;464(2):269\u201376.","journal-title":"Arch Biochem Biophys"},{"issue":"9","key":"1147_CR111","doi-asserted-by":"publisher","first-page":"2039","DOI":"10.1038\/leu.2012.157","volume":"26","author":"A Spr\u00fcssel","year":"2012","unstructured":"Spr\u00fcssel A, Schulte J, Weber S, Necke M, H\u00e4ndschke K, Thor T, et al. Lysine-specific demethylase 1 restricts hematopoietic progenitor proliferation and is essential for terminal differentiation. Leukemia. 2012;26(9):2039\u201351.","journal-title":"Leukemia"},{"issue":"11","key":"1147_CR112","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.1093\/annonc\/mdf314","volume":"13","author":"J Goffin","year":"2002","unstructured":"Goffin J, Eisenhauer E. DNA methyltransferase inhibitors-state of the art. Ann Oncol. 2002;13(11):1699\u2013716.","journal-title":"Ann Oncol"},{"key":"1147_CR113","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.3389\/fonc.2020.01152","volume":"10","author":"S Romero-Garcia","year":"2020","unstructured":"Romero-Garcia S, Prado-Garcia H, Carlos-Reyes A. Role of DNA Methylation in the Resistance to Therapy in Solid Tumors. Front Oncol. 2020;10:1152.","journal-title":"Front Oncol"},{"issue":"1","key":"1147_CR114","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1038\/s41420-024-01803-z","volume":"10","author":"X Yu","year":"2024","unstructured":"Yu X, Zhao H, Wang R, Chen Y, Ouyang X, Li W, et al. Cancer epigenetics: from laboratory studies and clinical trials to precision medicine. Cell Death Discovery. 2024;10(1):28.","journal-title":"Cell Death Discovery"},{"key":"1147_CR115","doi-asserted-by":"publisher","unstructured":"Rossi A, Zacchi F, Reni A, Rota M, Palmerio S, Menis J, Zivi A, Milleri S, Milella M. Progresses and pitfalls of epigeneticsin solid tumors clinical trials. Int J Mol Sci. 2024;25(21):11740. https:\/\/doi.org\/10.3390\/ijms252111740","DOI":"10.3390\/ijms252111740"},{"issue":"1","key":"1147_CR116","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1038\/s41698-025-01003-7","volume":"9","author":"HE Marei","year":"2025","unstructured":"Marei HE. Epigenetic regulators in cancer therapy and progression. NPJ Precis Oncol. 2025;9(1):206.","journal-title":"NPJ Precis Oncol"},{"issue":"1","key":"1147_CR117","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1097\/01.cco.0000147383.04709.10","volume":"17","author":"M Esteller","year":"2005","unstructured":"Esteller M. DNA methylation and cancer therapy: new developments and expectations. Curr Opin Oncol. 2005;17(1):55\u201360.","journal-title":"Curr Opin Oncol"},{"issue":"5","key":"1147_CR118","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1053\/j.seminoncol.2005.07.003","volume":"32","author":"M Toyota","year":"2005","unstructured":"Toyota M, Issa JP. Epigenetic changes in solid and hematopoietic tumors. Semin Oncol. 2005;32(5):521\u201330.","journal-title":"Semin Oncol"},{"issue":"1","key":"1147_CR119","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s40164-026-00760-w","volume":"15","author":"Y Zhu","year":"2026","unstructured":"Zhu Y, Liu K, Zhu H. Targeting epigenetic methylation: emerging diagnosis and therapeutic strategies in cancer. Exp Hematol Oncol. 2026;15(1):27.","journal-title":"Exp Hematol Oncol"},{"key":"1147_CR120","doi-asserted-by":"publisher","unstructured":"Fu M, Deng F, Chen J, Fu L, Lei J, Xu T, Chen Y, Zhou J, Gao Q, Ding H. Current data and future perspectives on DNAmethylation in ovarian cancer: review. Int J Oncol. 2024;64(6):62. https:\/\/doi.org\/10.3892\/ijo.2024.5650","DOI":"10.3892\/ijo.2024.5650"},{"issue":"15","key":"1147_CR121","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1080\/17501911.2025.2548755","volume":"17","author":"S Williams","year":"2025","unstructured":"Williams S, Clark SJ, Pidsley R, Stirzaker C. DNA methylation biomarkers for the diagnosis and treatment management of breast cancer: where are we now? Epigenomics. 2025;17(15):1107\u201322.","journal-title":"Epigenomics"},{"issue":"2","key":"1147_CR122","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/s13148-011-0032-8","volume":"2","author":"N Kitkumthorn","year":"2011","unstructured":"Kitkumthorn N, Mutirangura A. Long interspersed nuclear element-1 hypomethylation in cancer: biology and clinical applications. Clin Epigenetics. 2011;2(2):315\u201330.","journal-title":"Clin Epigenetics"},{"key":"1147_CR123","doi-asserted-by":"publisher","unstructured":"Mendez-Dorantes C, Zeng X, Karlow JA, Schofi eld P, Turner S, Kalinowski J, Denisko D, Lee EA, Burns KH, Zhang CZ.Chromosomal rearrangements and instability caused by the LINE-1 retrotransposon. bioRxiv.2024:2024.12.14.628481. https:\/\/doi.org\/10.1101\/2024.12.14.628481","DOI":"10.1101\/2024.12.14.628481"},{"issue":"1","key":"1147_CR124","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1186\/s12964-025-02343-4","volume":"23","author":"DPW Arachchillage","year":"2025","unstructured":"Arachchillage DPW, Udomsinprasert W. Long interspersed nuclear element 1 methylation in non-small cell lung cancer: implications for diagnosis, prognosis, and therapeutic targeting. Cell Commun Signal. 2025;23(1):350.","journal-title":"Cell Commun Signal"},{"issue":"7","key":"1147_CR125","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1080\/17501911.2025.2476380","volume":"17","author":"A Reyila","year":"2025","unstructured":"Reyila A, Gao X, Yu J, Nie Y. Insight into the role of DNA methylation in prognosis and treatment response prediction of gastrointestinal cancers. Epigenomics. 2025;17(7):475\u201388.","journal-title":"Epigenomics"},{"key":"1147_CR126","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.semcancer.2019.09.018","volume":"61","author":"RM Chabanon","year":"2020","unstructured":"Chabanon RM, Morel D, Postel-Vinay S. Exploiting epigenetic vulnerabilities in solid tumors: Novel therapeutic opportunities in the treatment of SWI\/SNF-defective cancers. Semin Cancer Biol. 2020;61:180\u201398.","journal-title":"Semin Cancer Biol"},{"issue":"2","key":"1147_CR127","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1093\/annonc\/mdw552","volume":"28","author":"D Morel","year":"2017","unstructured":"Morel D, Almouzni G, Soria JC, Postel-Vinay S. Targeting chromatin defects in selected solid tumors based on oncogene addiction, synthetic lethality and epigenetic antagonism. Ann Oncol. 2017;28(2):254\u201369.","journal-title":"Ann Oncol"},{"issue":"24","key":"1147_CR128","doi-asserted-by":"publisher","first-page":"5449","DOI":"10.1158\/0008-5472.CAN-20-2147","volume":"80","author":"ML Eich","year":"2020","unstructured":"Eich ML, Athar M, Ferguson JE 3rd, Varambally S. EZH2-Targeted Therapies in Cancer: Hype or a Reality. Cancer Res. 2020;80(24):5449\u201358.","journal-title":"Cancer Res"},{"issue":"3","key":"1147_CR129","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1002\/ajmg.c.31410","volume":"166c","author":"JA Biegel","year":"2014","unstructured":"Biegel JA, Busse TM, Weissman BE. SWI\/SNF chromatin remodeling complexes and cancer. Am J Med Genet C Semin Med Genet. 2014;166c(3):350\u201366.","journal-title":"Am J Med Genet C Semin Med Genet"},{"issue":"1","key":"1147_CR130","doi-asserted-by":"publisher","first-page":"88","DOI":"10.21873\/cgp.20432","volume":"21","author":"C Hozumi","year":"2024","unstructured":"Hozumi C, Iizuka A, Ikeya T, Miyata H, Maeda C, Ashizawa T, et al. Impact of Mutations in Subunit Genes of the Mammalian SWI\/SNF Complex on Immunological Tumor Microenvironment. Cancer Genomics Proteom. 2024;21(1):88\u2013101.","journal-title":"Cancer Genomics Proteom"},{"key":"1147_CR131","doi-asserted-by":"publisher","first-page":"1136248","DOI":"10.3389\/fonc.2023.1136248","volume":"13","author":"B Fontana","year":"2023","unstructured":"Fontana B, Gallerani G, Salamon I, Pace I, Roncarati R, Ferracin M. ARID1A in cancer: Friend or foe? Front Oncol. 2023;13:1136248.","journal-title":"Front Oncol"},{"issue":"11","key":"1147_CR132","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1016\/S1470-2045(20)30451-4","volume":"21","author":"M Gounder","year":"2020","unstructured":"Gounder M, Sch\u00f6ffski P, Jones RL, Agulnik M, Cote GM, Villalobos VM, et al. Tazemetostat in advanced epithelioid sarcoma with loss of INI1\/SMARCB1: an international, open-label, phase 2 basket study. Lancet Oncol. 2020;21(11):1423\u201332.","journal-title":"Lancet Oncol"},{"issue":"1","key":"1147_CR133","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1080\/17501911.2024.2430169","volume":"17","author":"R Vatapalli","year":"2025","unstructured":"Vatapalli R, Rossi AP, Chan HM, Zhang J. Cancer epigenetic therapy: recent advances, challenges, and emerging opportunities. Epigenomics. 2025;17(1):59\u201374.","journal-title":"Epigenomics"},{"issue":"7534","key":"1147_CR134","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/nature14192","volume":"517","author":"D Sch\u00fcbeler","year":"2015","unstructured":"Sch\u00fcbeler D. Function and information content of DNA methylation. Nature. 2015;517(7534):321\u20136.","journal-title":"Nature"},{"issue":"1","key":"1147_CR135","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/S0006-291X(83)80115-6","volume":"111","author":"AP Feinberg","year":"1983","unstructured":"Feinberg AP, Vogelstein B. Hypomethylation of ras oncogenes in primary human cancers. Biochem Biophys Res Commun. 1983;111(1):47\u201354.","journal-title":"Biochem Biophys Res Commun"},{"issue":"21","key":"1147_CR136","doi-asserted-by":"publisher","first-page":"2042","DOI":"10.1056\/NEJMra023075","volume":"349","author":"JG Herman","year":"2003","unstructured":"Herman JG, Baylin SB. Gene silencing in cancer in association with promoter hypermethylation. N Engl J Med. 2003;349(21):2042\u201354.","journal-title":"N Engl J Med"},{"issue":"16","key":"1147_CR137","first-page":"4346","volume":"60","author":"SJ Nass","year":"2000","unstructured":"Nass SJ, Herman JG, Gabrielson E, Iversen PW, Parl FF, Davidson NE, et al. Aberrant methylation of the estrogen receptor and E-cadherin 5\u2032 CpG islands increases with malignant progression in human breast cancer. Cancer Res. 2000;60(16):4346\u20138.","journal-title":"Cancer Res"},{"issue":"4","key":"1147_CR138","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1038\/s41556-020-0491-2","volume":"22","author":"J Nishida","year":"2020","unstructured":"Nishida J, Momoi Y, Miyakuni K, Tamura Y, Takahashi K, Koinuma D, et al. Epigenetic remodelling shapes inflammatory renal cancer and neutrophil-dependent metastasis. Nat Cell Biol. 2020;22(4):465\u201375.","journal-title":"Nat Cell Biol"},{"key":"1147_CR139","doi-asserted-by":"crossref","unstructured":"Chatterjee A, Rodger EJ, Eccles MR, editors. Epigenetic drivers of tumourigenesis and cancer metastasis. Seminars in cancer biology. Elsevier; 2018.","DOI":"10.1016\/j.semcancer.2017.08.004"},{"issue":"1","key":"1147_CR140","doi-asserted-by":"publisher","first-page":"4627","DOI":"10.1038\/s41467-018-06715-y","volume":"9","author":"JI Orozco","year":"2018","unstructured":"Orozco JI, Knijnenburg TA, Manughian-Peter AO, Salomon MP, Barkhoudarian G, Jalas JR, et al. Epigenetic profiling for the molecular classification of metastatic brain tumors. Nat Commun. 2018;9(1):4627.","journal-title":"Nat Commun"},{"issue":"1","key":"1147_CR141","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.cell.2018.11.046","volume":"176","author":"S Gkountela","year":"2019","unstructured":"Gkountela S, Castro-Giner F, Szczerba BM, Vetter M, Landin J, Scherrer R, et al. Circulating tumor cell clustering shapes DNA methylation to enable metastasis seeding. Cell. 2019;176(1):98\u2013112. e14.","journal-title":"Cell"},{"issue":"4","key":"1147_CR142","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.1172\/JCI130887","volume":"130","author":"A Wu","year":"2020","unstructured":"Wu A, Cremaschi P, Wetterskog D, Conteduca V, Franceschini GM, Kleftogiannis D, et al. Genome-wide plasma DNA methylation features of metastatic prostate cancer. J Clin Investig. 2020;130(4):1991\u20132000.","journal-title":"J Clin Investig"},{"key":"1147_CR143","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/2045-3701-4-45","volume":"4","author":"E Baxter","year":"2014","unstructured":"Baxter E, Windloch K, Gannon F, Lee JS. Epigenetic regulation in cancer progression. Cell bioscience. 2014;4:1\u201311.","journal-title":"Cell bioscience"},{"issue":"12","key":"1147_CR144","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1038\/nrc2540","volume":"8","author":"JA Bertout","year":"2008","unstructured":"Bertout JA, Patel SA, Simon MC. The impact of O2 availability on human cancer. Nat Rev Cancer. 2008;8(12):967\u201375.","journal-title":"Nat Rev Cancer"},{"issue":"2","key":"1147_CR145","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.bbrc.2008.03.056","volume":"370","author":"DR Borger","year":"2008","unstructured":"Borger DR, Gavrilescu LC, Bucur MC, Ivan M, DeCaprio JA. AMP-activated protein kinase is essential for survival in chronic hypoxia. Biochem Biophys Res Commun. 2008;370(2):230\u20134.","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"1147_CR146","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.cell.2007.01.047","volume":"129","author":"R Fukuda","year":"2007","unstructured":"Fukuda R, Zhang H, Kim J-w, Shimoda L, Dang CV, Semenza GL. HIF-1 regulates cytochrome oxidase subunits to optimize efficiency of respiration in hypoxic cells. Cell. 2007;129(1):111\u201322.","journal-title":"Cell"},{"issue":"1","key":"1147_CR147","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.gde.2009.10.009","volume":"20","author":"GL Semenza","year":"2010","unstructured":"Semenza GL. HIF-1: upstream and downstream of cancer metabolism. Curr Opin Genet Dev. 2010;20(1):51\u20136.","journal-title":"Curr Opin Genet Dev"},{"issue":"1","key":"1147_CR148","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/nrc704","volume":"2","author":"AL Harris","year":"2002","unstructured":"Harris AL. Hypoxia\u2014a key regulatory factor in tumour growth. Nat Rev Cancer. 2002;2(1):38\u201347.","journal-title":"Nat Rev Cancer"},{"issue":"2","key":"1147_CR149","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.molcel.2010.09.022","volume":"40","author":"AJ Majmundar","year":"2010","unstructured":"Majmundar AJ, Wong WJ, Simon MC. Hypoxia-inducible factors and the response to hypoxic stress. Mol Cell. 2010;40(2):294\u2013309.","journal-title":"Mol Cell"},{"key":"1147_CR150","doi-asserted-by":"crossref","unstructured":"Ema M, Taya S, Yokotani N, Sogawa K, Matsuda Y, Fujii-Kuriyama Y. A novel bHLH-PAS factor with close sequence similarity to hypoxia-inducible factor 1\u03b1 regulates the VEGF expression and is potentially involved in lung and vascular development. Proceedings of the National Academy of Sciences. 1997;94(9):4273-8.","DOI":"10.1073\/pnas.94.9.4273"},{"key":"1147_CR151","doi-asserted-by":"crossref","unstructured":"Semenza GL, Wang GL. A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation. Molecular and cellular biology. 1992.","DOI":"10.1128\/mcb.12.12.5447-5454.1992"},{"issue":"4","key":"1147_CR152","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1172\/JCI57349","volume":"122","author":"C Dong","year":"2012","unstructured":"Dong C, Wu Y, Yao J, Wang Y, Yu Y, Rychahou PG, et al. G9a interacts with Snail and is critical for Snail-mediated E-cadherin repression in human breast cancer. J Clin Investig. 2012;122(4):1469\u201386.","journal-title":"J Clin Investig"},{"issue":"36","key":"1147_CR153","doi-asserted-by":"publisher","first-page":"22642","DOI":"10.1074\/jbc.272.36.22642","volume":"272","author":"S Salceda","year":"1997","unstructured":"Salceda S, Caro J. Hypoxia-inducible factor 1\u03b1 (HIF-1\u03b1) protein is rapidly degraded by the ubiquitin-proteasome system under normoxic conditions: its stabilization by hypoxia depends on redox-induced changes. J Biol Chem. 1997;272(36):22642\u20137.","journal-title":"J Biol Chem"},{"key":"1147_CR154","doi-asserted-by":"publisher","unstructured":"Magar AG, Morya VK, Kwak MK, Oh JU, Noh KC. A molecular perspective on HIF-1\u03b1 and angiogenic stimulatornetworks and their role in solid tumors: an update. Int J Mol Sci. 2024;25(6):3313. https:\/\/doi.org\/10.3390\/ijms25063313","DOI":"10.3390\/ijms25063313"},{"issue":"6","key":"1147_CR155","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1038\/sj.onc.1209842","volume":"26","author":"S Ivanov","year":"2007","unstructured":"Ivanov S, Salnikow K, Ivanova A, Bai L, Lerman M. Hypoxic repression of STAT1 and its downstream genes by a pVHL\/HIF-1 target DEC1\/STRA13. Oncogene. 2007;26(6):802\u201312.","journal-title":"Oncogene"},{"issue":"18","key":"1147_CR156","doi-asserted-by":"publisher","first-page":"9009","DOI":"10.1158\/0008-5472.CAN-06-0101","volume":"66","author":"H Chen","year":"2006","unstructured":"Chen H, Yan Y, Davidson TL, Shinkai Y, Costa M. Hypoxic stress induces dimethylated histone H3 lysine 9 through histone methyltransferase G9a in mammalian cells. Cancer Res. 2006;66(18):9009\u201316.","journal-title":"Cancer Res"},{"issue":"2","key":"1147_CR157","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1038\/onc.2008.377","volume":"28","author":"S Lee","year":"2009","unstructured":"Lee S, Kim J, Kim W, Lee Y. Hypoxic silencing of tumor suppressor RUNX3 by histone modification in gastric cancer cells. Oncogene. 2009;28(2):184\u201394.","journal-title":"Oncogene"},{"key":"1147_CR158","doi-asserted-by":"crossref","unstructured":"Lee JS, Kim Y, Bhin J, Shin H-JR, Nam HJ, Lee SH et al. Hypoxia-induced methylation of a pontin chromatin remodeling factor. Proceedings of the National Academy of Sciences. 2011;108(33):13510-5.","DOI":"10.1073\/pnas.1106106108"},{"issue":"1","key":"1147_CR159","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.molcel.2010.06.008","volume":"39","author":"JS Lee","year":"2010","unstructured":"Lee JS, Kim Y, Kim IS, Kim B, Choi HJ, Lee JM, et al. Negative regulation of hypoxic responses via induced Reptin methylation. Mol Cell. 2010;39(1):71\u201385.","journal-title":"Mol Cell"},{"issue":"4","key":"1147_CR160","doi-asserted-by":"publisher","first-page":"e19229","DOI":"10.1371\/journal.pone.0019229","volume":"6","author":"Z Wang","year":"2011","unstructured":"Wang Z, Yang D, Zhang X, Li T, Li J, Tang Y, et al. Hypoxia-induced down-regulation of neprilysin by histone modification in mouse primary cortical and hippocampal neurons. PLoS ONE. 2011;6(4):e19229.","journal-title":"PLoS ONE"},{"issue":"32","key":"1147_CR161","doi-asserted-by":"publisher","first-page":"22306","DOI":"10.1074\/jbc.M114.567032","volume":"289","author":"S Shukla","year":"2014","unstructured":"Shukla S, Patric IRP, Patil V, Shwetha SD, Hegde AS, Chandramouli BA, et al. Methylation silencing of ULK2, an autophagy gene, is essential for astrocyte transformation and tumor growth. J Biol Chem. 2014;289(32):22306\u201318.","journal-title":"J Biol Chem"},{"issue":"5","key":"1147_CR162","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1080\/15548627.2017.1314897","volume":"14","author":"J Yamaguchi","year":"2018","unstructured":"Yamaguchi J, Suzuki C, Nanao T, Kakuta S, Ozawa K, Tanida I, et al. Atg9a deficiency causes axon-specific lesions including neuronal circuit dysgenesis. Autophagy. 2018;14(5):764\u201377.","journal-title":"Autophagy"},{"issue":"2","key":"1147_CR163","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.gene.2016.05.036","volume":"590","author":"X Zhang","year":"2016","unstructured":"Zhang X, Li C, Wang D, Chen Q, Li C-L, Li H-J. Aberrant methylation of ATG2B, ATG4D, ATG9A and ATG9B CpG island promoter is associated with decreased mRNA expression in sporadic breast carcinoma. Gene. 2016;590(2):285\u201392.","journal-title":"Gene"},{"issue":"52","key":"1147_CR164","doi-asserted-by":"publisher","first-page":"37298","DOI":"10.1074\/jbc.C700195200","volume":"282","author":"T Hanada","year":"2007","unstructured":"Hanada T, Noda NN, Satomi Y, Ichimura Y, Fujioka Y, Takao T, et al. The Atg12-Atg5 conjugate has a novel E3-like activity for protein lipidation in autophagy. J Biol Chem. 2007;282(52):37298\u2013302.","journal-title":"J Biol Chem"},{"issue":"202","key":"1147_CR165","doi-asserted-by":"publisher","first-page":"ra202123","DOI":"10.1126\/scitranslmed.3005864","volume":"5","author":"H Liu","year":"2013","unstructured":"Liu H, He Z, von Ruette T, Yousefi S, Hunger RE, Simon H-U. Down-regulation of autophagy-related protein 5 (ATG5) contributes to the pathogenesis of early-stage cutaneous melanoma. Sci Transl Med. 2013;5(202):ra202123\u2013202123.","journal-title":"Sci Transl Med"},{"issue":"3","key":"1147_CR166","first-page":"1301","volume":"53","author":"C-L Wu","year":"2018","unstructured":"Wu C-L, Zhang SM, Lin L, Gao S-S, Fu K-F, Liu X-D, et al. BECN1-knockout impairs tumor growth, migration and invasion by suppressing the cell cycle and partially suppressing the epithelial-mesenchymal transition of human triple-negative breast cancer cells. Int J Oncol. 2018;53(3):1301\u201312.","journal-title":"Int J Oncol"},{"key":"1147_CR167","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2407-10-98","volume":"10","author":"Z Li","year":"2010","unstructured":"Li Z, Chen B, Wu Y, Jin F, Xia Y, Liu X. Genetic and epigenetic silencing of the beclin 1 gene in sporadic breast tumors. BMC Cancer. 2010;10:1\u201312.","journal-title":"BMC Cancer"},{"issue":"10","key":"1147_CR168","doi-asserted-by":"publisher","first-page":"2272","DOI":"10.1002\/ijc.30657","volume":"140","author":"JS Muhammad","year":"2017","unstructured":"Muhammad JS, Nanjo S, Ando T, Yamashita S, Maekita T, Ushijima T, et al. Autophagy impairment by H elicobacter pylori-induced methylation silencing of MAP1LC3Av1 promotes gastric carcinogenesis. Int J Cancer. 2017;140(10):2272\u201383.","journal-title":"Int J Cancer"},{"issue":"1","key":"1147_CR169","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1002\/path.4093","volume":"229","author":"X Hu","year":"2013","unstructured":"Hu X, Sui X, Li L, Huang X, Rong R, Su X, et al. Protocadherin 17 acts as a tumour suppressor inducing tumour cell apoptosis and autophagy, and is frequently methylated in gastric and colorectal cancers. J Pathol. 2013;229(1):62\u201373.","journal-title":"J Pathol"},{"issue":"32","key":"1147_CR170","doi-asserted-by":"publisher","first-page":"52960","DOI":"10.18632\/oncotarget.17674","volume":"8","author":"Y Peng","year":"2017","unstructured":"Peng Y, Cao J, Yao X-Y, Wang J-X, Zhong M-Z, Gan P-P, et al. TUSC3 induces autophagy in human non-small cell lung cancer cells through Wnt\/\u03b2-catenin signaling. Oncotarget. 2017;8(32):52960.","journal-title":"Oncotarget"},{"key":"1147_CR171","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/S0076-6879(05)07037-0","volume":"407","author":"Y Yu","year":"2006","unstructured":"Yu Y, Luo R, Lu Z, Feng WW, Badgwell D, Issa JP, et al. Biochemistry and biology of ARHI (DIRAS3), an imprinted tumor suppressor gene whose expression is lost in ovarian and breast cancers. Methods Enzymol. 2006;407:455\u201368.","journal-title":"Methods Enzymol"},{"issue":"23","key":"1147_CR172","doi-asserted-by":"publisher","first-page":"19685","DOI":"10.18632\/oncotarget.4081","volume":"6","author":"H-c Zheng","year":"2015","unstructured":"Zheng H-c, Li J, Shen D-f, Yang X-f, Zhao S, Wu Y-z, et al. BTG1 expression correlates with pathogenesis, aggressive behaviors and prognosis of gastric cancer: a potential target for gene therapy. Oncotarget. 2015;6(23):19685.","journal-title":"Oncotarget"},{"issue":"23","key":"1147_CR173","doi-asserted-by":"publisher","first-page":"19841","DOI":"10.18632\/oncotarget.3734","volume":"6","author":"W-f Gou","year":"2015","unstructured":"Gou W-f, Yang X-f, Shen D-f, Zhao S, Liu Y-p, Sun H-z, et al. The roles of BTG3 expression in gastric cancer: a potential marker for carcinogenesis and a target molecule for gene therapy. Oncotarget. 2015;6(23):19841.","journal-title":"Oncotarget"},{"issue":"5","key":"1147_CR174","doi-asserted-by":"publisher","first-page":"7502","DOI":"10.18632\/oncotarget.10649","volume":"8","author":"S Zhao","year":"2016","unstructured":"Zhao S, Chen S-r, Yang X-f, Shen D-f, Takano Y, Su R-j, et al. BTG1 might be employed as a biomarker for carcinogenesis and a target for gene therapy in colorectal cancers. Oncotarget. 2016;8(5):7502.","journal-title":"Oncotarget"},{"key":"1147_CR175","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.canlet.2017.02.030","volume":"395","author":"X Liu","year":"2017","unstructured":"Liu X, Hu X, Kuang Y, Yan P, Li L, Li C, et al. BCLB, methylated in hepatocellular carcinoma, is a starvation stress sensor that induces apoptosis and autophagy through the AMPK-mTOR signaling cascade. Cancer Lett. 2017;395:63\u201371.","journal-title":"Cancer Lett"},{"key":"1147_CR176","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/s12079-017-0418-2","volume":"12","author":"B Chen","year":"2018","unstructured":"Chen B, Zeng C, Ye Y, Wu D, Mu Z, Liu J, et al. Promoter methylation of TCF21 may repress autophagy in the progression of lung cancer. J cell communication Signal. 2018;12:423\u201332.","journal-title":"J cell communication Signal"},{"issue":"8","key":"1147_CR177","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1038\/s41389-018-0064-4","volume":"7","author":"JH Shin","year":"2018","unstructured":"Shin JH, Park CW, Yoon G, Hong SM, Choi KY. NNMT depletion contributes to liver cancer cell survival by enhancing autophagy under nutrient starvation. Oncogenesis. 2018;7(8):58.","journal-title":"Oncogenesis"},{"issue":"1","key":"1147_CR178","doi-asserted-by":"publisher","first-page":"e458","DOI":"10.1038\/cddis.2012.197","volume":"4","author":"N Syed","year":"2013","unstructured":"Syed N, Langer J, Janczar K, Singh P, Lo Nigro C, Lattanzio L, et al. Epigenetic status of argininosuccinate synthetase and argininosuccinate lyase modulates autophagy and cell death in glioblastoma. Cell Death Dis. 2013;4(1):e458\u2013e.","journal-title":"Cell Death Dis"},{"issue":"2","key":"1147_CR179","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1002\/path.4354","volume":"234","author":"K Nihira","year":"2014","unstructured":"Nihira K, Miki Y, Iida S, Narumi S, Ono K, Iwabuchi E, et al. An activation of LC3A-mediated autophagy contributes to de novo and acquired resistance to EGFR tyrosine kinase inhibitors in lung adenocarcinoma. J Pathol. 2014;234(2):277\u201388.","journal-title":"J Pathol"},{"issue":"7","key":"1147_CR180","doi-asserted-by":"publisher","first-page":"1894","DOI":"10.1093\/hmg\/ddt583","volume":"23","author":"Y-P Liao","year":"2014","unstructured":"Liao Y-P, Chen L-Y, Huang R-L, Su P-H, Chan MW, Chang C-C, et al. Hypomethylation signature of tumor-initiating cells predicts poor prognosis of ovarian cancer patients. Hum Mol Genet. 2014;23(7):1894\u2013906.","journal-title":"Hum Mol Genet"},{"issue":"9","key":"1147_CR181","doi-asserted-by":"publisher","first-page":"2267","DOI":"10.1016\/j.ymthe.2018.06.019","volume":"26","author":"C Liu","year":"2018","unstructured":"Liu C, Fu H, Liu X, Lei Q, Zhang Y, She X, et al. LINC00470 coordinates the epigenetic regulation of ELFN2 to distract GBM cell autophagy. Mol Ther. 2018;26(9):2267\u201381.","journal-title":"Mol Ther"},{"issue":"22","key":"1147_CR182","doi-asserted-by":"publisher","first-page":"4628","DOI":"10.1038\/emboj.2011.331","volume":"30","author":"LB Frankel","year":"2011","unstructured":"Frankel LB, Wen J, Lees M, H\u00f8yer-Hansen M, Farkas T, Krogh A, et al. microRNA\u2010101 is a potent inhibitor of autophagy. EMBO J. 2011;30(22):4628\u201341.","journal-title":"EMBO J"},{"issue":"9","key":"1147_CR183","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1111\/cas.13315","volume":"108","author":"H Chen","year":"2017","unstructured":"Chen H, Zhang Z, Lu Y, Song K, Liu X, Xia F, et al. Downregulation of ULK 1 by micro RNA-372 inhibits the survival of human pancreatic adenocarcinoma cells. Cancer Sci. 2017;108(9):1811\u20139.","journal-title":"Cancer Sci"},{"issue":"7","key":"1147_CR184","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1158\/0008-5472.CAN-11-3671","volume":"72","author":"V Kovaleva","year":"2012","unstructured":"Kovaleva V, Mora R, Park YJ, Plass C, Chiramel AI, Bartenschlager R, et al. miRNA-130a targets ATG2B and DICER1 to inhibit autophagy and trigger killing of chronic lymphocytic leukemia cells. Cancer Res. 2012;72(7):1763\u201372.","journal-title":"Cancer Res"},{"issue":"4","key":"1147_CR185","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1016\/j.ccr.2012.02.019","volume":"21","author":"O Mikhaylova","year":"2012","unstructured":"Mikhaylova O, Stratton Y, Hall D, Kellner E, Ehmer B, Drew AF, et al. VHL-regulated MiR-204 suppresses tumor growth through inhibition of LC3B-mediated autophagy in renal clear cell carcinoma. Cancer Cell. 2012;21(4):532\u201346.","journal-title":"Cancer Cell"},{"issue":"1","key":"1147_CR186","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1053\/j.gastro.2012.04.009","volume":"143","author":"Y Chang","year":"2012","unstructured":"Chang Y, Yan W, He X, Zhang L, Li C, Huang H, et al. miR-375 inhibits autophagy and reduces viability of hepatocellular carcinoma cells under hypoxic conditions. Gastroenterology. 2012;143(1):177\u201387. e8.","journal-title":"Gastroenterology"},{"issue":"1","key":"1147_CR187","doi-asserted-by":"publisher","first-page":"571","DOI":"10.3892\/mmr.2014.2675","volume":"11","author":"J Wei","year":"2015","unstructured":"Wei J, Ma Z, Li Y, Zhao B, Wang D, Jin Y, et al. miR\u2013143 inhibits cell proliferation by targeting autophagy\u2013related 2B in non\u2013small cell lung cancer H1299 cells. Mol Med Rep. 2015;11(1):571\u20136.","journal-title":"Mol Med Rep"},{"issue":"11","key":"1147_CR188","doi-asserted-by":"publisher","first-page":"9257","DOI":"10.18632\/oncotarget.3288","volume":"6","author":"D Huang","year":"2015","unstructured":"Huang D, Qiu S, Ge R, He L, Li M, Li Y, et al. miR-340 suppresses glioblastoma multiforme. Oncotarget. 2015;6(11):9257.","journal-title":"Oncotarget"},{"issue":"39","key":"1147_CR189","doi-asserted-by":"publisher","first-page":"41620","DOI":"10.18632\/oncotarget.5871","volume":"6","author":"X Guo","year":"2015","unstructured":"Guo X, Xue H, Guo X, Gao X, Xu S, Yan S, et al. MiR224-3p inhibits hypoxia-induced autophagy by targeting autophagy-related genes in human glioblastoma cells. Oncotarget. 2015;6(39):41620.","journal-title":"Oncotarget"},{"issue":"8","key":"1147_CR190","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.4161\/auto.29486","volume":"10","author":"L Feng","year":"2014","unstructured":"Feng L, Ma Y, Sun J, Shen Q, Liu L, Lu H, et al. YY1-MIR372-SQSTM1 regulatory axis in autophagy. Autophagy. 2014;10(8):1442\u201353.","journal-title":"Autophagy"},{"issue":"5","key":"1147_CR191","doi-asserted-by":"publisher","first-page":"e2764","DOI":"10.1038\/cddis.2017.145","volume":"8","author":"C Liang","year":"2017","unstructured":"Liang C, Zhang X, Wang H-M, Liu X-M, Zhang X-j, Zheng B, et al. MicroRNA-18a-5p functions as an oncogene by directly targeting IRF2 in lung cancer. Cell Death Dis. 2017;8(5):e2764\u2013e.","journal-title":"Cell Death Dis"},{"key":"1147_CR192","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.bcp.2016.06.018","volume":"115","author":"Y Ye","year":"2016","unstructured":"Ye Y, Fang Y, Xu W, Wang Q, Zhou J, Lu R. 3, 3\u2032-Diindolylmethane induces anti-human gastric cancer cells by the miR-30e-ATG5 modulating autophagy. Biochem Pharmacol. 2016;115:77\u201384.","journal-title":"Biochem Pharmacol"},{"issue":"5532","key":"1147_CR193","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1126\/science.1063127","volume":"293","author":"T Jenuwein","year":"2001","unstructured":"Jenuwein T, Allis CD. Translating the histone code. Science. 2001;293(5532):1074\u201380.","journal-title":"Science"},{"issue":"7","key":"1147_CR194","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/nrc2876","volume":"10","author":"P Chi","year":"2010","unstructured":"Chi P, Allis CD, Wang GG. Covalent histone modifications\u2014miswritten, misinterpreted and mis-erased in human cancers. Nat Rev Cancer. 2010;10(7):457\u201369.","journal-title":"Nat Rev Cancer"},{"issue":"6","key":"1147_CR195","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1016\/S1097-2765(03)00479-9","volume":"12","author":"JC Rice","year":"2003","unstructured":"Rice JC, Briggs SD, Ueberheide B, Barber CM, Shabanowitz J, Hunt DF, et al. Histone methyltransferases direct different degrees of methylation to define distinct chromatin domains. Mol Cell. 2003;12(6):1591\u20138.","journal-title":"Mol Cell"},{"issue":"2","key":"1147_CR196","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/nrc1279","volume":"4","author":"AP Feinberg","year":"2004","unstructured":"Feinberg AP, Tycko B. The history of cancer epigenetics. Nat Rev Cancer. 2004;4(2):143\u201353.","journal-title":"Nat Rev Cancer"},{"issue":"6","key":"1147_CR197","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/S0962-8924(01)02001-3","volume":"11","author":"T Jenuwein","year":"2001","unstructured":"Jenuwein T. Re-SET-ting heterochromatin by histone methyltransferases. Trends Cell Biol. 2001;11(6):266\u201373.","journal-title":"Trends Cell Biol"},{"issue":"4","key":"1147_CR198","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/S0968-0004(97)01016-5","volume":"22","author":"PA Wade","year":"1997","unstructured":"Wade PA, Pruss D, Wolffe AP. Histone acetylation: chromatin in action. Trends Biochem Sci. 1997;22(4):128\u201332.","journal-title":"Trends Biochem Sci"},{"issue":"14","key":"1147_CR199","doi-asserted-by":"publisher","first-page":"R546","DOI":"10.1016\/j.cub.2004.07.007","volume":"14","author":"CL Peterson","year":"2004","unstructured":"Peterson CL, Laniel M-A. Histones and histone modifications. Curr Biol. 2004;14(14):R546\u201351.","journal-title":"Curr Biol"},{"issue":"1","key":"1147_CR200","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1146\/annurev.biochem.75.103004.142422","volume":"75","author":"A Shilatifard","year":"2006","unstructured":"Shilatifard A. Chromatin modifications by methylation and ubiquitination: implications in the regulation of gene expression. Annu Rev Biochem. 2006;75(1):243\u201369.","journal-title":"Annu Rev Biochem"},{"issue":"23","key":"1147_CR201","doi-asserted-by":"publisher","first-page":"13225","DOI":"10.1073\/pnas.1735528100","volume":"100","author":"Y Shiio","year":"2003","unstructured":"Shiio Y, Eisenman RN. Histone sumoylation is associated with transcriptional repression. Proc Natl Acad Sci. 2003;100(23):13225\u201330.","journal-title":"Proc Natl Acad Sci"},{"issue":"2","key":"1147_CR202","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/S0955-0674(03)00013-9","volume":"15","author":"W Fischle","year":"2003","unstructured":"Fischle W, Wang Y, Allis CD. Histone and chromatin cross-talk. Curr Opin Cell Biol. 2003;15(2):172\u201383.","journal-title":"Curr Opin Cell Biol"},{"issue":"9","key":"1147_CR203","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1016\/j.tcb.2011.06.001","volume":"21","author":"S Messner","year":"2011","unstructured":"Messner S, Hottiger MO. Histone ADP-ribosylation in DNA repair, replication and transcription. Trends Cell Biol. 2011;21(9):534\u201342.","journal-title":"Trends Cell Biol"},{"issue":"3","key":"1147_CR204","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1111\/j.1440-1827.2011.02776.x","volume":"62","author":"JS Song","year":"2012","unstructured":"Song JS, Kim YS, Kim DK, Park SI, Jang SJ. Global histone modification pattern associated with recurrence and disease-free survival in non\u2010small cell lung cancer patients. Pathol Int. 2012;62(3):182\u201390.","journal-title":"Pathol Int"},{"issue":"6","key":"1147_CR205","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1038\/s41419-021-03738-0","volume":"12","author":"ME Massett","year":"2021","unstructured":"Massett ME, Monaghan L, Patterson S, Mannion N, Bunschoten RP, Hoose A, et al. A KDM4A-PAF1-mediated epigenomic network is essential for acute myeloid leukemia cell self-renewal and survival. Cell Death Dis. 2021;12(6):573.","journal-title":"Cell Death Dis"},{"issue":"1","key":"1147_CR206","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/s41392-020-00252-1","volume":"5","author":"Y Chen","year":"2020","unstructured":"Chen Y, Ren B, Yang J, Wang H, Yang G, Xu R, et al. The role of histone methylation in the development of digestive cancers: a potential direction for cancer management. Signal Transduct Target Therapy. 2020;5(1):143.","journal-title":"Signal Transduct Target Therapy"},{"issue":"1","key":"1147_CR207","doi-asserted-by":"publisher","first-page":"53","DOI":"10.4048\/jbc.2016.19.1.53","volume":"19","author":"S-H Jang","year":"2016","unstructured":"Jang S-H, Lee JE, Oh M-H, Lee J-H, Cho HD, Kim K-J, et al. High EZH2 Protein Expression Is Associated with Poor Overall Survival in Patients with Luminal A Breast Cancer. J Breast Cancer. 2016;19(1):53\u201360.","journal-title":"J Breast Cancer"},{"issue":"20","key":"1147_CR208","doi-asserted-by":"publisher","first-page":"7830","DOI":"10.1158\/0008-5472.CAN-10-0833","volume":"70","author":"MW Chen","year":"2010","unstructured":"Chen MW, Hua KT, Kao HJ, Chi CC, Wei LH, Johansson G, et al. H3K9 histone methyltransferase G9a promotes lung cancer invasion and metastasis by silencing the cell adhesion molecule Ep-CAM. Cancer Res. 2010;70(20):7830\u201340.","journal-title":"Cancer Res"},{"issue":"7","key":"1147_CR209","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1016\/j.cell.2004.12.012","volume":"119","author":"Y Shi","year":"2004","unstructured":"Shi Y, Lan F, Matson C, Mulligan P, Whetstine JR, Cole PA, et al. Histone demethylation mediated by the nuclear amine oxidase homolog LSD1. Cell. 2004;119(7):941\u201353.","journal-title":"Cell"},{"issue":"7158","key":"1147_CR210","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1038\/nature06092","volume":"449","author":"J Huang","year":"2007","unstructured":"Huang J, Sengupta R, Espejo AB, Lee MG, Dorsey JA, Richter M, et al. p53 is regulated by the lysine demethylase LSD1. Nature. 2007;449(7158):105\u20138.","journal-title":"Nature"},{"issue":"12","key":"1147_CR211","doi-asserted-by":"publisher","first-page":"1936","DOI":"10.1038\/s12276-020-00542-2","volume":"52","author":"B Perillo","year":"2020","unstructured":"Perillo B, Tramontano A, Pezone A, Migliaccio A. LSD1: more than demethylation of histone lysine residues. Exp Mol Med. 2020;52(12):1936\u201347.","journal-title":"Exp Mol Med"},{"issue":"1","key":"1147_CR212","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s12929-021-00737-3","volume":"28","author":"D Kim","year":"2021","unstructured":"Kim D, Kim KI, Baek SH. Roles of lysine-specific demethylase 1 (LSD1) in homeostasis and diseases. J Biomed Sci. 2021;28(1):41.","journal-title":"J Biomed Sci"},{"issue":"1","key":"1147_CR213","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1038\/ncomms1755","volume":"3","author":"S Hino","year":"2012","unstructured":"Hino S, Sakamoto A, Nagaoka K, Anan K, Wang Y, Mimasu S, et al. FAD-dependent lysine-specific demethylase-1 regulates cellular energy expenditure. Nat Commun. 2012;3(1):758.","journal-title":"Nat Commun"},{"issue":"2","key":"1147_CR214","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1038\/s41433-021-01726-4","volume":"36","author":"ND Nolan","year":"2022","unstructured":"Nolan ND, Caruso SM, Cui X, Tsang SH. Renormalization of metabolic coupling treats age-related degenerative disorders: an oxidative RPE niche fuels the more glycolytic photoreceptors. Eye. 2022;36(2):278\u201383.","journal-title":"Eye"},{"issue":"1","key":"1147_CR215","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.tcb.2020.09.010","volume":"31","author":"SC Baksh","year":"2021","unstructured":"Baksh SC, Finley LWS. Metabolic Coordination of Cell Fate by \u03b1-Ketoglutarate-Dependent Dioxygenases. Trends Cell Biol. 2021;31(1):24\u201336.","journal-title":"Trends Cell Biol"},{"issue":"7149","key":"1147_CR216","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/nature05971","volume":"448","author":"SS Ng","year":"2007","unstructured":"Ng SS, Kavanagh KL, McDonough MA, Butler D, Pilka ES, Lienard BM, et al. Crystal structures of histone demethylase JMJD2A reveal basis for substrate specificity. Nature. 2007;448(7149):87\u201391.","journal-title":"Nature"},{"issue":"7166","key":"1147_CR217","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1038\/nature06236","volume":"450","author":"Y Okada","year":"2007","unstructured":"Okada Y, Scott G, Ray MK, Mishina Y, Zhang Y. Histone demethylase JHDM2A is critical for Tnp1 and Prm1 transcription and spermatogenesis. Nature. 2007;450(7166):119\u201323.","journal-title":"Nature"},{"issue":"1","key":"1147_CR218","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1038\/s41420-025-02809-x","volume":"11","author":"Y Liu","year":"2025","unstructured":"Liu Y, Yan Z, Fu Z, Wu X, Wang F, Yuan Y. Crosstalk between acetylation modification and autophagy in cancer: roles, mechanisms, and therapeutic potential. Cell Death Discovery. 2025;11(1):522.","journal-title":"Cell Death Discovery"},{"issue":"4","key":"1147_CR219","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1111\/jop.12560","volume":"46","author":"MY Ahn","year":"2017","unstructured":"Ahn MY, Yoon JH. Histone deacetylase 7 silencing induces apoptosis and autophagy in salivary mucoepidermoid carcinoma cells. J Oral Pathol Med. 2017;46(4):276\u201383.","journal-title":"J Oral Pathol Med"},{"key":"1147_CR220","doi-asserted-by":"crossref","unstructured":"Oehme I, Linke J-P, B\u00f6ck BC, Milde T, Lodrini M, Hartenstein B et al. Histone deacetylase 10 promotes autophagy-mediated cell survival. Proceedings of the National Academy of Sciences. 2013;110(28):E2592-E601.","DOI":"10.1073\/pnas.1300113110"},{"issue":"7","key":"1147_CR221","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1038\/ncb2069","volume":"12","author":"Y Zhao","year":"2010","unstructured":"Zhao Y, Yang J, Liao W, Liu X, Zhang H, Wang S, et al. Cytosolic FoxO1 is essential for the induction of autophagy and tumour suppressor activity. Nat Cell Biol. 2010;12(7):665\u201375.","journal-title":"Nat Cell Biol"},{"issue":"10","key":"1147_CR222","doi-asserted-by":"publisher","first-page":"e2400","DOI":"10.1038\/cddis.2016.247","volume":"7","author":"Y-L Jia","year":"2016","unstructured":"Jia Y-L, Xu M, Dou C-W, Liu Z-K, Xue Y-M, Yao B-W, et al. P300\/CBP-associated factor (PCAF) inhibits the growth of hepatocellular carcinoma by promoting cell autophagy. Cell Death Dis. 2016;7(10):e2400\u2013e.","journal-title":"Cell Death Dis"},{"issue":"3","key":"1147_CR223","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1158\/0008-5472.CAN-10-3172","volume":"71","author":"MJ Powell","year":"2011","unstructured":"Powell MJ, Casimiro MC, Cordon-Cardo C, He X, Yeow W-S, Wang C, et al. Disruption of a Sirt1-dependent autophagy checkpoint in the prostate results in prostatic intraepithelial neoplasia lesion formation. Cancer Res. 2011;71(3):964\u201375.","journal-title":"Cancer Res"},{"issue":"1","key":"1147_CR224","doi-asserted-by":"publisher","first-page":"540","DOI":"10.3892\/or.2016.5280","volume":"37","author":"M-Y Ahn","year":"2017","unstructured":"Ahn M-Y, Yoon J-H. Histone deacetylase 8 as a novel therapeutic target in oral squamous cell carcinoma. Oncol Rep. 2017;37(1):540\u20136.","journal-title":"Oncol Rep"},{"issue":"6","key":"1147_CR225","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1002\/pros.23487","volume":"78","author":"X Jiang","year":"2018","unstructured":"Jiang X, Huang Y, Liang X, Jiang F, He Y, Li T, et al. Metastatic prostate cancer-associated P62 inhibits autophagy flux and promotes epithelial to mesenchymal transition by sustaining the level of HDAC6. Prostate. 2018;78(6):426\u201334.","journal-title":"Prostate"},{"issue":"1","key":"1147_CR226","doi-asserted-by":"publisher","first-page":"7215","DOI":"10.1038\/ncomms8215","volume":"6","author":"T Sun","year":"2015","unstructured":"Sun T, Li X, Zhang P, Chen W-D, Zhang H-l, Li D-D, et al. Acetylation of Beclin 1 inhibits autophagosome maturation and promotes tumour growth. Nat Commun. 2015;6(1):7215.","journal-title":"Nat Commun"},{"issue":"43","key":"1147_CR227","doi-asserted-by":"publisher","first-page":"27318","DOI":"10.18632\/oncotarget.25620","volume":"9","author":"A Qiao","year":"2018","unstructured":"Qiao A, Wang K, Yuan Y, Guan Y, Ren X, Li L, et al. Correction: Sirt3-mediated mitophagy protects tumor cells against apoptosis under hypoxia. Oncotarget. 2018;9(43):27318.","journal-title":"Oncotarget"},{"key":"1147_CR228","doi-asserted-by":"publisher","first-page":"7371","DOI":"10.1007\/s13277-015-4410-2","volume":"37","author":"B Shen","year":"2016","unstructured":"Shen B, Tan M, Mu X, Qin Y, Zhang F, Liu Y, et al. Upregulated SMYD3 promotes bladder cancer progression by targeting BCLAF1 and activating autophagy. Tumor Biology. 2016;37:7371\u201381.","journal-title":"Tumor Biology"},{"issue":"20","key":"1147_CR229","doi-asserted-by":"publisher","first-page":"3983","DOI":"10.1128\/MCB.00813-13","volume":"33","author":"A Artal-Martinez de Narvajas","year":"2013","unstructured":"Artal-Martinez de Narvajas A, Gomez TS, Zhang J-S, Mann AO, Taoda Y, Gorman JA, et al. Epigenetic regulation of autophagy by the methyltransferase G9a. Mol Cell Biol. 2013;33(20):3983\u201393.","journal-title":"Mol Cell Biol"},{"key":"1147_CR230","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.cellsig.2017.05.011","volume":"36","author":"E Zhao","year":"2017","unstructured":"Zhao E, Tang C, Jiang X, Weng X, Zhong X, Zhang D, et al. Inhibition of cell proliferation and induction of autophagy by KDM2B\/FBXL10 knockdown in gastric cancer cells. Cell Signal. 2017;36:222\u20139.","journal-title":"Cell Signal"},{"key":"1147_CR231","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/s12031-016-0796-6","volume":"60","author":"B Wang","year":"2016","unstructured":"Wang B, Fan X, Ma C, Lei H, Long Q, Chai Y. Downregulation of KDM4A suppresses the survival of glioma cells by promoting autophagy. J Mol Neurosci. 2016;60:137\u201344.","journal-title":"J Mol Neurosci"},{"issue":"2","key":"1147_CR232","doi-asserted-by":"publisher","first-page":"e0213135","DOI":"10.1371\/journal.pone.0213135","volume":"14","author":"X-X Ke","year":"2019","unstructured":"Ke X-X, Zhang D, Zhu S, Xia Q, Xiang Z, Cui H. Correction: inhibition of H3K9 methyltransferase G9a repressed cell proliferation and induced autophagy in neuroblastoma cells. PLoS ONE. 2019;14(2):e0213135.","journal-title":"PLoS ONE"},{"issue":"42","key":"1147_CR233","doi-asserted-by":"publisher","first-page":"4348","DOI":"10.18632\/oncotarget.27046","volume":"10","author":"SE Park","year":"2019","unstructured":"Park SE, Yi HJ, Suh N, Park Y-Y, Koh J-Y, Jeong S-Y, et al. Correction: Inhibition of EHMT2\/G9a epigenetically increases the transcription of Beclin-1 via an increase in ROS and activation of NF-\u03baB. Oncotarget. 2019;10(42):4348.","journal-title":"Oncotarget"},{"issue":"1","key":"1147_CR234","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1038\/s41392-024-02039-0","volume":"9","author":"W Dai","year":"2024","unstructured":"Dai W, Qiao X, Fang Y, Guo R, Bai P, Liu S, et al. Epigenetics-targeted drugs: current paradigms and future challenges. Signal Transduct Target Therapy. 2024;9(1):332.","journal-title":"Signal Transduct Target Therapy"},{"issue":"12","key":"1147_CR235","doi-asserted-by":"publisher","first-page":"6563","DOI":"10.1093\/nar\/gkaa441","volume":"48","author":"X Zhu","year":"2020","unstructured":"Zhu X, Lan B, Yi X, He C, Dang L, Zhou X, et al. HRP2-DPF3a-BAF complex coordinates histone modification and chromatin remodeling to regulate myogenic gene transcription. Nucleic Acids Res. 2020;48(12):6563\u201382.","journal-title":"Nucleic Acids Res"},{"issue":"5","key":"1147_CR236","doi-asserted-by":"publisher","first-page":"109943","DOI":"10.1016\/j.celrep.2021.109943","volume":"37","author":"S Bl\u00fcmli","year":"2021","unstructured":"Bl\u00fcmli S, Wiechens N, Wu MY, Singh V, Gierlinski M, Schweikert G, et al. Acute depletion of the ARID1A subunit of SWI\/SNF complexes reveals distinct pathways for activation and repression of transcription. Cell Rep. 2021;37(5):109943.","journal-title":"Cell Rep"},{"key":"1147_CR237","doi-asserted-by":"publisher","unstructured":"Rehman H, Chandrashekar DS, Balabhadrapatruni C, et al. ARID1A-defi cient bladder cancer is dependent on PI3Ksignaling and sensitive to EZH2 and PI3K inhibitors. JCI Insight. 2022;7(16):e155899. https:\/\/doi.org\/10.1172\/jci.insight.155899","DOI":"10.1172\/jci.insight.155899"},{"issue":"49","key":"1147_CR238","doi-asserted-by":"publisher","first-page":"7058","DOI":"10.1038\/sj.onc.1210514","volume":"26","author":"S Glaros","year":"2007","unstructured":"Glaros S, Cirrincione G, Muchardt C, Kleer C, Michael C, Reisman D. The reversible epigenetic silencing of BRM: implications for clinical targeted therapy. Oncogene. 2007;26(49):7058\u201366.","journal-title":"Oncogene"},{"issue":"17","key":"1147_CR239","doi-asserted-by":"publisher","first-page":"5508","DOI":"10.1158\/0008-5472.CAN-12-4593","volume":"73","author":"T Oike","year":"2013","unstructured":"Oike T, Ogiwara H, Tominaga Y, Ito K, Ando O, Tsuta K, et al. A synthetic lethality\u2013based strategy to treat cancers harboring a genetic deficiency in the chromatin remodeling factor BRG1. Cancer Res. 2013;73(17):5508\u201318.","journal-title":"Cancer Res"},{"issue":"14","key":"1147_CR240","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1038\/onc.2009.4","volume":"28","author":"D Reisman","year":"2009","unstructured":"Reisman D, Glaros S, Thompson E. The SWI\/SNF complex and cancer. Oncogene. 2009;28(14):1653\u201368.","journal-title":"Oncogene"},{"key":"1147_CR241","doi-asserted-by":"crossref","unstructured":"Wilson BG, Helming KC, Wang X, Kim Y, Vazquez F, Jagani Z, et al. Residual complexes containing SMARCA2 (BRM) underlie the oncogenic drive of SMARCA4 (BRG1) mutation. Molecular and cellular biology; 2014.","DOI":"10.1128\/MCB.01372-13"},{"issue":"1","key":"1147_CR242","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.cmet.2016.08.009","volume":"25","author":"GS Ducker","year":"2017","unstructured":"Ducker GS, Rabinowitz JD. One-Carbon Metabolism in Health and Disease. Cell Metabol. 2017;25(1):27\u201342.","journal-title":"Cell Metabol"},{"issue":"1","key":"1147_CR243","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1111\/nyas.12956","volume":"1363","author":"SJ Mentch","year":"2016","unstructured":"Mentch SJ, Locasale JW. One-carbon metabolism and epigenetics: understanding the specificity. Ann N Y Acad Sci. 2016;1363(1):91\u20138.","journal-title":"Ann N Y Acad Sci"},{"key":"1147_CR244","doi-asserted-by":"publisher","first-page":"764","DOI":"10.3389\/fgene.2019.00764","volume":"10","author":"M Serefidou","year":"2019","unstructured":"Serefidou M, Venkatasubramani AV, Imhof A. The Impact of One Carbon Metabolism on Histone Methylation. Front Genet. 2019;10:764.","journal-title":"Front Genet"},{"issue":"12","key":"1147_CR245","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1038\/bjc.2017.118","volume":"116","author":"AC Newman","year":"2017","unstructured":"Newman AC, Maddocks ODK. One-carbon metabolism in cancer. Br J Cancer. 2017;116(12):1499\u2013504.","journal-title":"Br J Cancer"},{"key":"1147_CR246","doi-asserted-by":"publisher","unstructured":"Lyon P, Strippoli V, Fang B, Cimmino L. B vitamins and one-carbon metabolism: implications in human health anddisease. Nutrients. 2020;12(9):2867. https:\/\/doi.org\/10.3390\/nu12092867","DOI":"10.3390\/nu12092867"},{"key":"1147_CR247","doi-asserted-by":"publisher","first-page":"427","DOI":"10.3389\/fgene.2018.00427","volume":"9","author":"V Miranda-Gon\u00e7alves","year":"2018","unstructured":"Miranda-Gon\u00e7alves V, Lameirinhas A, Henrique R, Jer\u00f3nimo C. Metabolism and Epigenetic Interplay in Cancer: Regulation and Putative Therapeutic Targets. Front Genet. 2018;9:427.","journal-title":"Front Genet"},{"issue":"2","key":"1147_CR248","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.trecan.2024.11.003","volume":"11","author":"S Li","year":"2025","unstructured":"Li S, Duan Y, Luo S, Zhou F, Wu Q, Lu Z. Short-chain fatty acids and cancer. Trends Cancer. 2025;11(2):154\u201368.","journal-title":"Trends Cancer"},{"key":"1147_CR249","doi-asserted-by":"publisher","first-page":"1451045","DOI":"10.3389\/fonc.2024.1451045","volume":"14","author":"M Hou","year":"2024","unstructured":"Hou M, Yu QQ, Yang L, Zhao H, Jiang P, Qin L, et al. The role of short-chain fatty acid metabolism in the pathogenesis, diagnosis and treatment of cancer. Front Oncol. 2024;14:1451045.","journal-title":"Front Oncol"},{"issue":"5","key":"1147_CR250","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.3390\/nu11051026","volume":"11","author":"J Chen","year":"2019","unstructured":"Chen J, Zhao K-N, Vitetta L. Effects of Intestinal Microbial\u2013Elaborated Butyrate on Oncogenic Signaling Pathways. Nutrients [Internet]. 2019;11(5):1026.","journal-title":"Nutrients [Internet]"},{"issue":"4","key":"1147_CR251","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1089\/biores.2012.0223","volume":"1","author":"K Steliou","year":"2012","unstructured":"Steliou K, Boosalis MS, Perrine SP, Sangerman J, Faller DV. Butyrate histone deacetylase inhibitors. Biores Open Access. 2012;1(4):192\u20138.","journal-title":"Biores Open Access"},{"issue":"7","key":"1147_CR252","doi-asserted-by":"publisher","first-page":"S2485","DOI":"10.1093\/jn\/133.7.2485S","volume":"133","author":"JR Davie","year":"2003","unstructured":"Davie JR. Inhibition of Histone Deacetylase Activity by Butyrate. J Nutr. 2003;133(7):S2485\u201393.","journal-title":"J Nutr"},{"issue":"12","key":"1147_CR253","first-page":"5244","volume":"96","author":"LG Silva","year":"2018","unstructured":"Silva LG, Ferguson BS, Avila AS, Faciola AP. Sodium propionate and sodium butyrate effects on histone deacetylase (HDAC) activity, histone acetylation, and inflammatory gene expression in bovine mammary epithelial cells. J Anim Sci. 2018;96(12):5244\u201352.","journal-title":"J Anim Sci"},{"key":"1147_CR254","doi-asserted-by":"publisher","first-page":"1179237x1772990","DOI":"10.1177\/1179237X17729900","volume":"9","author":"KS Bishop","year":"2017","unstructured":"Bishop KS, Xu H, Marlow G. Epigenetic Regulation of Gene Expression Induced by Butyrate in Colorectal Cancer: Involvement of MicroRNA. Genet Epigenet. 2017;9:1179237x17729900.","journal-title":"Genet Epigenet"},{"issue":"43","key":"1147_CR255","doi-asserted-by":"publisher","first-page":"27280","DOI":"10.18632\/oncotarget.25546","volume":"9","author":"A Han","year":"2018","unstructured":"Han A, Bennett N, Ahmed B, Whelan J, Donohoe DR. Butyrate decreases its own oxidation in colorectal cancer cells through inhibition of histone deacetylases. Oncotarget. 2018;9(43):27280\u201392.","journal-title":"Oncotarget"},{"issue":"4","key":"1147_CR256","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1158\/1078-0432.CCR-13-2483","volume":"20","author":"SJ Bultman","year":"2014","unstructured":"Bultman SJ. Molecular Pathways: Gene\u2013Environment Interactions Regulating Dietary Fiber Induction of Proliferation and Apoptosis via Butyrate for Cancer Prevention. Clin Cancer Res. 2014;20(4):799\u2013803.","journal-title":"Clin Cancer Res"},{"issue":"1","key":"1147_CR257","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1038\/s42255-024-01191-9","volume":"7","author":"M Nshanian","year":"2025","unstructured":"Nshanian M, Gruber JJ, Geller BS, Chleilat F, Lancaster SM, White SM, et al. Short-chain fatty acid metabolites propionate and butyrate are unique epigenetic regulatory elements linking diet, metabolism and gene expression. Nat Metabolism. 2025;7(1):196\u2013211.","journal-title":"Nat Metabolism"},{"issue":"1","key":"1147_CR258","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejmg.2014.10.004","volume":"58","author":"SC Liew","year":"2015","unstructured":"Liew SC, Gupta ED. Methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism: epidemiology, metabolism and the associated diseases. Eur J Med Genet. 2015;58(1):1\u201310.","journal-title":"Eur J Med Genet"},{"issue":"6","key":"1147_CR259","doi-asserted-by":"publisher","first-page":"360","DOI":"10.3961\/jpmph.2009.42.6.360","volume":"42","author":"SA Lee","year":"2009","unstructured":"Lee SA. Gene-diet interaction on cancer risk in epidemiological studies. J Prev Med Public Health. 2009;42(6):360\u201370.","journal-title":"J Prev Med Public Health"},{"issue":"6","key":"1147_CR260","doi-asserted-by":"publisher","first-page":"459","DOI":"10.3177\/jnsv.65.459","volume":"65","author":"X Chen","year":"2019","unstructured":"Chen X, Ahamada H, Zhang T, Bai Z, Wang C. Association of Intake Folate and Related Gene Polymorphisms with Breast Cancer. J Nutr Sci Vitaminol (Tokyo). 2019;65(6):459\u201369.","journal-title":"J Nutr Sci Vitaminol (Tokyo)"},{"issue":"3","key":"1147_CR261","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1007\/s10552-009-9464-2","volume":"21","author":"A Hazra","year":"2010","unstructured":"Hazra A, Fuchs CS, Kawasaki T, Kirkner GJ, Hunter DJ, Ogino S. Germline polymorphisms in the one-carbon metabolism pathway and DNA methylation in colorectal cancer. Cancer Causes Control. 2010;21(3):331\u201345.","journal-title":"Cancer Causes Control"},{"key":"1147_CR262","doi-asserted-by":"publisher","unstructured":"Reng Q, Zhu LL, Feng L, Li YJ, Zhu YX, Wang TT, Jiang F. Dietary meat mutagens intake and cancer risk: a systematicreview and meta-analysis. Front Nutr. 2022;9:962688. https:\/\/doi.org\/10.3389\/fnut.2022.962688","DOI":"10.3389\/fnut.2022.962688"},{"issue":"6","key":"1147_CR263","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1016\/j.advnut.2023.08.004","volume":"14","author":"MF Fenech","year":"2023","unstructured":"Fenech MF, Bull CF, Van Klinken BJ-W. Protective Effects of Micronutrient Supplements, Phytochemicals and Phytochemical-Rich Beverages and Foods Against DNA Damage in Humans: A Systematic Review of Randomized Controlled Trials and Prospective Studies. Adv Nutr. 2023;14(6):1337\u201358.","journal-title":"Adv Nutr"},{"issue":"2","key":"1147_CR264","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1017\/S0029665108006988","volume":"67","author":"C Bull","year":"2008","unstructured":"Bull C, Fenech M. Genome-health nutrigenomics and nutrigenetics: nutritional requirements or \u2018nutriomes\u2019 for chromosomal stability and telomere maintenance at the individual level: Symposium on \u2018Diet and cancer\u2019. Proc Nutr Soc. 2008;67(2):146\u201356.","journal-title":"Proc Nutr Soc"},{"key":"1147_CR265","doi-asserted-by":"publisher","unstructured":"Shuvalov O, Kirdeeva Y, Daks A, Fedorova O, Parfenyev S, Simon HU, Barlev NA. Phytochemicals target multiplemetabolic pathways in cancer. Antioxidants (Basel). 2023;12(11):2012. https:\/\/doi.org\/10.3390\/antiox12112012","DOI":"10.3390\/antiox12112012"},{"key":"1147_CR266","doi-asserted-by":"publisher","unstructured":"Rodr\u00edguez Reyes SC, Rico Fuentes C, Pereira Su\u00e1rez AL, Sierra D\u00edaz E, Moreno Ort\u00edz JM, Ram\u00edrez de Arellano A.Nutrition and diet in the prevention and management of prostate cancer in Mexico: a narrative review. Nutrients.2025;17(13):2151. https:\/\/doi.org\/10.3390\/nu17132151","DOI":"10.3390\/nu17132151"},{"issue":"3","key":"1147_CR267","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.jmau.2016.02.002","volume":"4","author":"AZ Elsamanoudy","year":"2016","unstructured":"Elsamanoudy AZ, Neamat-Allah MAM, Mohammad FAH, Hassanien M, Nada HA. The role of nutrition related genes and nutrigenetics in understanding the pathogenesis of cancer. J Microscopy Ultrastructure. 2016;4(3):115\u201322.","journal-title":"J Microscopy Ultrastructure"},{"issue":"13","key":"1147_CR268","doi-asserted-by":"publisher","first-page":"e33564","DOI":"10.1016\/j.heliyon.2024.e33564","volume":"10","author":"M Khalighi Sikaroudi","year":"2024","unstructured":"Khalighi Sikaroudi M, Soltani S, Kolahdouz-Mohammadi R, Imanifard R, Abdollahi S, Shahinfar H, et al. The association between dietary folate intake and risk of colorectal cancer incidence: A systematic review and dose\u2013response meta-analysis of cohort studies. Heliyon. 2024;10(13):e33564.","journal-title":"Heliyon"},{"issue":"3","key":"1147_CR269","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1158\/1055-9965.EPI-23-0717","volume":"33","author":"MC Stern","year":"2024","unstructured":"Stern MC, Sanchez Mendez J, Kim AE, Ob\u00f3n-Santacana M, Moratalla-Navarro F, Mart\u00edn V, et al. Genome-Wide Gene-Environment Interaction Analyses to Understand the Relationship between Red Meat and Processed Meat Intake and Colorectal Cancer Risk. Cancer Epidemiol Biomarkers Prev. 2024;33(3):400\u201310.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"1","key":"1147_CR270","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1186\/s12876-025-04163-9","volume":"25","author":"B Lai","year":"2025","unstructured":"Lai B, Li Z, Li J. Cruciferous vegetables intake and risk of colon cancer: a dose-response meta-analysis. BMC Gastroenterol. 2025;25(1):575.","journal-title":"BMC Gastroenterol"},{"key":"1147_CR271","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13059-017-1185-3","volume":"18","author":"JJ Cole","year":"2017","unstructured":"Cole JJ, Robertson NA, Rather MI, Thomson JP, McBryan T, Sproul D, et al. Diverse interventions that extend mouse lifespan suppress shared age-associated epigenetic changes at critical gene regulatory regions. Genome Biol. 2017;18:1\u201316.","journal-title":"Genome Biol"},{"issue":"4","key":"1147_CR272","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1111\/acel.12338","volume":"14","author":"VD Longo","year":"2015","unstructured":"Longo VD, Antebi A, Bartke A, Barzilai N, Brown-Borg HM, Caruso C, et al. Interventions to slow aging in humans: are we ready? Aging Cell. 2015;14(4):497\u2013510.","journal-title":"Aging Cell"},{"issue":"3","key":"1147_CR273","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/j.arr.2011.11.005","volume":"11","author":"EM Mercken","year":"2012","unstructured":"Mercken EM, Carboneau BA, Krzysik-Walker SM, de Cabo R. Of mice and men: the benefits of caloric restriction, exercise, and mimetics. Ageing Res Rev. 2012;11(3):390\u20138.","journal-title":"Ageing Res Rev"},{"issue":"1","key":"1147_CR274","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1093\/jn\/10.1.63","volume":"10","author":"CM McCay","year":"1935","unstructured":"McCay CM, Crowell MF, Maynard LA. The effect of retarded growth upon the length of life span and upon the ultimate body size: one figure. J Nutr. 1935;10(1):63\u201379.","journal-title":"J Nutr"},{"issue":"1","key":"1147_CR275","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1242\/jeb.107110","volume":"218","author":"M Daniel","year":"2015","unstructured":"Daniel M, Tollefsbol TO. Epigenetic linkage of aging, cancer and nutrition. J Exp Biol. 2015;218(1):59\u201370.","journal-title":"J Exp Biol"},{"issue":"5937","key":"1147_CR276","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1126\/science.1173635","volume":"325","author":"RJ Colman","year":"2009","unstructured":"Colman RJ, Anderson RM, Johnson SC, Kastman EK, Kosmatka KJ, Beasley TM, et al. Caloric restriction delays disease onset and mortality in rhesus monkeys. Science. 2009;325(5937):201\u20134.","journal-title":"Science"},{"issue":"1","key":"1147_CR277","doi-asserted-by":"publisher","first-page":"3557","DOI":"10.1038\/ncomms4557","volume":"5","author":"RJ Colman","year":"2014","unstructured":"Colman RJ, Beasley TM, Kemnitz JW, Johnson SC, Weindruch R, Anderson RM. Caloric restriction reduces age-related and all-cause mortality in rhesus monkeys. Nat Commun. 2014;5(1):3557.","journal-title":"Nat Commun"},{"issue":"7415","key":"1147_CR278","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1038\/nature11432","volume":"489","author":"JA Mattison","year":"2012","unstructured":"Mattison JA, Roth GS, Beasley TM, Tilmont EM, Handy AM, Herbert RL, et al. Impact of caloric restriction on health and survival in rhesus monkeys from the NIA study. Nature. 2012;489(7415):318\u201321.","journal-title":"Nature"},{"issue":"11","key":"1147_CR279","doi-asserted-by":"publisher","first-page":"3425","DOI":"10.3390\/ijms19113425","volume":"19","author":"C Tiffon","year":"2018","unstructured":"Tiffon C. The impact of nutrition and environmental epigenetics on human health and disease. Int J Mol Sci. 2018;19(11):3425.","journal-title":"Int J Mol Sci"},{"issue":"4","key":"1147_CR280","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.3390\/nu12041194","volume":"12","author":"D-S Hwangbo","year":"2020","unstructured":"Hwangbo D-S, Lee H-Y, Abozaid LS, Min K-J. Mechanisms of lifespan regulation by calorie restriction and intermittent fasting in model organisms. Nutrients. 2020;12(4):1194.","journal-title":"Nutrients"},{"issue":"4","key":"1147_CR281","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1152\/physiol.00010.2011","volume":"26","author":"C Cant\u00f3","year":"2011","unstructured":"Cant\u00f3 C, Auwerx J. Calorie restriction: is AMPK a key sensor and effector? Physiology. 2011;26(4):214\u201324.","journal-title":"Physiology"},{"key":"1147_CR282","doi-asserted-by":"publisher","unstructured":"Ma L, Wang R, Wang H, Zhang Y, Zhao Z. Long-term caloric restriction activates the myocardial SIRT1\/AMPK\/PGC-1\u03b1pathway in C57BL\/6J male mice. Food Nutr Res. 2020;64:3668. https:\/\/doi.org\/10.29219\/fnr.v64.3668","DOI":"10.29219\/fnr.v64.3668"},{"issue":"4","key":"1147_CR283","doi-asserted-by":"publisher","first-page":"928","DOI":"10.3390\/ijms19040928","volume":"19","author":"A Zullo","year":"2018","unstructured":"Zullo A, Simone E, Grimaldi M, Musto V, Mancini FP. Sirtuins as mediator of the anti-ageing effects of calorie restriction in skeletal and cardiac muscle. Int J Mol Sci. 2018;19(4):928.","journal-title":"Int J Mol Sci"},{"issue":"6","key":"1147_CR284","first-page":"284","volume":"2","author":"GY-Q Ng","year":"2019","unstructured":"Ng GY-Q, Fann DY-W, Jo D-G, Sobey CG, Arumugam TV. Dietary restriction and epigenetics: part I. Conditioning Med. 2019;2(6):284.","journal-title":"Conditioning Med"},{"issue":"5","key":"1147_CR285","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1096\/fj.09-149328","volume":"24","author":"Y Li","year":"2010","unstructured":"Li Y, Liu L, Tollefsbol TO. Glucose restriction can extend normal cell lifespan and impair precancerous cell growth through epigenetic control of hTERT and p16 expression. FASEB J. 2010;24(5):1442.","journal-title":"FASEB J"},{"issue":"1","key":"1147_CR286","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1038\/s41467-017-00607-3","volume":"8","author":"S Maegawa","year":"2017","unstructured":"Maegawa S, Lu Y, Tahara T, Lee JT, Madzo J, Liang S, et al. Caloric restriction delays age-related methylation drift. Nat Commun. 2017;8(1):539.","journal-title":"Nat Commun"},{"issue":"1","key":"1147_CR287","doi-asserted-by":"publisher","first-page":"4361","DOI":"10.1038\/s41467-019-12293-4","volume":"10","author":"I Hernando-Herraez","year":"2019","unstructured":"Hernando-Herraez I, Evano B, Stubbs T, Commere P-H, Jan Bonder M, Clark S, et al. Ageing affects DNA methylation drift and transcriptional cell-to-cell variability in mouse muscle stem cells. Nat Commun. 2019;10(1):4361.","journal-title":"Nat Commun"},{"issue":"8","key":"1147_CR288","doi-asserted-by":"publisher","first-page":"2022","DOI":"10.3390\/ijms20082022","volume":"20","author":"N Gensous","year":"2019","unstructured":"Gensous N, Franceschi C, Santoro A, Milazzo M, Garagnani P, Bacalini MG. The impact of caloric restriction on the epigenetic signatures of aging. Int J Mol Sci. 2019;20(8):2022.","journal-title":"Int J Mol Sci"},{"key":"1147_CR289","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.neurobiolaging.2018.03.009","volume":"67","author":"N Hadad","year":"2018","unstructured":"Hadad N, Unnikrishnan A, Jackson JA, Masser DR, Otalora L, Stanford DR, et al. Caloric restriction mitigates age-associated hippocampal differential CG and non-CG methylation. Neurobiol Aging. 2018;67:53\u201366.","journal-title":"Neurobiol Aging"},{"issue":"6","key":"1147_CR290","first-page":"300","volume":"2","author":"GY-Q Ng","year":"2019","unstructured":"Ng GY-Q, Fann DY-W, Jo D-G, Sobey CG, Arumugam TV. Epigenetic regulation by dietary restriction: part II. Conditioning Med. 2019;2(6):300.","journal-title":"Conditioning Med"},{"issue":"1","key":"1147_CR291","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1186\/s12943-024-02119-3","volume":"23","author":"M Tufail","year":"2024","unstructured":"Tufail M, Jiang C-H, Li N. Altered metabolism in cancer: insights into energy pathways and therapeutic targets. Mol Cancer. 2024;23(1):203.","journal-title":"Mol Cancer"},{"issue":"2","key":"1147_CR292","doi-asserted-by":"publisher","first-page":"164","DOI":"10.18632\/aging.101382","volume":"10","author":"DD Weber","year":"2018","unstructured":"Weber DD, Aminazdeh-Gohari S, Kofler B. Ketogenic diet in cancer therapy. Aging. 2018;10(2):164.","journal-title":"Aging"},{"issue":"3","key":"1147_CR293","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.plefa.2003.09.008","volume":"70","author":"TE Cullingford","year":"2004","unstructured":"Cullingford TE. The ketogenic diet; fatty acids, fatty acid-activated receptors and neurological disorders. Prostaglandins Leukot Essent Fatty Acids. 2004;70(3):253\u201364.","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"issue":"4","key":"1147_CR294","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1080\/152165401753311780","volume":"51","author":"RL Veech","year":"2001","unstructured":"Veech RL, Chance B, Kashiwaya Y, Lardy HA, Cahill GF Jr. Ketone bodies, potential therapeutic uses. IUBMB Life. 2001;51(4):241\u20137.","journal-title":"IUBMB Life"},{"key":"1147_CR295","doi-asserted-by":"publisher","first-page":"103061","DOI":"10.1016\/j.critrevonc.2020.103061","volume":"153","author":"F Bozzetti","year":"2020","unstructured":"Bozzetti F, Stanga Z. Does nutrition for cancer patients feed the tumour? A clinical perspective. Crit Rev Oncol\/Hematol. 2020;153:103061.","journal-title":"Crit Rev Oncol\/Hematol"},{"issue":"2","key":"1147_CR296","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1177\/02611929231157756","volume":"51","author":"LJ Marshall","year":"2023","unstructured":"Marshall LJ, Bailey J, Cassotta M, Herrmann K, Pistollato F. Poor Translatability of Biomedical Research Using Animals \u2014 A Narrative Review. Altern Lab Anim. 2023;51(2):102\u201335.","journal-title":"Altern Lab Anim"},{"key":"1147_CR297","doi-asserted-by":"publisher","unstructured":"Pati S, Irfan W, Jameel A, Ahmed S, Shahid RK. Obesity and cancer: a current overview of epidemiology,pathogenesis, outcomes, and management. Cancers (Basel). 2023;15(2):485. https:\/\/doi.org\/10.3390\/cancers15020485","DOI":"10.3390\/cancers15020485"},{"key":"1147_CR298","doi-asserted-by":"publisher","first-page":"738550","DOI":"10.3389\/fnut.2021.738550","volume":"8","author":"Q Zhang","year":"2021","unstructured":"Zhang Q, Qian L, Liu T, Ding JS, Zhang X, Song MM, et al. Prevalence and Prognostic Value of Malnutrition Among Elderly Cancer Patients Using Three Scoring Systems. Front Nutr. 2021;8:738550.","journal-title":"Front Nutr"},{"issue":"2","key":"1147_CR299","first-page":"189062","volume":"1879","author":"O Menyh\u00e1rt","year":"2024","unstructured":"Menyh\u00e1rt O, Gy\u0151rffy B. Dietary approaches for exploiting metabolic vulnerabilities in cancer. Biochimica et Biophysica Acta (BBA) -. Reviews Cancer. 2024;1879(2):189062.","journal-title":"Reviews Cancer"},{"issue":"10","key":"1147_CR300","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1016\/j.bcp.2006.02.009","volume":"71","author":"BB Aggarwal","year":"2006","unstructured":"Aggarwal BB, Shishodia S. Molecular targets of dietary agents for prevention and therapy of cancer. Biochem Pharmacol. 2006;71(10):1397\u2013421.","journal-title":"Biochem Pharmacol"},{"issue":"1","key":"1147_CR301","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1002\/mnfr.201300195","volume":"58","author":"VBO Ayissi","year":"2014","unstructured":"Ayissi VBO, Ebrahimi A, Schluesenner H. Epigenetic effects of natural polyphenols: A focus on SIRT1-mediated mechanisms. Mol Nutr Food Res. 2014;58(1):22\u201332.","journal-title":"Mol Nutr Food Res"},{"key":"1147_CR302","doi-asserted-by":"publisher","first-page":"79","DOI":"10.3389\/fgene.2019.00079","volume":"10","author":"\u00c1 Carlos-Reyes","year":"2019","unstructured":"Carlos-Reyes \u00c1, L\u00f3pez-Gonz\u00e1lez JS, Meneses-Flores M, Gallardo-Rinc\u00f3n D, Ru\u00edz-Garc\u00eda E, Marchat LA, et al. Dietary compounds as epigenetic modulating agents in cancer. Front Genet. 2019;10:79.","journal-title":"Front Genet"},{"issue":"6","key":"1147_CR303","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.3390\/ijms18061178","volume":"18","author":"L Budisan","year":"2017","unstructured":"Budisan L, Gulei D, Zanoaga OM, Irimie AI, Chira S, Braicu C, et al. Dietary intervention by phytochemicals and their role in modulating coding and non-coding genes in cancer. Int J Mol Sci. 2017;18(6):1178.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"1147_CR304","first-page":"792527","volume":"2013","author":"DF Gomez-Casati","year":"2013","unstructured":"Gomez-Casati DF, Zanor MI, Busi MV. Metabolomics in plants and humans: applications in the prevention and diagnosis of diseases. Biomed Res Int. 2013;2013(1):792527.","journal-title":"Biomed Res Int"},{"key":"1147_CR305","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.fct.2018.01.022","volume":"113","author":"AB Santhakumar","year":"2018","unstructured":"Santhakumar AB, Battino M, Alvarez-Suarez JM. Dietary polyphenols: Structures, bioavailability and protective effects against atherosclerosis. Food Chem Toxicol. 2018;113:49\u201365.","journal-title":"Food Chem Toxicol"},{"key":"1147_CR306","doi-asserted-by":"publisher","unstructured":"de Kok TM, van Breda SG, Manson MM. Mechanisms of combined action of diff erent chemopreventive dietarycompounds: a review. Eur J Nutr. 2008;47 Suppl 2:51-59. https:\/\/doi.org\/10.1007\/s00394-008-2006-y","DOI":"10.1007\/s00394-008-2006-y"},{"issue":"9","key":"1147_CR307","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1111\/nure.12051","volume":"71","author":"M Gonz\u00e1lez-Vallinas","year":"2013","unstructured":"Gonz\u00e1lez-Vallinas M, Gonz\u00e1lez-Castej\u00f3n M, Rodr\u00edguez-Casado A, Ram\u00edrez de Molina A. Dietary phytochemicals in cancer prevention and therapy: a complementary approach with promising perspectives. Nutr Rev. 2013;71(9):585\u201399.","journal-title":"Nutr Rev"},{"issue":"4","key":"1147_CR308","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1158\/1940-6207.CAPR-09-0117","volume":"3","author":"X Cui","year":"2010","unstructured":"Cui X, Jin Y, Hofseth AB, Pena E, Habiger J, Chumanevich A, et al. Resveratrol suppresses colitis and colon cancer associated with colitis. Cancer Prev Res. 2010;3(4):549\u201359.","journal-title":"Cancer Prev Res"},{"issue":"17","key":"1147_CR309","doi-asserted-by":"publisher","first-page":"2908","DOI":"10.1080\/10408398.2017.1345853","volume":"58","author":"L Chen","year":"2018","unstructured":"Chen L, Teng H, Jia Z, Battino M, Miron A, Yu Z, et al. Intracellular signaling pathways of inflammation modulated by dietary flavonoids: The most recent evidence. Crit Rev Food Sci Nutr. 2018;58(17):2908\u201324.","journal-title":"Crit Rev Food Sci Nutr"},{"issue":"5","key":"1147_CR310","doi-asserted-by":"publisher","first-page":"2379","DOI":"10.7314\/APJCP.2014.15.5.2379","volume":"15","author":"MH Sehitoglu","year":"2014","unstructured":"Sehitoglu MH, Farooqi AA, Qureshi MZ, Butt G, Aras A. Anthocyanins: targeting of signaling networks in cancer cells. Asian Pac J Cancer Prev. 2014;15(5):2379\u201381.","journal-title":"Asian Pac J Cancer Prev"},{"issue":"6","key":"1147_CR311","doi-asserted-by":"publisher","first-page":"S1520","DOI":"10.1093\/ajcn\/83.6.1520S","volume":"83","author":"RJ Deckelbaum","year":"2006","unstructured":"Deckelbaum RJ, Worgall TS, Seo T. n\u2009\u2013\u20093 fatty acids and gene expression. Am J Clin Nutr. 2006;83(6):S1520\u20135.","journal-title":"Am J Clin Nutr"},{"issue":"6","key":"1147_CR312","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1038\/nchembio.367","volume":"6","author":"AL Groeger","year":"2010","unstructured":"Groeger AL, Cipollina C, Cole MP, Woodcock SR, Bonacci G, Rudolph TK, et al. Cyclooxygenase-2 generates anti-inflammatory mediators from omega-3 fatty acids. Nat Chem Biol. 2010;6(6):433\u201341.","journal-title":"Nat Chem Biol"},{"key":"1147_CR313","doi-asserted-by":"crossref","unstructured":"Gu Z, Suburu J, Chen H, Chen YQ. Mechanisms of omega-3 polyunsaturated fatty acids in prostate cancer prevention. BioMed research international. 2013;2013.","DOI":"10.1155\/2013\/824563"},{"key":"1147_CR314","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.prostaglandins.2014.07.002","volume":"113","author":"W Wang","year":"2014","unstructured":"Wang W, Zhu J, Lyu F, Panigrahy D, Ferrara KW, Hammock B, et al. \u03c9-3 polyunsaturated fatty acids-derived lipid metabolites on angiogenesis, inflammation and cancer. Prostaglandins Other Lipid mediat. 2014;113:13\u201320.","journal-title":"Prostaglandins Other Lipid mediat"},{"issue":"7","key":"1147_CR315","doi-asserted-by":"publisher","first-page":"2559","DOI":"10.1158\/1078-0432.CCR-08-2503","volume":"15","author":"V Fradet","year":"2009","unstructured":"Fradet V, Cheng I, Casey G, Witte JS. Dietary omega-3 fatty acids, cyclooxygenase-2 genetic variation, and aggressive prostate cancer risk. Clin Cancer Res. 2009;15(7):2559\u201366.","journal-title":"Clin Cancer Res"},{"issue":"1","key":"1147_CR316","first-page":"968040","volume":"2012","author":"S Sikka","year":"2012","unstructured":"Sikka S, Chen L, Sethi G, Kumar AP. Targeting PPAR\u03b3 signaling cascade for the prevention and treatment of prostate cancer. PPAR Res. 2012;2012(1):968040.","journal-title":"PPAR Res"},{"issue":"2","key":"1147_CR317","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1002\/ijc.22319","volume":"120","author":"M Hedelin","year":"2007","unstructured":"Hedelin M, Chang ET, Wiklund F, Bellocco R, Klint \u00c5, Adolfsson J, et al. Association of frequent consumption of fatty fish with prostate cancer risk is modified by COX-2 polymorphism. Int J Cancer. 2007;120(2):398\u2013405.","journal-title":"Int J Cancer"},{"issue":"1\u20133","key":"1147_CR318","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.ejphar.2010.04.032","volume":"638","author":"B Stefanska","year":"2010","unstructured":"Stefanska B, Rudnicka K, Bednarek A, Fabianowska-Majewska K. Hypomethylation and induction of retinoic acid receptor beta 2 by concurrent action of adenosine analogues and natural compounds in breast cancer cells. Eur J Pharmacol. 2010;638(1\u20133):47\u201353.","journal-title":"Eur J Pharmacol"},{"key":"1147_CR319","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s12263-008-0079-0","volume":"3","author":"L Iacoviello","year":"2008","unstructured":"Iacoviello L, Santimone I, Latella MC, de Gaetano G, Donati MB. Nutrigenomics: a case for the common soil between cardiovascular disease and cancer. Genes Nutr. 2008;3:19\u201324.","journal-title":"Genes Nutr"},{"issue":"4","key":"1147_CR320","doi-asserted-by":"publisher","first-page":"616","DOI":"10.3390\/nu17040616","volume":"17","author":"N Singaravelan","year":"2025","unstructured":"Singaravelan N, Tollefsbol TO. Polyphenol-Based Prevention and Treatment of Cancer Through Epigenetic and Combinatorial Mechanisms. Nutrients [Internet]. 2025;17(4):616.","journal-title":"Nutrients [Internet]"},{"key":"1147_CR321","doi-asserted-by":"publisher","unstructured":"Zhao T, Li C, Wang S, Song X. Green tea (Camellia sinensis): a review of its phytochemistry, pharmacology, andtoxicology. Molecules. 2022;27(12):3909. https:\/\/doi.org\/10.3390\/molecules27123909","DOI":"10.3390\/molecules27123909"},{"issue":"11","key":"1147_CR322","first-page":"3881","volume":"7","author":"X Fei","year":"2014","unstructured":"Fei X, Shen Y, Li X, Guo H. The association of tea consumption and the risk and progression of prostate cancer: a meta-analysis. Int J Clin Exp Med. 2014;7(11):3881.","journal-title":"Int J Clin Exp Med"},{"issue":"12","key":"1147_CR323","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1016\/j.bcp.2010.06.036","volume":"80","author":"A Link","year":"2010","unstructured":"Link A, Balaguer F, Goel A. Cancer chemoprevention by dietary polyphenols: promising role for epigenetics. Biochem Pharmacol. 2010;80(12):1771\u201392.","journal-title":"Biochem Pharmacol"},{"issue":"4","key":"1147_CR324","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/S2222-1808(15)61040-4","volume":"6","author":"N Ullah","year":"2016","unstructured":"Ullah N, Ahmad M, Aslam H, Tahir MA, Aftab M, Bibi N, et al. Green tea phytocompounds as anticancer: A review. Asian Pac J Trop Disease. 2016;6(4):330\u20136.","journal-title":"Asian Pac J Trop Disease"},{"issue":"3","key":"1147_CR325","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1093\/carcin\/bgp314","volume":"31","author":"S Balasubramanian","year":"2010","unstructured":"Balasubramanian S, Adhikary G, Eckert RL. The Bmi-1 polycomb protein antagonizes the (\u2013)-epigallocatechin-3-gallate-dependent suppression of skin cancer cell survival. Carcinogenesis. 2010;31(3):496\u2013503.","journal-title":"Carcinogenesis"},{"issue":"5","key":"1147_CR326","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.phymed.2010.01.001","volume":"17","author":"F Farabegoli","year":"2010","unstructured":"Farabegoli F, Papi A, Bartolini G, Ostan R, Orlandi M. (-)-Epigallocatechin-3-gallate downregulates Pg-P and BCRP in a tamoxifen resistant MCF-7 cell line. Phytomedicine. 2010;17(5):356\u201362.","journal-title":"Phytomedicine"},{"key":"1147_CR327","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.phrs.2017.12.008","volume":"129","author":"MI Khan","year":"2018","unstructured":"Khan MI, Rath S, Adhami VM, Mukhtar H. Targeting epigenome with dietary nutrients in cancer: Current advances and future challenges. Pharmacol Res. 2018;129:375\u201387.","journal-title":"Pharmacol Res"},{"issue":"4","key":"1147_CR328","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1093\/carcin\/bgq285","volume":"32","author":"V Nandakumar","year":"2011","unstructured":"Nandakumar V, Vaid M, Katiyar SK. (\u2013)-Epigallocatechin-3-gallate reactivates silenced tumor suppressor genes, Cip1\/p21 and p 16 INK4a, by reducing DNA methylation and increasing histones acetylation in human skin cancer cells. Carcinogenesis. 2011;32(4):537\u201344.","journal-title":"Carcinogenesis"},{"issue":"1","key":"1147_CR329","first-page":"1","volume":"5","author":"I Rady","year":"2018","unstructured":"Rady I, Mohamed H, Rady M, Siddiqui IA, Mukhtar H. Cancer preventive and therapeutic effects of EGCG, the major polyphenol in green tea. Egypt J Basic Appl Sci. 2018;5(1):1\u201323.","journal-title":"Egypt J Basic Appl Sci"},{"key":"1147_CR330","doi-asserted-by":"crossref","unstructured":"Shankar E, Montellano J, Gupta S. Green tea polyphenols in the prevention and therapy of prostate cancer. Complementary and Alternative Medicines in Prostate Cancer: A Comprehensive Approach. 2016:114\u2009\u2013\u200924.","DOI":"10.1201\/9781315370156-6"},{"issue":"13","key":"1147_CR331","doi-asserted-by":"publisher","first-page":"e6426","DOI":"10.1097\/MD.0000000000006426","volume":"96","author":"Y Guo","year":"2017","unstructured":"Guo Y, Zhi F, Chen P, Zhao K, Xiang H, Mao Q, et al. Green tea and the risk of prostate cancer: A systematic review and meta-analysis. Medicine. 2017;96(13):e6426.","journal-title":"Medicine"},{"issue":"3","key":"1147_CR332","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1080\/01635581.2017.1285037","volume":"69","author":"SA Jacob","year":"2017","unstructured":"Jacob SA, Khan TM, Lee L-H. The effect of green tea consumption on prostate cancer risk and progression: a systematic review. Nutr Cancer. 2017;69(3):353\u201364.","journal-title":"Nutr Cancer"},{"issue":"1","key":"1147_CR333","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1002\/mc.21939","volume":"53","author":"R Kanwal","year":"2014","unstructured":"Kanwal R, Pandey M, Bhaskaran N, MacLennan GT, Fu P, Ponsky LE, et al. Protection against oxidative DNA damage and stress in human prostate by glutathione S-transferase P1. Mol Carcinog. 2014;53(1):8\u201318.","journal-title":"Mol Carcinog"},{"issue":"4","key":"1147_CR334","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1093\/carcin\/bgq285","volume":"32","author":"V Nandakumar","year":"2011","unstructured":"Nandakumar V, Vaid M, Katiyar SK. (-)-Epigallocatechin-3-gallate reactivates silenced tumor suppressor genes, Cip1\/p21 and p16INK4a, by reducing DNA methylation and increasing histones acetylation in human skin cancer cells. Carcinogenesis. 2011;32(4):537\u201344.","journal-title":"Carcinogenesis"},{"key":"1147_CR335","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1476-4598-9-274","volume":"9","author":"Y Li","year":"2010","unstructured":"Li Y, Yuan Y-Y, Meeran SM, Tollefsbol TO. Synergistic epigenetic reactivation of estrogen receptor-\u03b1 (ER\u03b1) by combined green tea polyphenol and histone deacetylase inhibitor in ER\u03b1-negative breast cancer cells. Mol Cancer. 2010;9:1\u201312.","journal-title":"Mol Cancer"},{"key":"1147_CR336","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1007\/s13167-018-0154-6","volume":"9","author":"S Uramova","year":"2018","unstructured":"Uramova S, Kubatka P, Dankova Z, Kapinova A, Zolakova B, Samec M, et al. Plant natural modulators in breast cancer prevention: status quo and future perspectives reinforced by predictive, preventive, and personalized medical approach. EPMA J. 2018;9:403\u201319.","journal-title":"EPMA J"},{"issue":"1","key":"1147_CR337","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.gene.2015.02.045","volume":"562","author":"F Vahid","year":"2015","unstructured":"Vahid F, Zand H, Nosrat\u2013Mirshekarlou E, Najafi R, Hekmatdoost A. The role dietary of bioactive compounds on the regulation of histone acetylases and deacetylases: a review. Gene. 2015;562(1):8\u201315.","journal-title":"Gene"},{"issue":"2","key":"1147_CR338","first-page":"73","volume":"41","author":"H Fujiki","year":"2018","unstructured":"Fujiki H, Watanabe T, Sueoka E, Rawangkan A, Suganuma M. Cancer prevention with green tea and its principal constituent, EGCG: From early investigations to current focus on human cancer stem cells. Mol Cells. 2018;41(2):73\u201382.","journal-title":"Mol Cells"},{"issue":"11","key":"1147_CR339","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1007\/s11095-005-7546-8","volume":"22","author":"G Shen","year":"2005","unstructured":"Shen G, Xu C, Hu R, Jain MR, Nair S, Lin W, et al. Comparison of (-)-epigallocatechin-3-gallate elicited liver and small intestine gene expression profiles between C57BL\/6J mice and C57BL\/6J\/Nrf2 (-\/-) mice. Pharm Res. 2005;22(11):1805\u201320.","journal-title":"Pharm Res"},{"issue":"8","key":"1147_CR340","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1002\/mnfr.201501017","volume":"60","author":"S Qin","year":"2016","unstructured":"Qin S, Hou DX. Multiple regulations of Keap1\/Nrf2 system by dietary phytochemicals. Mol Nutr Food Res. 2016;60(8):1731\u201355.","journal-title":"Mol Nutr Food Res"},{"issue":"1","key":"1147_CR341","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.canlet.2014.09.017","volume":"355","author":"S Shukla","year":"2014","unstructured":"Shukla S, Meeran SM, Katiyar SK. Epigenetic regulation by selected dietary phytochemicals in cancer chemoprevention. Cancer Lett. 2014;355(1):9\u201317.","journal-title":"Cancer Lett"},{"issue":"2","key":"1147_CR342","doi-asserted-by":"publisher","first-page":"627","DOI":"10.3892\/ijmm.2016.2626","volume":"38","author":"S Choi","year":"2016","unstructured":"Choi S, Youn J, Kim K, Joo DH, Shin S, Lee J, et al. Apigenin inhibits UVA-induced cytotoxicity in vitro and prevents signs of skin aging in vivo. Int J Mol Med. 2016;38(2):627\u201334.","journal-title":"Int J Mol Med"},{"key":"1147_CR343","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.redox.2015.04.009","volume":"5","author":"K Banerjee","year":"2015","unstructured":"Banerjee K, Mandal M. Oxidative stress triggered by naturally occurring flavone apigenin results in senescence and chemotherapeutic effect in human colorectal cancer cells. Redox Biol. 2015;5:153\u201362.","journal-title":"Redox Biol"},{"issue":"19","key":"1147_CR344","doi-asserted-by":"publisher","first-page":"9366","DOI":"10.3390\/ijms26199366","volume":"26","author":"A Zafar","year":"2025","unstructured":"Zafar A, Lahori D, Namit AF, Paxton Z, Ratna N, Thornton D, et al. Curcumin in Inflammatory Complications: Therapeutic Applications and Clinical Evidence. Int J Mol Sci [Internet]. 2025;26(19):9366.","journal-title":"Int J Mol Sci [Internet]"},{"issue":"3","key":"1147_CR345","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1016\/j.bmcl.2008.12.041","volume":"19","author":"Z Liu","year":"2009","unstructured":"Liu Z, Xie Z, Jones W, Pavlovicz RE, Liu S, Yu J, et al. Curcumin is a potent DNA hypomethylation agent. Bioorg Med Chem Lett. 2009;19(3):706\u20139.","journal-title":"Bioorg Med Chem Lett"},{"issue":"2","key":"1147_CR346","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s12263-011-0222-1","volume":"6","author":"S Reuter","year":"2011","unstructured":"Reuter S, Gupta SC, Park B, Goel A, Aggarwal BB. Epigenetic changes induced by curcumin and other natural compounds. Genes Nutr. 2011;6(2):93\u2013108.","journal-title":"Genes Nutr"},{"issue":"1","key":"1147_CR347","doi-asserted-by":"publisher","first-page":"9324085","DOI":"10.1155\/2016\/9324085","volume":"2016","author":"NV Klinger","year":"2016","unstructured":"Klinger NV, Mittal S. Therapeutic potential of curcumin for the treatment of brain tumors. Oxidative Med Cell Longev. 2016;2016(1):9324085.","journal-title":"Oxidative Med Cell Longev"},{"issue":"1","key":"1147_CR348","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1186\/s12885-024-12898-z","volume":"24","author":"W Deng","year":"2024","unstructured":"Deng W, Xiong X, Lu M, Huang S, Luo Y, Wang Y, et al. Curcumin suppresses colorectal tumorigenesis through restoring the gut microbiota and metabolites. BMC Cancer. 2024;24(1):1141.","journal-title":"BMC Cancer"},{"issue":"4","key":"1147_CR349","doi-asserted-by":"publisher","first-page":"2150","DOI":"10.3390\/ijms23042150","volume":"23","author":"SK Vemuri","year":"2022","unstructured":"Vemuri SK, Halder S, Banala RR, Rachamalla HK, Devraj VM, Mallarpu CS, et al. Modulatory effects of biosynthesized gold nanoparticles conjugated with curcumin and paclitaxel on tumorigenesis and metastatic pathways\u2014in vitro and in vivo studies. Int J Mol Sci. 2022;23(4):2150.","journal-title":"Int J Mol Sci"},{"issue":"8","key":"1147_CR350","doi-asserted-by":"publisher","first-page":"2608","DOI":"10.3390\/nu13082608","volume":"13","author":"Y Sunagawa","year":"2021","unstructured":"Sunagawa Y, Funamoto M, Shimizu K, Shimizu S, Sari N, Katanasaka Y, et al. Curcumin, an inhibitor of p300-HAT activity, suppresses the development of hypertension-induced left ventricular hypertrophy with preserved ejection fraction in dahl rats. Nutrients. 2021;13(8):2608.","journal-title":"Nutrients"},{"key":"1147_CR351","doi-asserted-by":"publisher","unstructured":"Kursvietiene L, Kopustinskiene DM, Staneviciene I, Mongirdiene A, Kubov\u00e1 K, Masteikova R, Bernatoniene J. Anti- cancer properties of resveratrol: a focus on its impact on mitochondrial functions. Antioxidants (Basel).2023;12(12):2056. https:\/\/doi.org\/10.3390\/antiox12122056","DOI":"10.3390\/antiox12122056"},{"key":"1147_CR352","doi-asserted-by":"publisher","first-page":"841818","DOI":"10.3389\/fphar.2022.841818","volume":"13","author":"HC Hu","year":"2022","unstructured":"Hu HC, Lei YH, Zhang WH, Luo XQ. Antioxidant and Anti-inflammatory Properties of Resveratrol in Diabetic Nephropathy: A Systematic Review and Meta-analysis of Animal Studies. Front Pharmacol. 2022;13:841818.","journal-title":"Front Pharmacol"},{"issue":"12","key":"1147_CR353","doi-asserted-by":"publisher","first-page":"2589","DOI":"10.3390\/ijms18122589","volume":"18","author":"J-H Ko","year":"2017","unstructured":"Ko J-H, Sethi G, Um J-Y, Shanmugam MK, Arfuso F, Kumar AP, et al. The role of resveratrol in cancer therapy. Int J Mol Sci. 2017;18(12):2589.","journal-title":"Int J Mol Sci"},{"issue":"15","key":"1147_CR354","doi-asserted-by":"publisher","first-page":"4521","DOI":"10.7150\/jca.34374","volume":"11","author":"B Rizeq","year":"2020","unstructured":"Rizeq B, Gupta I, Ilesanmi J, AlSafran M, Rahman MM, Ouhtit A. The power of phytochemicals combination in cancer chemoprevention. J Cancer. 2020;11(15):4521.","journal-title":"J Cancer"},{"issue":"19","key":"1147_CR355","doi-asserted-by":"publisher","first-page":"7033","DOI":"10.1158\/1078-0432.CCR-05-0406","volume":"11","author":"MZ Fang","year":"2005","unstructured":"Fang MZ, Chen D, Sun Y, Jin Z, Christman JK, Yang CS. Reversal of hypermethylation and reactivation of p16INK4a, RAR\u03b2, and MGMT genes by genistein and other isoflavones from soy. Clin Cancer Res. 2005;11(19):7033\u201341.","journal-title":"Clin Cancer Res"},{"issue":"1","key":"1147_CR356","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1002\/em.20363","volume":"49","author":"A King-Batoon","year":"2008","unstructured":"King-Batoon A, Leszczynska JM, Klein CB. Modulation of gene methylation by genistein or lycopene in breast cancer cells. Environ Mol Mutagen. 2008;49(1):36\u201345.","journal-title":"Environ Mol Mutagen"},{"issue":"1","key":"1147_CR357","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1166\/jnn.2013.6882","volume":"13","author":"C Braicu","year":"2013","unstructured":"Braicu C, Gherman CD, Irimie A, Berindan-Neagoe I. Epigallocatechin-3-Gallate (EGCG) inhibits cell proliferation and migratory behaviour of triple negative breast cancer cells. J Nanosci Nanotechnol. 2013;13(1):632\u20137.","journal-title":"J Nanosci Nanotechnol"},{"key":"1147_CR358","doi-asserted-by":"publisher","unstructured":"Tardy AL, Pouteau E, Marquez D, Yilmaz C, Scholey A. Vitamins and minerals for energy, fatigue and cognition: anarrative review of the biochemical and clinical evidence. Nutrients. 2020;12(1):228. https:\/\/doi.org\/10.3390\/nu12010228","DOI":"10.3390\/nu12010228"},{"issue":"4","key":"1147_CR359","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1016\/j.fct.2007.06.035","volume":"46","author":"M Fenech","year":"2008","unstructured":"Fenech M. Genome health nutrigenomics and nutrigenetics\u2013diagnosis and nutritional treatment of genome damage on an individual basis. Food Chem Toxicol. 2008;46(4):1365\u201370.","journal-title":"Food Chem Toxicol"},{"issue":"2","key":"1147_CR360","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1158\/0008-5472.CAN-09-3410","volume":"70","author":"CA Stidley","year":"2010","unstructured":"Stidley CA, Picchi MA, Leng S, Willink R, Crowell RE, Flores KG, et al. Multivitamins, folate, and green vegetables protect against gene promoter methylation in the aerodigestive tract of smokers. Cancer Res. 2010;70(2):568\u201374.","journal-title":"Cancer Res"},{"issue":"3","key":"1147_CR361","doi-asserted-by":"publisher","first-page":"2633","DOI":"10.3390\/ijms24032633","volume":"24","author":"G Genchi","year":"2023","unstructured":"Genchi G, Lauria G, Catalano A, Sinicropi MS, Carocci A. Biological Activity of Selenium and Its Impact on Human Health. Int J Mol Sci [Internet]. 2023;24(3):2633.","journal-title":"Int J Mol Sci [Internet]"},{"issue":"3","key":"1147_CR362","first-page":"313","volume":"23","author":"H Busch","year":"1963","unstructured":"Busch H, Byvoet P, Smetana K. The nucleolus of the cancer cell: a review. Cancer Res. 1963;23(3):313\u201339.","journal-title":"Cancer Res"},{"key":"1147_CR363","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.gde.2017.10.011","volume":"48","author":"S Biffo","year":"2018","unstructured":"Biffo S, Manfrini N, Ricciardi S. Crosstalks between translation and metabolism in cancer. Curr Opin Genet Dev. 2018;48:75\u201381.","journal-title":"Curr Opin Genet Dev"},{"key":"1147_CR364","doi-asserted-by":"publisher","first-page":"101097","DOI":"10.1016\/j.mam.2022.101097","volume":"86","author":"S Pan","year":"2022","unstructured":"Pan S, Chen R. Pathological implication of protein post-translational modifications in cancer. Mol Aspects Med. 2022;86:101097.","journal-title":"Mol Aspects Med"},{"issue":"3","key":"1147_CR365","first-page":"118","volume":"3","author":"JR Hoffman","year":"2004","unstructured":"Hoffman JR, Falvo MJ. Protein\u2013which is best? J sports Sci Med. 2004;3(3):118.","journal-title":"J sports Sci Med"},{"issue":"1","key":"1147_CR366","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/s12276-020-0375-3","volume":"52","author":"EL Lieu","year":"2020","unstructured":"Lieu EL, Nguyen T, Rhyne S, Kim J. Amino acids in cancer. Exp Mol Med. 2020;52(1):15\u201330.","journal-title":"Exp Mol Med"},{"issue":"1","key":"1147_CR367","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s12916-023-02739-4","volume":"21","author":"JA Rothwell","year":"2023","unstructured":"Rothwell JA, Be\u0161evi\u0107 J, Dimou N, Breeur M, Murphy N, Jenab M, et al. Circulating amino acid levels and colorectal cancer risk in the European Prospective Investigation into Cancer and Nutrition and UK Biobank cohorts. BMC Med. 2023;21(1):80.","journal-title":"BMC Med"},{"issue":"1","key":"1147_CR368","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1186\/s12885-023-11514-w","volume":"23","author":"Y Wang","year":"2023","unstructured":"Wang Y, Jia Z, Wang Q, Zhu Z. Amino acids and risk of colon adenocarcinoma: a Mendelian randomization study. BMC Cancer. 2023;23(1):1041.","journal-title":"BMC Cancer"},{"issue":"1","key":"1147_CR369","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1186\/s12864-022-08442-7","volume":"23","author":"Y Lin","year":"2022","unstructured":"Lin Y, Yang Z, Li J, Sun Y, Zhang X, Qu Z, et al. Effects of glutamate and aspartate on prostate cancer and breast cancer: a Mendelian randomization study. BMC Genomics. 2022;23(1):213.","journal-title":"BMC Genomics"},{"issue":"4","key":"1147_CR370","doi-asserted-by":"publisher","first-page":"568","DOI":"10.3390\/biom10040568","volume":"10","author":"P Kaiser","year":"2020","unstructured":"Kaiser P. Methionine dependence of cancer. Biomolecules. 2020;10(4):568.","journal-title":"Biomolecules"},{"issue":"2","key":"1147_CR371","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1016\/0003-9861(59)90225-5","volume":"81","author":"T Sugimura","year":"1959","unstructured":"Sugimura T, Birnbaum SM, Winitz M, Greenstein JP. Quantitative nutritional studies with water-soluble, chemically defined diets. VIII. The forced feeding of diets each lacking in one essential amino acid. Arch Biochem Biophys. 1959;81(2):448\u201355.","journal-title":"Arch Biochem Biophys"},{"issue":"23","key":"1147_CR372","first-page":"5676","volume":"53","author":"H Guo","year":"1993","unstructured":"Guo H, Lishko VK, Herrera H, Groce A, Kubota T, Hoffman RM. Therapeutic tumor-specific cell cycle block induced by methionine starvation in vivo. Cancer Res. 1993;53(23):5676\u20139.","journal-title":"Cancer Res"},{"issue":"2","key":"1147_CR373","first-page":"643","volume":"6","author":"F Poirson-Bichat","year":"2000","unstructured":"Poirson-Bichat F, Goncalves RB, Miccoli L, Dutrillaux B, Poupon M. Methionine depletion enhances the antitumoral efficacy of cytotoxic agents in drug-resistant human tumor xenografts. Clin Cancer Res. 2000;6(2):643\u201353.","journal-title":"Clin Cancer Res"},{"issue":"8","key":"1147_CR374","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1016\/j.jnutbio.2012.03.003","volume":"23","author":"OS Anderson","year":"2012","unstructured":"Anderson OS, Sant KE, Dolinoy DC. Nutrition and epigenetics: an interplay of dietary methyl donors, one-carbon metabolism and DNA methylation. J Nutr Biochem. 2012;23(8):853\u20139.","journal-title":"J Nutr Biochem"},{"issue":"4","key":"1147_CR375","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1093\/jnci\/87.4.265","volume":"87","author":"E Giovannucci","year":"1995","unstructured":"Giovannucci E, Rimm EB, Ascherio A, Stampfer MJ, Colditz GA, Willett WC. Alcohol, low-methionine-low-folate diets, and risk of colon cancer in men. JNCI: J Natl Cancer Inst. 1995;87(4):265\u201373.","journal-title":"JNCI: J Natl Cancer Inst"},{"key":"1147_CR376","doi-asserted-by":"publisher","first-page":"102851","DOI":"10.1016\/j.ctim.2022.102851","volume":"70","author":"MA Alzahrani","year":"2022","unstructured":"Alzahrani MA, Ahmad MS, Alkhamees M, Aljuhayman A, Binsaleh S, Tiwari R, et al. Dietary protein intake and prostate cancer risk in adults: A systematic review and dose-response meta-analysis of prospective cohort studies. Complement Ther Med. 2022;70:102851.","journal-title":"Complement Ther Med"},{"issue":"10","key":"1147_CR377","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1017\/S0007114522002380","volume":"129","author":"Z Zhao","year":"2023","unstructured":"Zhao Z, Wu D, Gao S, Zhou D, Zeng X, Yao Y, et al. The association between dairy products consumption and prostate cancer risk: a systematic review and meta-analysis. Br J Nutr. 2023;129(10):1714\u201331.","journal-title":"Br J Nutr"},{"issue":"12","key":"1147_CR378","doi-asserted-by":"publisher","first-page":"a030361","DOI":"10.1101\/cshperspect.a030361","volume":"8","author":"CH Pernar","year":"2018","unstructured":"Pernar CH, Ebot EM, Wilson KM, Mucci LA. The epidemiology of prostate cancer. Cold Spring Harbor Perspect Med. 2018;8(12):a030361.","journal-title":"Cold Spring Harbor Perspect Med"},{"key":"1147_CR379","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1007\/s10552-019-01210-1","volume":"30","author":"LM Liao","year":"2019","unstructured":"Liao LM, Loftfield E, Etemadi A, Graubard BI, Sinha R. Substitution of dietary protein sources in relation to colorectal cancer risk in the NIH-AARP cohort study. Cancer Causes Control. 2019;30:1127\u201335.","journal-title":"Cancer Causes Control"},{"key":"1147_CR380","doi-asserted-by":"publisher","unstructured":"K\u00fchn T, Kalotai N, Amini AM, Haardt J, Lehmann A, Schmidt A, Buyken AE, Egert S, Ellinger S, Kroke A, Lorkowski S,Louis S, Schulze MB, Schwingshackl L, Siener R, Stangl GI, Watzl B, Zittermann A, Nimptsch K; German NutritionSociety. Protein intake and cancer: an umbrella review of systematic reviews for the evidence-based guideline of theGerman Nutrition Society. Eur J Nutr. 2024;63(5):1471-1486. https:\/\/doi.org\/10.1007\/s00394-024-03380-4","DOI":"10.1007\/s00394-024-03380-4"},{"issue":"5","key":"1147_CR381","doi-asserted-by":"publisher","first-page":"2898","DOI":"10.1016\/j.clnu.2021.02.005","volume":"40","author":"M Muscaritoli","year":"2021","unstructured":"Muscaritoli M, Arends J, Bachmann P, Baracos V, Barthelemy N, Bertz H, et al. ESPEN practical guideline: Clinical Nutrition in cancer. Clin Nutr. 2021;40(5):2898\u2013913.","journal-title":"Clin Nutr"},{"issue":"10","key":"1147_CR382","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1016\/j.devcel.2021.04.013","volume":"56","author":"LA Broadfield","year":"2021","unstructured":"Broadfield LA, Pane AA, Talebi A, Swinnen JV, Fendt S-M. Lipid metabolism in cancer: New perspectives and emerging mechanisms. Dev Cell. 2021;56(10):1363\u201393.","journal-title":"Dev Cell"},{"issue":"9","key":"1147_CR383","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1038\/sj.bjc.6605007","volume":"100","author":"T Mashima","year":"2009","unstructured":"Mashima T, Seimiya H, Tsuruo T. De novo fatty-acid synthesis and related pathways as molecular targets for cancer therapy. Br J Cancer. 2009;100(9):1369\u201372.","journal-title":"Br J Cancer"},{"issue":"1","key":"1147_CR384","doi-asserted-by":"publisher","first-page":"R146","DOI":"10.1152\/ajpregu.1984.247.1.R146","volume":"247","author":"M Ookhtens","year":"1984","unstructured":"Ookhtens M, Kannan R, Lyon I, Baker N. Liver and adipose tissue contributions to newly formed fatty acids in an ascites tumor. Am J Physiology-Regulatory Integr Comp Physiol. 1984;247(1):R146\u201353.","journal-title":"Am J Physiology-Regulatory Integr Comp Physiol"},{"issue":"3","key":"1147_CR385","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1002\/pros.10297","volume":"57","author":"BR Pflug","year":"2003","unstructured":"Pflug BR, Pecher SM, Brink AW, Nelson JB, Foster BA. Increased fatty acid synthase expression and activity during progression of prostate cancer in the TRAMP model. Prostate. 2003;57(3):245\u201354.","journal-title":"Prostate"},{"issue":"1","key":"1147_CR386","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1002\/ijc.10127","volume":"98","author":"JV Swinnen","year":"2002","unstructured":"Swinnen JV, Roskams T, Joniau S, Van Poppel H, Oyen R, Baert L, et al. Overexpression of fatty acid synthase is an early and common event in the development of prostate cancer. Int J Cancer. 2002;98(1):19\u201322.","journal-title":"Int J Cancer"},{"issue":"4","key":"1147_CR387","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1016\/j.bbrc.2015.05.108","volume":"463","author":"Y Bian","year":"2015","unstructured":"Bian Y, Yu Y, Wang S, Li L. Up-regulation of fatty acid synthase induced by EGFR\/ERK activation promotes tumor growth in pancreatic cancer. Biochem Biophys Res Commun. 2015;463(4):612\u20137.","journal-title":"Biochem Biophys Res Commun"},{"key":"1147_CR388","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.addr.2020.07.013","volume":"159","author":"LM Butler","year":"2020","unstructured":"Butler LM, Perone Y, Dehairs J, Lupien LE, de Laat V, Talebi A, et al. Lipids and cancer: Emerging roles in pathogenesis, diagnosis and therapeutic intervention. Adv Drug Deliv Rev. 2020;159:245\u201393.","journal-title":"Adv Drug Deliv Rev"},{"issue":"1","key":"1147_CR389","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1002\/mco2.27","volume":"2","author":"Y Fu","year":"2021","unstructured":"Fu Y, Zou T, Shen X, Nelson PJ, Li J, Wu C, et al. Lipid metabolism in cancer progression and therapeutic strategies. MedComm. 2021;2(1):27\u201359.","journal-title":"MedComm"},{"issue":"3","key":"1147_CR390","doi-asserted-by":"publisher","first-page":"311","DOI":"10.2174\/156802607779941314","volume":"7","author":"SP Khanapure","year":"2007","unstructured":"Khanapure SP, Garvey DS, Janero DR, Gordon Letts L. Eicosanoids in inflammation: biosynthesis, pharmacology, and therapeutic frontiers. Curr Top Med Chem. 2007;7(3):311\u201340.","journal-title":"Curr Top Med Chem"},{"issue":"3","key":"1147_CR391","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/nrc2809","volume":"10","author":"D Wang","year":"2010","unstructured":"Wang D, DuBois RN. Eicosanoids and cancer. Nat Rev Cancer. 2010;10(3):181\u201393.","journal-title":"Nat Rev Cancer"},{"issue":"12","key":"1147_CR392","doi-asserted-by":"publisher","first-page":"434","DOI":"10.3390\/biology9120434","volume":"9","author":"F Finetti","year":"2020","unstructured":"Finetti F, Travelli C, Ercoli J, Colombo G, Buoso E, Trabalzini L. Prostaglandin E2 and cancer: insight into tumor progression and immunity. Biology. 2020;9(12):434.","journal-title":"Biology"},{"key":"1147_CR393","doi-asserted-by":"crossref","unstructured":"Jala VR, Bodduluri SR, Satpathy SR, Chheda Z, Sharma RK, Haribabu B, editors. The yin and yang of leukotriene B4 mediated inflammation in cancer. Seminars in immunology. Elsevier; 2017.","DOI":"10.1016\/j.smim.2017.09.005"},{"key":"1147_CR394","doi-asserted-by":"crossref","unstructured":"Murata T, Aritake K, Matsumoto S, Kamauchi S, Nakagawa T, Hori M et al. Prostagladin D2 is a mast cell-derived antiangiogenic factor in lung carcinoma. Proceedings of the National Academy of Sciences. 2011;108(49):19802-7.","DOI":"10.1073\/pnas.1110011108"},{"issue":"5","key":"1147_CR395","doi-asserted-by":"publisher","first-page":"945","DOI":"10.3390\/nu11050945","volume":"11","author":"RD Freitas","year":"2019","unstructured":"Freitas RD, Campos MM. Protective effects of omega-3 fatty acids in cancer-related complications. Nutrients. 2019;11(5):945.","journal-title":"Nutrients"},{"issue":"5","key":"1147_CR396","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1093\/advances\/nmaa055","volume":"11","author":"KH Lee","year":"2020","unstructured":"Lee KH, Seong HJ, Kim G, Jeong GH, Kim JY, Park H, et al. Consumption of fish and \u03c9-3 fatty acids and cancer risk: an umbrella review of meta-analyses of observational studies. Adv Nutr. 2020;11(5):1134\u201349.","journal-title":"Adv Nutr"},{"key":"1147_CR397","doi-asserted-by":"publisher","unstructured":"Batch JT, Lamsal SP, Adkins M, Sultan S, Ramirez MN. Advantages and disadvantages of the ketogenic diet: a reviewarticle. Cureus. 2020;12(8):e9639. https:\/\/doi.org\/10.7759\/cureus.9639","DOI":"10.7759\/cureus.9639"},{"issue":"2","key":"1147_CR398","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1159\/000484045","volume":"25","author":"RJ Klement","year":"2018","unstructured":"Klement RJ. Fasting, fats, and physics: combining ketogenic and radiation therapy against cancer. Complement Med Res. 2018;25(2):102\u201313.","journal-title":"Complement Med Res"},{"issue":"13","key":"1147_CR399","doi-asserted-by":"publisher","first-page":"17060","DOI":"10.18632\/oncotarget.7929","volume":"7","author":"RJ Morscher","year":"2016","unstructured":"Morscher RJ, Aminzadeh-Gohari S, Hauser-Kronberger C, Feichtinger RG, Sperl W, Kofler B. Combination of metronomic cyclophosphamide and dietary intervention inhibits neuroblastoma growth in a CD1-nu mouse model. Oncotarget. 2016;7(13):17060.","journal-title":"Oncotarget"},{"issue":"2","key":"1147_CR400","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.medj.2021.12.008","volume":"3","author":"L Yang","year":"2022","unstructured":"Yang L, TeSlaa T, Ng S, Nofal M, Wang L, Lan T, et al. Ketogenic diet and chemotherapy combine to disrupt pancreatic cancer metabolism and growth. Med. 2022;3(2):119\u201336. e8.","journal-title":"Med"},{"key":"1147_CR401","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.molmet.2019.06.026","volume":"33","author":"DD Weber","year":"2020","unstructured":"Weber DD, Aminzadeh-Gohari S, Tulipan J, Catalano L, Feichtinger RG, Kofler B. Ketogenic diet in the treatment of cancer\u2013where do we stand? Mol metabolism. 2020;33:102\u201321.","journal-title":"Mol metabolism"},{"issue":"20","key":"1147_CR402","doi-asserted-by":"publisher","first-page":"4357","DOI":"10.3390\/nu15204357","volume":"15","author":"AG Urz\u00ec","year":"2023","unstructured":"Urz\u00ec AG, Tropea E, Gattuso G, Spoto G, Marsala G, Calina D, et al. Ketogenic diet and breast cancer: recent findings and therapeutic approaches. Nutrients. 2023;15(20):4357.","journal-title":"Nutrients"},{"issue":"3","key":"1147_CR403","doi-asserted-by":"publisher","first-page":"794","DOI":"10.3390\/nu15030794","volume":"15","author":"R Bajracharya","year":"2023","unstructured":"Bajracharya R, Katzke V, Mukama T, Kaaks R. Effect of iso-caloric substitution of animal protein for other macro nutrients on risk of overall, cardiovascular and cancer mortality: prospective evaluation in EPIC-Heidelberg cohort and systematic review. Nutrients. 2023;15(3):794.","journal-title":"Nutrients"},{"issue":"3","key":"1147_CR404","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1080\/10408398.2017.1379470","volume":"59","author":"K Ganesan","year":"2019","unstructured":"Ganesan K, Sukalingam K, Xu B. Impact of consumption of repeatedly heated cooking oils on the incidence of various cancers-A critical review. Crit Rev Food Sci Nutr. 2019;59(3):488\u2013505.","journal-title":"Crit Rev Food Sci Nutr"},{"issue":"10","key":"1147_CR405","doi-asserted-by":"publisher","first-page":"2819","DOI":"10.3390\/cancers12102819","volume":"12","author":"RM Pascale","year":"2020","unstructured":"Pascale RM, Calvisi DF, Simile MM, Feo CF, Feo F. The Warburg effect 97 years after its discovery. Cancers. 2020;12(10):2819.","journal-title":"Cancers"},{"issue":"3","key":"1147_CR406","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.tibs.2015.12.001","volume":"41","author":"MV Liberti","year":"2016","unstructured":"Liberti MV, Locasale JW. The Warburg effect: how does it benefit cancer cells? Trends Biochem Sci. 2016;41(3):211\u20138.","journal-title":"Trends Biochem Sci"},{"key":"1147_CR407","doi-asserted-by":"publisher","unstructured":"Barba I, Carrillo-Bosch L, Seoane J. Targeting the Warburg eff ect in cancer: where do we stand? Int J Mol Sci.2024;25(6):3142. https:\/\/doi.org\/10.3390\/ijms25063142","DOI":"10.3390\/ijms25063142"},{"issue":"11","key":"1147_CR408","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1038\/nrc1478","volume":"4","author":"RA Gatenby","year":"2004","unstructured":"Gatenby RA, Gillies RJ. Why do cancers have high aerobic glycolysis? Nat Rev Cancer. 2004;4(11):891\u20139.","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"1147_CR409","first-page":"205357","volume":"2010","author":"MB Calvo","year":"2010","unstructured":"Calvo MB, Figueroa A, Pulido EG, Campelo RG, Aparicio LA. Potential role of sugar transporters in cancer and their relationship with anticancer therapy. Int J Endocrinol. 2010;2010(1):205357.","journal-title":"Int J Endocrinol"},{"issue":"16","key":"1147_CR410","doi-asserted-by":"publisher","first-page":"4184","DOI":"10.3390\/cancers13164184","volume":"13","author":"M Pliszka","year":"2021","unstructured":"Pliszka M, Szablewski L. Glucose transporters as a target for anticancer therapy. Cancers. 2021;13(16):4184.","journal-title":"Cancers"},{"issue":"3","key":"1147_CR411","doi-asserted-by":"publisher","first-page":"345","DOI":"10.3390\/metabo13030345","volume":"13","author":"MK Ediriweera","year":"2023","unstructured":"Ediriweera MK, Jayasena S. The role of reprogrammed glucose metabolism in cancer. Metabolites. 2023;13(3):345.","journal-title":"Metabolites"},{"issue":"6","key":"1147_CR412","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1038\/s41581-019-0129-4","volume":"15","author":"C Reily","year":"2019","unstructured":"Reily C, Stewart TJ, Renfrow MB, Novak J. Glycosylation in health and disease. Nat Rev Nephrol. 2019;15(6):346\u201366.","journal-title":"Nat Rev Nephrol"},{"key":"1147_CR413","doi-asserted-by":"publisher","unstructured":"Thomas D, Rathinavel AK, Radhakrishnan P. Altered glycosylation in cancer: a promising target for biomarkers andtherapeutics. Biochim Biophys Acta Rev Cancer. 2021;1875(1):188464. https:\/\/doi.org\/10.1016\/j.bbcan.2020.188464","DOI":"10.1016\/j.bbcan.2020.188464"},{"issue":"1084","key":"1147_CR414","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1136\/postgradmedj-2015-133281","volume":"92","author":"F Zaccardi","year":"2016","unstructured":"Zaccardi F, Webb DR, Yates T, Davies MJ. Pathophysiology of type 1 and type 2 diabetes mellitus: a 90-year perspective. Postgrad Med J. 2016;92(1084):63\u20139.","journal-title":"Postgrad Med J"},{"issue":"22","key":"1147_CR415","doi-asserted-by":"publisher","first-page":"5735","DOI":"10.3390\/cancers13225735","volume":"13","author":"RK Shahid","year":"2021","unstructured":"Shahid RK, Ahmed S, Le D, Yadav S. Diabetes and cancer: risk, challenges, management and outcomes. Cancers. 2021;13(22):5735.","journal-title":"Cancers"},{"key":"1147_CR416","doi-asserted-by":"publisher","first-page":"800995","DOI":"10.3389\/fendo.2022.800995","volume":"13","author":"B Zhu","year":"2022","unstructured":"Zhu B, Qu S. The relationship between diabetes mellitus and cancers and its underlying mechanisms. Front Endocrinol. 2022;13:800995.","journal-title":"Front Endocrinol"},{"issue":"8","key":"1147_CR417","doi-asserted-by":"publisher","first-page":"2179","DOI":"10.3390\/molecules26082179","volume":"26","author":"WH Talib","year":"2021","unstructured":"Talib WH, Mahmod AI, Abuarab SF, Hasen E, Munaim AA, Haif SK, et al. Diabetes and cancer: metabolic association, therapeutic challenges, and the role of natural products. Molecules. 2021;26(8):2179.","journal-title":"Molecules"},{"issue":"22","key":"1147_CR418","doi-asserted-by":"publisher","first-page":"6802","DOI":"10.3390\/molecules26226802","volume":"26","author":"Z-W Guan","year":"2021","unstructured":"Guan Z-W, Yu E-Z, Feng Q. Soluble dietary fiber, one of the most important nutrients for the gut microbiota. Molecules. 2021;26(22):6802.","journal-title":"Molecules"},{"key":"1147_CR419","doi-asserted-by":"publisher","unstructured":"Weisburger JH, Reddy BS, Rose DP, Cohen LA, Kendall ME, Wynder EL. Protective mechanisms of dietary fi bers innutritional carcinogenesis. Basic Life Sci. 1993;61:45-63. https:\/\/doi.org\/10.1007\/978-1-4615-2984-2_4","DOI":"10.1007\/978-1-4615-2984-2_4"},{"issue":"2","key":"1147_CR420","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.jand.2016.09.021","volume":"117","author":"JW McRorie Jr","year":"2017","unstructured":"McRorie JW Jr, McKeown NM. Understanding the physics of functional fibers in the gastrointestinal tract: an evidence-based approach to resolving enduring misconceptions about insoluble and soluble fiber. J Acad Nutr Dietetics. 2017;117(2):251\u201364.","journal-title":"J Acad Nutr Dietetics"},{"issue":"3","key":"1147_CR421","doi-asserted-by":"publisher","first-page":"230014","DOI":"10.1098\/rsob.230014","volume":"13","author":"L-M Ney","year":"2023","unstructured":"Ney L-M, Wipplinger M, Grossmann M, Engert N, Wegner VD, Mosig AS. Short chain fatty acids: key regulators of the local and systemic immune response in inflammatory diseases and infections. Open Biology. 2023;13(3):230014.","journal-title":"Open Biology"},{"issue":"7","key":"1147_CR422","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.3390\/nu16071047","volume":"16","author":"J Khan","year":"2024","unstructured":"Khan J, Gul P, Rashid MT, Li Q, Liu K. Composition of Whole Grain Dietary Fiber and Phenolics and Their Impact on Markers of Inflammation. Nutrients. 2024;16(7):1047.","journal-title":"Nutrients"},{"issue":"4","key":"1147_CR423","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.1016\/j.clnu.2020.10.032","volume":"40","author":"Y Xie","year":"2021","unstructured":"Xie Y, Gou L, Peng M, Zheng J, Chen L. Effects of soluble fiber supplementation on glycemic control in adults with type 2 diabetes mellitus: a systematic review and meta-analysis of randomized controlled trials. Clin Nutr. 2021;40(4):1800\u201310.","journal-title":"Clin Nutr"},{"issue":"1","key":"1147_CR424","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1093\/jn\/nxx008","volume":"148","author":"MO Weickert","year":"2018","unstructured":"Weickert MO, Pfeiffer AF. Impact of dietary fiber consumption on insulin resistance and the prevention of type 2 diabetes. J Nutr. 2018;148(1):7\u201312.","journal-title":"J Nutr"},{"issue":"21","key":"1147_CR425","doi-asserted-by":"publisher","first-page":"11556","DOI":"10.3390\/ijerph182111556","volume":"18","author":"D Nucci","year":"2021","unstructured":"Nucci D, Santangelo OE, Provenzano S, Fatigoni C, Nardi M, Ferrara P, et al. Dietary fiber intake and risk of pancreatic cancer: systematic review and meta-analysis of observational studies. Int J Environ Res Public Health. 2021;18(21):11556.","journal-title":"Int J Environ Res Public Health"},{"issue":"13","key":"1147_CR426","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1093\/jnci\/88.13.899","volume":"88","author":"LA Cohen","year":"1996","unstructured":"Cohen LA, Zhao Z, Zang EA, Wynn TT, Simi B, Rivenson A. Wheat Bran and Psylium Diets: Effects on N-Methylnitrosourea-Induced Mammary Tumorigenesis in F344 Rats. JNCI: J Natl Cancer Inst. 1996;88(13):899\u2013907.","journal-title":"JNCI: J Natl Cancer Inst"},{"issue":"1","key":"1147_CR427","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1017\/S095442242100024X","volume":"36","author":"J Walton","year":"2023","unstructured":"Walton J, Bell H, Re R, Nugent AP. Current perspectives on global sugar consumption: definitions, recommendations, population intakes, challenges and future direction. Nutr Res Rev. 2023;36(1):1\u201322.","journal-title":"Nutr Res Rev"},{"key":"1147_CR428","doi-asserted-by":"publisher","unstructured":"Huang Y, Chen Z, Chen B, Li J, Yuan X, Li J, Wang W, Dai T, Chen H, Wang Y, Wang R, Wang P, Guo J, Dong Q, Liu C,Wei Q, Cao D, Liu L. Dietary sugar consumption and health: umbrella review. BMJ. 2023;381:e071609. https:\/\/doi.org\/10.1136\/bmj-2022-071609","DOI":"10.1136\/bmj-2022-071609"},{"issue":"4","key":"1147_CR429","doi-asserted-by":"publisher","first-page":"889","DOI":"10.3390\/nu15040889","volume":"15","author":"KM Gillespie","year":"2023","unstructured":"Gillespie KM, Kemps E, White MJ, Bartlett SE. The impact of free sugar on human health\u2014a narrative review. Nutrients. 2023;15(4):889.","journal-title":"Nutrients"},{"issue":"24","key":"1147_CR430","doi-asserted-by":"publisher","first-page":"6042","DOI":"10.3390\/cancers14246042","volume":"14","author":"M Epner","year":"2022","unstructured":"Epner M, Yang P, Wagner RW, Cohen L. Understanding the link between sugar and cancer: an examination of the preclinical and clinical evidence. Cancers. 2022;14(24):6042.","journal-title":"Cancers"},{"key":"1147_CR431","doi-asserted-by":"publisher","unstructured":"Plata-G\u00f3mez AB, Ho PC. Age- and diet-instructed metabolic rewiring of the tumor\u2013immune microenvironment. J ExpMed. 2025;222(6):e20241102. https:\/\/doi.org\/10.1084\/jem.20241102","DOI":"10.1084\/jem.20241102"},{"issue":"5","key":"1147_CR432","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1016\/j.chembiol.2024.02.001","volume":"31","author":"NM Chapman","year":"2024","unstructured":"Chapman NM, Chi H. Metabolic rewiring and communication in cancer immunity. Cell Chem Biol. 2024;31(5):862\u201383.","journal-title":"Cell Chem Biol"},{"issue":"1","key":"1147_CR433","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1038\/s42255-024-01191-9","volume":"7","author":"M Nshanian","year":"2025","unstructured":"Nshanian M, Gruber JJ, Geller BS, Chleilat F, Lancaster SM, White SM, et al. Short-chain fatty acid metabolites propionate and butyrate are unique epigenetic regulatory elements linking diet, metabolism and gene expression. Nat Metab. 2025;7(1):196\u2013211.","journal-title":"Nat Metab"},{"key":"1147_CR434","unstructured":"Cancer Nutrition Study: CaNS - A Pilot Study of Dietary Interventions in Cancer Patients Treated With Immune Checkpoint Inhibitors [Internet]. 2024. Available from: https:\/\/clinicaltrials.gov\/study\/NCT06475807"},{"key":"1147_CR435","doi-asserted-by":"publisher","unstructured":"Grafanaki K, Maniatis A, Anastogianni A, Bania A, Pasmatzi E, Stathopoulos C. Nutrition and diet patterns as keymodulators of metabolic reprogramming in melanoma immunotherapy. J Clin Med. 2025;14(12):4193. https:\/\/doi.org\/10.3390\/jcm14124193","DOI":"10.3390\/jcm14124193"},{"issue":"1","key":"1147_CR436","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1007\/s10565-025-10054-2","volume":"41","author":"S Bakrim","year":"2025","unstructured":"Bakrim S, El Omari N, El Yaagoubi OM, Khalid A, Abdalla AN, Hamza SMA, et al. Epi-nutrients for cancer prevention: Molecular mechanisms and emerging insights. Cell Biol Toxicol. 2025;41(1):116.","journal-title":"Cell Biol Toxicol"},{"issue":"1","key":"1147_CR437","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1186\/s12967-025-06586-0","volume":"23","author":"C Somodi","year":"2025","unstructured":"Somodi C, Dora D, Horv\u00e1th M, Szegvari G, Lohinai Z. Gut microbiome changes and cancer immunotherapy outcomes associated with dietary interventions: a systematic review of preclinical and clinical evidence. J Transl Med. 2025;23(1):756.","journal-title":"J Transl Med"},{"key":"1147_CR438","doi-asserted-by":"publisher","unstructured":"Sun J, Chen S, Zang D, Sun H, Sun Y, Chen J. Butyrate as a promising therapeutic target in cancer: from pathogenesisto clinic. Int J Oncol. 2024;64(4):44. https:\/\/doi.org\/10.3892\/ijo.2024.5632","DOI":"10.3892\/ijo.2024.5632"},{"key":"1147_CR439","doi-asserted-by":"publisher","first-page":"1577906","DOI":"10.3389\/fmed.2025.1577906","volume":"12","author":"DA Gaskarth","year":"2025","unstructured":"Gaskarth DA, Fan S, Highton AJ, Kemp RA. The microbial metabolite butyrate enhances the effector and memory functions of murine CD8\u2009+\u2009T cells and improves anti-tumor activity. Front Med (Lausanne). 2025;12:1577906.","journal-title":"Front Med (Lausanne)"},{"key":"1147_CR440","doi-asserted-by":"publisher","unstructured":"Salvi PS, Cowles RA. Butyrate and the intestinal epithelium: modulation of proliferation and infl ammation inhomeostasis and disease. Cells. 2021;10(7):1775. https:\/\/doi.org\/10.3390\/cells10071775","DOI":"10.3390\/cells10071775"},{"key":"1147_CR441","doi-asserted-by":"publisher","unstructured":"\u010c\u00ed\u017e M, Dvo\u0159\u00e1kov\u00e1 A, Sko\u010dkov\u00e1 V, Kubala L. The role of dietary phenolic compounds in epigenetic modulation involvedin infl ammatory processes. Antioxidants (Basel). 2020;9(8):691. https:\/\/doi.org\/10.3390\/antiox9080691","DOI":"10.3390\/antiox9080691"},{"key":"1147_CR442","doi-asserted-by":"publisher","unstructured":"Kurzava Kendall L, Ma Y, Yang T, Lubecka K, Stefanska B. Epigenetic eff ects of resveratrol on oncogenic signaling inbreast cancer. Nutrients. 2024;16(5):699. https:\/\/doi.org\/10.3390\/nu16050699","DOI":"10.3390\/nu16050699"},{"key":"1147_CR443","doi-asserted-by":"crossref","unstructured":"Ren ZQ, Zheng SY, Sun Z, Luo Y, Wang YT, Yi P et al. Resveratrol: Molecular Mechanisms, Health Benefits, and Potential Adverse Effects. MedComm (2020). 2025;6(6):e70252.","DOI":"10.1002\/mco2.70252"},{"key":"1147_CR444","doi-asserted-by":"publisher","unstructured":"Talib WH, Baban MM, Bulbul MF, Al-Zaidaneen E, Allan A, Al-Rousan EW, Ahmad RHY, Alshaeri HK, Alasmari MM, LawD. Natural products and altered metabolism in cancer: therapeutic targets and mechanisms of action. Int J Mol Sci.2024;25(17):9593. https:\/\/doi.org\/10.3390\/ijms25179593","DOI":"10.3390\/ijms25179593"},{"key":"1147_CR445","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.freeradbiomed.2020.12.007","volume":"179","author":"R Wu","year":"2022","unstructured":"Wu R, Li S, Hudlikar R, Wang L, Shannar A, Peter R, et al. Redox signaling, mitochondrial metabolism, epigenetics and redox active phytochemicals. Free Radic Biol Med. 2022;179:328\u201336.","journal-title":"Free Radic Biol Med"},{"issue":"5","key":"1147_CR446","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1002\/biof.1544","volume":"45","author":"B Chatterjee","year":"2019","unstructured":"Chatterjee B, Ghosh K, Kanade SR. Resveratrol modulates epigenetic regulators of promoter histone methylation and acetylation that restores BRCA1, p53, p21(CIP1) in human breast cancer cell lines. BioFactors. 2019;45(5):818\u201329.","journal-title":"BioFactors"},{"issue":"10","key":"1147_CR447","doi-asserted-by":"publisher","first-page":"114815","DOI":"10.1016\/j.celrep.2024.114815","volume":"43","author":"P Wang","year":"2024","unstructured":"Wang P, Chen LL, Xiong Y, Ye D. Metabolite regulation of epigenetics in cancer. Cell Rep. 2024;43(10):114815.","journal-title":"Cell Rep"},{"issue":"2","key":"1147_CR448","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.cmet.2020.01.006","volume":"31","author":"DG Roy","year":"2020","unstructured":"Roy DG, Chen J, Mamane V, Ma EH, Muhire BM, Sheldon RD, et al. Methionine Metabolism Shapes T Helper Cell Responses through Regulation of Epigenetic Reprogramming. Cell Metabol. 2020;31(2):250\u2013. \u2013\u200966.e9.","journal-title":"Cell Metabol"},{"key":"1147_CR449","doi-asserted-by":"publisher","unstructured":"Joudi AM, Reyes Flores CP, Singer BD. Epigenetic control of regulatory T cell stability and function: implications fortranslation. Front Immunol. 2022;13:861607. https:\/\/doi.org\/10.3389\/fimmu.2022.861607","DOI":"10.3389\/fimmu.2022.861607"},{"key":"1147_CR450","doi-asserted-by":"publisher","unstructured":"Liu W, Dong S, Hao F, Gao Y, Wei Q. Lipid metabolic reprogramming in colorectal cancer: mechanisms andtherapeutic strategies. Front Immunol. 2025;16:1603032. https:\/\/doi.org\/10.3389\/fimmu.2025.1603032","DOI":"10.3389\/fimmu.2025.1603032"},{"issue":"1","key":"1147_CR451","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/s13045-023-01498-2","volume":"16","author":"H-R Jin","year":"2023","unstructured":"Jin H-R, Wang J, Wang Z-J, Xi M-J, Xia B-H, Deng K, et al. Lipid metabolic reprogramming in tumor microenvironment: from mechanisms to therapeutics. J Hematol Oncol. 2023;16(1):103.","journal-title":"J Hematol Oncol"},{"key":"1147_CR452","doi-asserted-by":"publisher","unstructured":"Siddiqui S, Glauben R. Fatty acid metabolism in myeloid-derived suppressor cells and tumor-associatedmacrophages: key factor in cancer immune evasion. Cancers (Basel). 2022;14(1):250. https:\/\/doi.org\/10.3390\/cancers14010250","DOI":"10.3390\/cancers14010250"},{"key":"1147_CR453","doi-asserted-by":"publisher","first-page":"115741","DOI":"10.1016\/j.biopha.2023.115741","volume":"168","author":"G Chen","year":"2023","unstructured":"Chen G, Bao B, Cheng Y, Tian M, Song J, Zheng L, et al. Acetyl-CoA metabolism as a therapeutic target for cancer. Biomed Pharmacother. 2023;168:115741.","journal-title":"Biomed Pharmacother"},{"key":"1147_CR454","doi-asserted-by":"publisher","unstructured":"Xu J, Li C, Kang X. The epigenetic regulatory eff ect of histone acetylation and deacetylation on skeletal musclemetabolism: a review. Front Physiol. 2023;14:1267456. https:\/\/doi.org\/10.3389\/fphys.2023.1267456","DOI":"10.3389\/fphys.2023.1267456"},{"key":"1147_CR455","doi-asserted-by":"publisher","first-page":"1603032","DOI":"10.3389\/fimmu.2025.1603032","volume":"16","author":"W Liu","year":"2025","unstructured":"Liu W, Dong S, Hao F, Gao Y, Wei Q. Lipid metabolic reprogramming in colorectal cancer: mechanisms and therapeutic strategies. Front Immunol. 2025;16:1603032.","journal-title":"Front Immunol"},{"key":"1147_CR456","doi-asserted-by":"crossref","unstructured":"Baksh SC, Finley LWS. Metabolic Coordination of Cell Fate by \u03b1-Ketoglutarate-Dependent Dioxygenases. Trends in Cell Biology. 2021;31(1):24\u201336.","DOI":"10.1016\/j.tcb.2020.09.010"},{"issue":"12","key":"1147_CR457","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1038\/s41418-024-01402-6","volume":"31","author":"L Lanzetti","year":"2024","unstructured":"Lanzetti L. Oncometabolites at the crossroads of genetic, epigenetic and ecological alterations in cancer. Cell Death Differ. 2024;31(12):1582\u201394.","journal-title":"Cell Death Differ"},{"key":"1147_CR458","doi-asserted-by":"publisher","unstructured":"Ma S, Dahabieh MS, Mann TH, Zhao S, McDonald B, Song WS, Chung HK, Farsakoglu Y, Garcia-Rivera L, Hoff mann FA,Xu S, Du VY, Chen D, Furgiuele J, LaPorta MA, Jacobs E, DeCamp LM, Oswald BM, Sheldon RD, Ellis AE, Liu L, He P,Wang Y, Jang C, Jones RG, Kaech SM. Nutrient-driven histone code determines exhausted CD8+ T cell fates. Science.2025;387(6734):eadj3020. https:\/\/doi.org\/10.1126\/science.adj3020","DOI":"10.1126\/science.adj3020"},{"issue":"5","key":"1147_CR459","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.it.2021.03.006","volume":"42","author":"HH Van Acker","year":"2021","unstructured":"Van Acker HH, Ma S, Scolaro T, Kaech SM, Mazzone M. How metabolism bridles cytotoxic CD8(+) T cells through epigenetic modifications. Trends Immunol. 2021;42(5):401\u201317.","journal-title":"Trends Immunol"},{"issue":"1","key":"1147_CR460","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s12943-025-02269-y","volume":"24","author":"X Xie","year":"2025","unstructured":"Xie X, Liu W, Yuan Z, Chen H, Mao W. Bridging epigenomics and tumor immunometabolism: molecular mechanisms and therapeutic implications. Mol Cancer. 2025;24(1):71.","journal-title":"Mol Cancer"},{"issue":"1","key":"1147_CR461","doi-asserted-by":"publisher","first-page":"2307542","DOI":"10.1080\/19490976.2024.2307542","volume":"16","author":"X Yu","year":"2024","unstructured":"Yu X, Ou J, Wang L, Li Z, Ren Y, Xie L, et al. Gut microbiota modulate CD8\u2009+\u2009T cell immunity in gastric cancer through Butyrate\/GPR109A\/HOPX. Gut Microbes. 2024;16(1):2307542.","journal-title":"Gut Microbes"},{"issue":"9","key":"1147_CR462","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1038\/s41423-025-01326-2","volume":"22","author":"M Xie","year":"2025","unstructured":"Xie M, Li X, Lau HC-H, Yu J. The gut microbiota in cancer immunity and immunotherapy. Cell Mol Immunol. 2025;22(9):1012\u201331.","journal-title":"Cell Mol Immunol"},{"issue":"2","key":"1147_CR463","doi-asserted-by":"publisher","first-page":"2249143","DOI":"10.1080\/19490976.2023.2249143","volume":"15","author":"X Zhu","year":"2023","unstructured":"Zhu X, Li K, Liu G, Wu R, Zhang Y, Wang S, et al. Microbial metabolite butyrate promotes anti-PD-1 antitumor efficacy by modulating T cell receptor signaling of cytotoxic CD8 T cell. Gut Microbes. 2023;15(2):2249143.","journal-title":"Gut Microbes"},{"issue":"1","key":"1147_CR464","doi-asserted-by":"publisher","first-page":"4077","DOI":"10.1038\/s41467-021-24331-1","volume":"12","author":"M Luu","year":"2021","unstructured":"Luu M, Riester Z, Baldrich A, Reichardt N, Yuille S, Busetti A, et al. Microbial short-chain fatty acids modulate CD8\u2009+\u2009T cell responses and improve adoptive immunotherapy for cancer. Nat Commun. 2021;12(1):4077.","journal-title":"Nat Commun"},{"key":"1147_CR465","doi-asserted-by":"publisher","unstructured":"Qi X, Liu Y, Hussein S, Choi G, Kimchi ET, Staveley-O'Carroll KF, Li G. The species of gut bacteria associated withantitumor immunity in cancer therapy. Cells. 2022;11(22):3684. https:\/\/doi.org\/10.3390\/cells11223684","DOI":"10.3390\/cells11223684"},{"issue":"1","key":"1147_CR466","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.cmet.2022.11.005","volume":"35","author":"S Han","year":"2023","unstructured":"Han S, Georgiev P, Ringel AE, Sharpe AH, Haigis MC. Age-associated remodeling of T cell immunity and metabolism. Cell Metab. 2023;35(1):36\u201355.","journal-title":"Cell Metab"},{"key":"1147_CR467","doi-asserted-by":"publisher","first-page":"1530578","DOI":"10.3389\/fendo.2025.1530578","volume":"16","author":"X Zhang","year":"2025","unstructured":"Zhang X, Liu D, Yin S, Gao Y, Li X, Wu G. Metabolism and epigenetics in cancer: toward personalized treatment. Front Endocrinol (Lausanne). 2025;16:1530578.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1147_CR468","doi-asserted-by":"publisher","unstructured":"Rom\u00e1n GC, Mancera-P\u00e1ez O, Bernal C. Epigenetic factors in late-onset Alzheimer's disease: MTHFR and CTH genepolymorphisms, metabolic transsulfuration and methylation pathways, and B vitamins. Int J Mol Sci. 2019;20(2):319. https:\/\/doi.org\/10.3390\/ijms20020319","DOI":"10.3390\/ijms20020319"},{"issue":"3","key":"1147_CR469","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1007\/s00277-024-05885-8","volume":"104","author":"G Huang","year":"2025","unstructured":"Huang G, Cai X, Li D. Significance of targeting DNMT3A mutations in AML. Ann Hematol. 2025;104(3):1399\u2013414.","journal-title":"Ann Hematol"},{"key":"1147_CR470","doi-asserted-by":"publisher","first-page":"210","DOI":"10.3389\/fonc.2019.00210","volume":"9","author":"Y Feng","year":"2019","unstructured":"Feng Y, Li X, Cassady K, Zou Z, Zhang X. TET2 Function in Hematopoietic Malignancies, Immune Regulation, and DNA Repair. Front Oncol. 2019;9:210.","journal-title":"Front Oncol"},{"issue":"1\u20132","key":"1147_CR471","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.bbrc.2014.08.004","volume":"455","author":"S Aumann","year":"2014","unstructured":"Aumann S, Abdel-Wahab O. Somatic alterations and dysregulation of epigenetic modifiers in cancers. Biochem Biophys Res Commun. 2014;455(1\u20132):24\u201334.","journal-title":"Biochem Biophys Res Commun"},{"key":"1147_CR472","doi-asserted-by":"crossref","first-page":"952508","DOI":"10.1155\/2012\/952508","volume":"2012","author":"DA Kennedy","year":"2012","unstructured":"Kennedy DA, Stern SJ, Matok I, Moretti ME, Sarkar M, Adams-Webber T, et al. Folate Intake, MTHFR Polymorphisms, and the Risk of Colorectal Cancer: A Systematic Review and Meta-Analysis. J Cancer Epidemiol. 2012;2012:952508.","journal-title":"J Cancer Epidemiol"},{"key":"1147_CR473","doi-asserted-by":"publisher","first-page":"102695","DOI":"10.1016\/j.redox.2023.102695","volume":"62","author":"C Carlberg","year":"2023","unstructured":"Carlberg C, Raczyk M, Zawrotna N, Vitamin D. A master example of nutrigenomics. Redox Biol. 2023;62:102695.","journal-title":"Redox Biol"},{"issue":"35","key":"1147_CR474","doi-asserted-by":"publisher","first-page":"e39527","DOI":"10.1097\/MD.0000000000039527","volume":"103","author":"M Guan","year":"2024","unstructured":"Guan M, Wang Y. Common variants of vitamin D receptor gene polymorphisms and risk of gastric cancer: A meta-analysis. Med (Baltim). 2024;103(35):e39527.","journal-title":"Med (Baltim)"},{"issue":"5","key":"1147_CR475","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1016\/j.ajcnut.2024.08.033","volume":"120","author":"L Bordoni","year":"2024","unstructured":"Bordoni L, Agostinho de Sousa J, Zhuo J, von Meyenn F. Evaluating the connection between diet quality, EpiNutrient intake and epigenetic age: an observational study. Am J Clin Nutr. 2024;120(5):1143\u201355.","journal-title":"Am J Clin Nutr"},{"issue":"2","key":"1147_CR476","doi-asserted-by":"publisher","first-page":"203","DOI":"10.59249\/BDGN2070","volume":"98","author":"R Asif","year":"2025","unstructured":"Asif R, Liu R, de Souza RJ, Azab S, Chong M, Anand SS, et al. A Scoping Review of Epigenetic Signatures of Diet and Diet-related Metabolites: Insights from Epigenome-Wide Association Studies and Their Implications for Cardiometabolic Health and Diseases. Yale J Biol Med. 2025;98(2):203\u201325.","journal-title":"Yale J Biol Med"},{"key":"1147_CR477","doi-asserted-by":"publisher","first-page":"1168321","DOI":"10.3389\/fonc.2023.1168321","volume":"13","author":"M Asif Ali","year":"2023","unstructured":"Asif Ali M, Khan N, Kaleem N, Ahmad W, Alharethi SH, Alharbi B, et al. Anticancer properties of sulforaphane: current insights at the molecular level. Front Oncol. 2023;13:1168321.","journal-title":"Front Oncol"},{"issue":"1","key":"1147_CR478","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/s10020-024-00842-7","volume":"30","author":"P Liu","year":"2024","unstructured":"Liu P, Zhang B, Li Y, Yuan Q. Potential mechanisms of cancer prevention and treatment by sulforaphane, a natural small molecule compound of plant-derived. Mol Med. 2024;30(1):94.","journal-title":"Mol Med"},{"issue":"8","key":"1147_CR479","doi-asserted-by":"publisher","first-page":"e70735","DOI":"10.1002\/fsn3.70735","volume":"13","author":"AM Noman","year":"2025","unstructured":"Noman AM, Sultan MT, Mazhar A, Baig I, Javaid J, Hussain M, et al. Anticancer Molecular Mechanisms of Epigallocatechin Gallate: An Updated Review on Clinical Trials. Food Sci Nutr. 2025;13(8):e70735.","journal-title":"Food Sci Nutr"},{"issue":"1","key":"1147_CR480","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s43556-024-00240-9","volume":"5","author":"M Alam","year":"2024","unstructured":"Alam M, Gulzar M, Akhtar MS, Rashid S, Zulfareen, Tanuja, et al. Epigallocatechin-3-gallate therapeutic potential in human diseases: molecular mechanisms and clinical studies. Mol Biomed. 2024;5(1):73.","journal-title":"Mol Biomed"},{"key":"1147_CR481","doi-asserted-by":"crossref","unstructured":"Yang C, Snelson M, El-Osta A, Marques FZ. Parental diet and offspring health: a role for the gut microbiome via epigenetics. Nature Reviews Gastroenterology & Hepatology; 2025.","DOI":"10.1038\/s41575-025-01106-3"},{"issue":"6575","key":"1147_CR482","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1126\/science.aaz7015","volume":"374","author":"CN Spencer","year":"2021","unstructured":"Spencer CN, McQuade JL, Gopalakrishnan V, McCulloch JA, Vetizou M, Cogdill AP, et al. Dietary fiber and probiotics influence the gut microbiome and melanoma immunotherapy response. Science. 2021;374(6575):1632\u201340.","journal-title":"Science"},{"key":"1147_CR483","unstructured":"Biomarkers of Sulforaphane\/Broccoli Sprout Extract in Prostate Cancer [Internet]. 2018. Available from: https:\/\/clinicaltrials.gov\/study\/NCT03665922"},{"key":"1147_CR484","doi-asserted-by":"publisher","unstructured":"Han J, Wang R, Bai L, Liu Y, Liao M, Zhang L, Liu L, Qi B. Associations of serum carotenoid concentrations with all-cause mortality in cancer survivors. Clin Nutr ESPEN. 2025;70:165-173. https:\/\/doi.org\/10.1016\/j.clnesp.2025.08.014","DOI":"10.1016\/j.clnesp.2025.08.014"},{"key":"1147_CR485","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.clnu.2025.06.021","volume":"51","author":"N Veronese","year":"2025","unstructured":"Veronese N, Gianfredi V, Solmi M, Barbagallo M, Dominguez LJ, Mandal\u00e0 C, et al. The impact of dietary fiber consumption on human health: An umbrella review of evidence from 17,155,277 individuals. Clin Nutr. 2025;51:325\u201333.","journal-title":"Clin Nutr"},{"key":"1147_CR486","first-page":"101999","volume":"21","author":"OYA Chan","year":"2025","unstructured":"Chan OYA, Tao L, Chen G, Kong L. The association of dietary fiber intake with colorectal cancer and related risks: A literature review of recent research. J Agric Food Res. 2025;21:101999.","journal-title":"J Agric Food Res"},{"issue":"3","key":"1147_CR487","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1097\/HEP.0000000000000819","volume":"80","author":"CZ Watling","year":"2024","unstructured":"Watling CZ, Wojt A, Florio AA, Butera G, Albanes D, Weinstein SJ, et al. Fiber and whole grain intakes in relation to liver cancer risk: An analysis in 2 prospective cohorts and systematic review and meta-analysis of prospective studies. Hepatology. 2024;80(3):552\u201365.","journal-title":"Hepatology"},{"issue":"1","key":"1147_CR488","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1002\/hep.32449","volume":"77","author":"C Hu","year":"2023","unstructured":"Hu C, Xu B, Wang X, Wan WH, Lu J, Kong D, et al. Gut microbiota-derived short-chain fatty acids regulate group 3 innate lymphoid cells in HCC. Hepatology. 2023;77(1):48\u201364.","journal-title":"Hepatology"},{"issue":"10","key":"1147_CR489","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1016\/j.trecan.2022.06.005","volume":"8","author":"M Casado-Pelaez","year":"2022","unstructured":"Casado-Pelaez M, Bueno-Costa A, Esteller M. Single cell cancer epigenetics. Trends Cancer. 2022;8(10):820\u201338.","journal-title":"Trends Cancer"},{"key":"1147_CR490","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/978-1-0716-1831-8_3","volume":"2399","author":"K Mazan-Mamczarz","year":"2022","unstructured":"Mazan-Mamczarz K, Ha J, De S, Sen P. Single-Cell Analysis of the Transcriptome and Epigenome. Methods Mol Biol. 2022;2399:21\u201360.","journal-title":"Methods Mol Biol"},{"key":"1147_CR491","doi-asserted-by":"publisher","first-page":"1636980","DOI":"10.3389\/fnut.2025.1636980","volume":"12","author":"K Agrawal","year":"2025","unstructured":"Agrawal K, Goktas P, Kumar N, Leung MF. Artificial intelligence in personalized nutrition and food manufacturing: a comprehensive review of methods, applications, and future directions. Front Nutr. 2025;12:1636980.","journal-title":"Front Nutr"},{"issue":"1","key":"1147_CR492","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1038\/s41467-025-56165-6","volume":"16","author":"T Wang","year":"2025","unstructured":"Wang T, Holscher HD, Maslov S, Hu FB, Weiss ST, Liu YY. Predicting metabolite response to dietary intervention using deep learning. Nat Commun. 2025;16(1):815.","journal-title":"Nat Commun"},{"issue":"4","key":"1147_CR493","doi-asserted-by":"publisher","first-page":"100398","DOI":"10.1016\/j.advnut.2025.100398","volume":"16","author":"X Wu","year":"2025","unstructured":"Wu X, Oniani D, Shao Z, Arciero P, Sivarajkumar S, Hilsman J, et al. A Scoping Review of Artificial Intelligence for Precision Nutrition. Adv Nutr. 2025;16(4):100398.","journal-title":"Adv Nutr"},{"issue":"1","key":"1147_CR494","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1186\/s12885-025-13546-w","volume":"25","author":"M Ye","year":"2025","unstructured":"Ye M, Xu G, Zhang L, Kong Z, Qiu Z. Meta Analysis of Methylenetetrahydrofolate Reductase (MTHFR) C677T polymorphism and its association with folate and colorectal cancer. BMC Cancer. 2025;25(1):169.","journal-title":"BMC Cancer"},{"key":"1147_CR495","doi-asserted-by":"publisher","unstructured":"Singar S, Nagpal R, Arjmandi BH, Akhavan NS. Personalized nutrition: tailoring dietary recommendations throughgenetic insights. Nutrients. 2024;16(16):2673. https:\/\/doi.org\/10.3390\/nu16162673","DOI":"10.3390\/nu16162673"},{"key":"1147_CR496","doi-asserted-by":"publisher","first-page":"1552904","DOI":"10.3389\/fmed.2025.1552904","volume":"12","author":"JFP Gaspary","year":"2025","unstructured":"Gaspary JFP, Lopes LFD, Camara AG. Bridging epigenetics and pharmacology through systematic reviews tailored to WBS methodology: the triangle decision-making model as a pioneering translational biological drug delivery system. Front Med (Lausanne). 2025;12:1552904.","journal-title":"Front Med (Lausanne)"},{"key":"1147_CR497","doi-asserted-by":"publisher","unstructured":"Davletgildeeva AT, Kuznetsov NA. The role of DNMT methyltransferases and TET dioxygenases in the maintenance ofthe DNA methylation level. Biomolecules. 2024;14(9):1117. https:\/\/doi.org\/10.3390\/biom14091117","DOI":"10.3390\/biom14091117"},{"issue":"10","key":"1147_CR498","doi-asserted-by":"publisher","first-page":"2228","DOI":"10.1158\/2159-8290.CD-23-0007","volume":"13","author":"AA Guirguis","year":"2023","unstructured":"Guirguis AA, Ofir-Rosenfeld Y, Knezevic K, Blackaby W, Hardick D, Chan YC, et al. Inhibition of METTL3 Results in a Cell-Intrinsic Interferon Response That Enhances Antitumor Immunity. Cancer Discov. 2023;13(10):2228\u201347.","journal-title":"Cancer Discov"},{"issue":"1","key":"1147_CR499","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1186\/s12967-025-06221-y","volume":"23","author":"X Chen","year":"2025","unstructured":"Chen X, Yuan Y, Zhou F, Li L, Pu J, Jiang X. m6A RNA methylation: a pivotal regulator of tumor immunity and a promising target for cancer immunotherapy. J Transl Med. 2025;23(1):245.","journal-title":"J Transl Med"},{"issue":"2","key":"1147_CR500","doi-asserted-by":"publisher","first-page":"113714","DOI":"10.1016\/j.celrep.2024.113714","volume":"43","author":"Q Zhang","year":"2024","unstructured":"Zhang Q, Shi Y, Liu S, Yang W, Chen H, Guo N, et al. EZH2\/G9a interact to mediate drug resistance in non-small-cell lung cancer by regulating the SMAD4\/ERK\/c-Myc signaling axis. Cell Rep. 2024;43(2):113714.","journal-title":"Cell Rep"},{"issue":"1","key":"1147_CR501","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1186\/s13148-024-01785-w","volume":"16","author":"Y Xiao","year":"2024","unstructured":"Xiao Y, Zhang Y, Hu Y, Zhang X, Tan J, Yao S, et al. Advances in the study of posttranslational modifications of histones in head and neck squamous cell carcinoma. Clin Epigenetics. 2024;16(1):165.","journal-title":"Clin Epigenetics"},{"key":"1147_CR502","doi-asserted-by":"publisher","first-page":"175883592413060","DOI":"10.1177\/17588359241306026","volume":"17","author":"M Wozniak","year":"2025","unstructured":"Wozniak M, Czyz M. Exploring oncogenic roles and clinical significance of EZH2: focus on non-canonical activities. Ther Adv Med Oncol. 2025;17:17588359241306026.","journal-title":"Ther Adv Med Oncol"},{"issue":"11","key":"1147_CR503","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1038\/s41416-020-0802-1","volume":"122","author":"DS Hong","year":"2020","unstructured":"Hong DS, Kang YK, Borad M, Sachdev J, Ejadi S, Lim HY, et al. Phase 1 study of MRX34, a liposomal miR-34a mimic, in patients with advanced solid tumours. Br J Cancer. 2020;122(11):1630\u20137.","journal-title":"Br J Cancer"},{"key":"1147_CR504","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.jconrel.2023.07.054","volume":"361","author":"SH El Moukhtari","year":"2023","unstructured":"El Moukhtari SH, Garbayo E, Amundarain A, Pascual-Gil S, Carrasco-Le\u00f3n A, Prosper F, et al. Lipid nanoparticles for siRNA delivery in cancer treatment. J Control Release. 2023;361:130\u201346.","journal-title":"J Control Release"},{"issue":"1","key":"1147_CR505","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1186\/s12967-025-06629-6","volume":"23","author":"D Mu","year":"2025","unstructured":"Mu D, Han B, Huang H, Zheng Y, Zhang J, Shi Y. Unraveling the advances of non-coding RNAs on the tumor microenvironment: innovative strategies for cancer therapies. J Transl Med. 2025;23(1):614.","journal-title":"J Transl Med"},{"issue":"1","key":"1147_CR506","doi-asserted-by":"publisher","first-page":"5011","DOI":"10.1038\/s41467-025-60424-x","volume":"16","author":"H Schwaemmle","year":"2025","unstructured":"Schwaemmle H, Soldati H, Lykoskoufis NMR, Docquier M, Hainard A, Braun SMG. CRISPR screen decodes SWI\/SNF chromatin remodeling complex assembly. Nat Commun. 2025;16(1):5011.","journal-title":"Nat Commun"},{"issue":"1","key":"1147_CR507","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s13072-025-00590-w","volume":"18","author":"F Hao","year":"2025","unstructured":"Hao F, Zhang Y, Hou J, Zhao B. Chromatin remodeling and cancer: the critical influence of the SWI\/SNF complex. Epigenetics Chromatin. 2025;18(1):22.","journal-title":"Epigenetics Chromatin"},{"key":"1147_CR508","doi-asserted-by":"publisher","first-page":"116624","DOI":"10.1016\/j.biopha.2024.116624","volume":"175","author":"Y Chen","year":"2024","unstructured":"Chen Y, Zhu H, Luo Y, Tong S, Liu Y. EZH2: The roles in targeted therapy and mechanisms of resistance in breast cancer. Biomed Pharmacother. 2024;175:116624.","journal-title":"Biomed Pharmacother"},{"key":"1147_CR509","doi-asserted-by":"publisher","first-page":"1499950","DOI":"10.3389\/fonc.2024.1499950","volume":"14","author":"G Mahendran","year":"2024","unstructured":"Mahendran G, Shangaradas AD, Romero-Moreno R, Wickramarachchige Dona N, Sarasija S, Perera S, et al. Unlocking the epigenetic code: new insights into triple-negative breast cancer. Front Oncol. 2024;14:1499950.","journal-title":"Front Oncol"},{"key":"1147_CR510","doi-asserted-by":"publisher","first-page":"1584087","DOI":"10.3389\/fimmu.2025.1584087","volume":"16","author":"Z Kang","year":"2025","unstructured":"Kang Z, Wang J, Liu J, Du L, Liu X. Epigenetic modifications in breast cancer: from immune escape mechanisms to therapeutic target discovery. Front Immunol. 2025;16:1584087.","journal-title":"Front Immunol"},{"key":"1147_CR511","doi-asserted-by":"publisher","first-page":"1420933","DOI":"10.3389\/fpubh.2024.1420933","volume":"12","author":"A Zhang","year":"2024","unstructured":"Zhang A, Luo X, Li Y, Yan L, Lai X, Yang Q, et al. Epigenetic changes driven by environmental pollutants in lung carcinogenesis: a comprehensive review. Front Public Health. 2024;12:1420933.","journal-title":"Front Public Health"},{"key":"1147_CR512","doi-asserted-by":"crossref","unstructured":"Bi L, Wang X, Li J, Li W, Wang Z. Epigenetic modifications in early stage lung cancer: pathogenesis, biomarkers, and early diagnosis. MedComm (2020). 2025;6(3):e70080.","DOI":"10.1002\/mco2.70080"},{"key":"1147_CR513","doi-asserted-by":"publisher","unstructured":"Cao Q, Tian Y, Deng Z, Yang F, Chen E. Epigenetic alteration in colorectal cancer: potential diagnostic and prognosticimplications. Int J Mol Sci. 2024;25(6):3358. https:\/\/doi.org\/10.3390\/ijms25063358","DOI":"10.3390\/ijms25063358"},{"key":"1147_CR514","doi-asserted-by":"publisher","first-page":"1466156","DOI":"10.3389\/fphar.2024.1466156","volume":"15","author":"S Tian","year":"2024","unstructured":"Tian S, Chen M. The mechanisms and drug therapies of colorectal cancer and epigenetics: bibliometrics and visualized analysis. Front Pharmacol. 2024;15:1466156.","journal-title":"Front Pharmacol"},{"key":"1147_CR515","doi-asserted-by":"publisher","unstructured":"Zhang S, Shen T, Zeng Y. Epigenetic modifi cations in prostate cancer metastasis and microenvironment. Cancers(Basel). 2023;15(8):2243. https:\/\/doi.org\/10.3390\/cancers15082243","DOI":"10.3390\/cancers15082243"},{"key":"1147_CR516","doi-asserted-by":"publisher","first-page":"1570193","DOI":"10.3389\/fonc.2025.1570193","volume":"15","author":"B Sharma","year":"2025","unstructured":"Sharma B, Shekhar H, Sahu A, Kaur D, Haque S, Tuli HS, et al. Epigenetic insights into prostate cancer: exploring histone modifications and their therapeutic implications. Front Oncol. 2025;15:1570193.","journal-title":"Front Oncol"},{"issue":"5","key":"1147_CR517","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1038\/nrg.2016.13","volume":"17","author":"AP Feinberg","year":"2016","unstructured":"Feinberg AP, Koldobskiy MA, G\u00f6nd\u00f6r A. Epigenetic modulators, modifiers and mediators in cancer aetiology and progression. Nat Rev Genet. 2016;17(5):284\u201399.","journal-title":"Nat Rev Genet"},{"key":"1147_CR518","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s40364-018-0122-2","volume":"6","author":"L Gan","year":"2018","unstructured":"Gan L, Yang Y, Li Q, Feng Y, Liu T, Guo W. Epigenetic regulation of cancer progression by EZH2: from biological insights to therapeutic potential. Biomark Res. 2018;6:10.","journal-title":"Biomark Res"},{"issue":"1","key":"1147_CR519","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/s41420-020-00400-0","volume":"7","author":"K Ishiguro","year":"2021","unstructured":"Ishiguro K, Kitajima H, Niinuma T, Maruyama R, Nishiyama N, Ohtani H, et al. Dual EZH2 and G9a inhibition suppresses multiple myeloma cell proliferation by regulating the interferon signal and IRF4-MYC axis. Cell Death Discov. 2021;7(1):7.","journal-title":"Cell Death Discov"},{"key":"1147_CR520","doi-asserted-by":"publisher","unstructured":"Song M, Nishihara R, Wu K, Qian ZR, Kim SA, Sukawa Y, Mima K, Inamura K, Masuda A, Yang J, Fuchs CS, GiovannucciEL, Ogino S, Chan AT. Marine \u03c9-3 polyunsaturated fatty acids and risk of colorectal cancer according to microsatelliteinstability. J Natl Cancer Inst. 2015;107(4):djv007. https:\/\/doi.org\/10.1093\/jnci\/djv007","DOI":"10.1093\/jnci\/djv007"},{"issue":"3","key":"1147_CR521","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1038\/s43587-024-00793-y","volume":"5","author":"HA Bischoff-Ferrari","year":"2025","unstructured":"Bischoff-Ferrari HA, G\u00e4ngler S, Wieczorek M, Belsky DW, Ryan J, Kressig RW, et al. Individual and additive effects of vitamin D, omega-3 and exercise on DNA methylation clocks of biological aging in older adults from the DO-HEALTH trial. Nat Aging. 2025;5(3):376\u201385.","journal-title":"Nat Aging"},{"key":"1147_CR522","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.semcancer.2020.11.018","volume":"83","author":"F Li","year":"2022","unstructured":"Li F, Qasim S, Li D, Dou QP. Updated review on green tea polyphenol epigallocatechin-3-gallate as a cancer epigenetic regulator. Sem Cancer Biol. 2022;83:335\u201352.","journal-title":"Sem Cancer Biol"},{"key":"1147_CR523","doi-asserted-by":"publisher","unstructured":"Agarwal A, Kansal V, Farooqi H, Prasad R, Singh VK. Epigallocatechin gallate (EGCG), an active phenolic compound ofgreen tea, inhibits tumor growth of head and neck cancer cells by targeting DNA hypermethylation. Biomedicines.2023;11(3):789. https:\/\/doi.org\/10.3390\/biomedicines11030789","DOI":"10.3390\/biomedicines11030789"},{"issue":"1","key":"1147_CR524","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1038\/s41392-024-02039-0","volume":"9","author":"W Dai","year":"2024","unstructured":"Dai W, Qiao X, Fang Y, Guo R, Bai P, Liu S, et al. Epigenetics-targeted drugs: current paradigms and future challenges. Signal Transduct Target Ther. 2024;9(1):332.","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"1147_CR525","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1007\/s12325-024-03018-1","volume":"42","author":"G Clack","year":"2025","unstructured":"Clack G, Moore C, Ruston L, Wilson D, Koch A, Webb D, et al. A Phase 1 Randomized, Placebo-Controlled Study Evaluating the Safety, Tolerability, and Pharmacokinetics of Enteric-Coated Stabilized Sulforaphane (SFX-01) in Male Participants. Adv Ther. 2025;42(1):216\u201332.","journal-title":"Adv Ther"},{"issue":"12","key":"1147_CR526","doi-asserted-by":"publisher","first-page":"2393","DOI":"10.3945\/jn.109.113332","volume":"139","author":"E Ho","year":"2009","unstructured":"Ho E, Clarke JD, Dashwood RH. Dietary sulforaphane, a histone deacetylase inhibitor for cancer prevention. J Nutr. 2009;139(12):2393\u20136.","journal-title":"J Nutr"},{"key":"1147_CR527","doi-asserted-by":"publisher","first-page":"1273993","DOI":"10.3389\/fphar.2023.1273993","volume":"14","author":"A Khan","year":"2023","unstructured":"Khan A, Khan A, Khan MA, Malik Z, Massey S, Parveen R, et al. Phytocompounds targeting epigenetic modulations: an assessment in cancer. Front Pharmacol. 2023;14:1273993.","journal-title":"Front Pharmacol"},{"issue":"1","key":"1147_CR528","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/s41698-017-0038-6","volume":"1","author":"AY Berman","year":"2017","unstructured":"Berman AY, Motechin RA, Wiesenfeld MY, Holz MK. The therapeutic potential of resveratrol: a review of clinical trials. npj Precision Oncol. 2017;1(1):35.","journal-title":"npj Precision Oncol"},{"issue":"1","key":"1147_CR529","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15430\/JCP.24.001","volume":"29","author":"A Ferraresi","year":"2024","unstructured":"Ferraresi A, Thongchot S, Isidoro C. Resveratrol Promotes Self-digestion to Put Cancer to Sleep. J Cancer Prev. 2024;29(1):1\u20135.","journal-title":"J Cancer Prev"},{"issue":"4","key":"1147_CR530","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1093\/carcin\/bgp042","volume":"30","author":"S Majid","year":"2009","unstructured":"Majid S, Dar AA, Ahmad AE, Hirata H, Kawakami K, Shahryari V, et al. BTG3 tumor suppressor gene promoter demethylation, histone modification and cell cycle arrest by genistein in renal cancer. Carcinogenesis. 2009;30(4):662\u201370.","journal-title":"Carcinogenesis"},{"issue":"1","key":"1147_CR531","doi-asserted-by":"publisher","first-page":"9540","DOI":"10.1038\/s41598-024-60395-x","volume":"14","author":"S Nimal","year":"2024","unstructured":"Nimal S, Kumbhar N, Saruchi, Rathore S, Naik N, Paymal S, et al. Apigenin and its combination with Vorinostat induces apoptotic-mediated cell death in TNBC by modulating the epigenetic and apoptotic regulators and related miRNAs. Sci Rep. 2024;14(1):9540.","journal-title":"Sci Rep"},{"key":"1147_CR532","doi-asserted-by":"publisher","unstructured":"Naponelli V, Rocchetti MT, Mangieri D. Apigenin: molecular mechanisms and therapeutic potential against cancerspreading. Int J Mol Sci. 2024;25(10):5569. https:\/\/doi.org\/10.3390\/ijms25105569","DOI":"10.3390\/ijms25105569"},{"issue":"1","key":"1147_CR533","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s13148-011-0021-y","volume":"2","author":"H Karlic","year":"2011","unstructured":"Karlic H, Varga F. Impact of vitamin D metabolism on clinical epigenetics. Clin Epigenetics. 2011;2(1):55\u201361.","journal-title":"Clin Epigenetics"},{"issue":"1","key":"1147_CR534","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.rdc.2012.03.014","volume":"38","author":"AV Krishnan","year":"2012","unstructured":"Krishnan AV, Trump DL, Johnson CS, Feldman D. The role of vitamin D in cancer prevention and treatment. Rheum Dis Clin North Am. 2012;38(1):161\u201378.","journal-title":"Rheum Dis Clin North Am"},{"key":"1147_CR535","unstructured":"National Institutes of Health OoDS, Vitamin D. Fact Sheet for Health Professionals: ODS, NIH; 2025 [Available from: https:\/\/ods.od.nih.gov\/factsheets\/VitaminD-HealthProfessional"},{"issue":"3","key":"1147_CR536","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1002\/mnfr.200600191","volume":"51","author":"YI Kim","year":"2007","unstructured":"Kim YI. Folate and colorectal cancer: an evidence-based critical review. Mol Nutr Food Res. 2007;51(3):267\u201392.","journal-title":"Mol Nutr Food Res"},{"issue":"1","key":"1147_CR537","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3945\/an.111.000992","volume":"3","author":"KS Crider","year":"2012","unstructured":"Crider KS, Yang TP, Berry RJ, Bailey LB. Folate and DNA methylation: a review of molecular mechanisms and the evidence for folate\u2019s role. Adv Nutr. 2012;3(1):21\u201338.","journal-title":"Adv Nutr"},{"key":"1147_CR538","unstructured":"Office of Dietary Supplements NIoH. Folate \u2014 Health Professional Fact Sheet: Office of Dietary Supplements, National Institutes of Health; U.S. Department of Health & Human Services. 2025 [Available from: https:\/\/ods.od.nih.gov\/factsheets\/Folate-HealthProfessional"},{"key":"1147_CR539","doi-asserted-by":"publisher","unstructured":"Boughanem H, Hernandez-Alonso P, Tinahones A, Babio N, Salas-Salvad\u00f3 J, Tinahones FJ, Macias-Gonzalez M.Association between serum vitamin B12 and global DNA methylation in colorectal cancer patients. Nutrients.2020;12(11):3567. https:\/\/doi.org\/10.3390\/nu12113567","DOI":"10.3390\/nu12113567"},{"issue":"2","key":"1147_CR540","doi-asserted-by":"publisher","first-page":"123","DOI":"10.32394\/rpzh.2021.0157","volume":"72","author":"P \u0141obo\u015b","year":"2021","unstructured":"\u0141obo\u015b P, Regulska-Ilow B. Link between methyl nutrients and the DNA methylation process in the course of selected diseases in adults. Rocz Panstw Zakl Hig. 2021;72(2):123\u201336.","journal-title":"Rocz Panstw Zakl Hig"},{"key":"1147_CR541","unstructured":"Office of Dietary Supplements NIoH. Vitamin B12 \u2013 Consumer Fact Sheet: Office of Dietary Supplements, National Institutes of Health; U.S. Department of Health & Human Services. 2023 [Available from: https:\/\/ods.od.nih.gov\/factsheets\/VitaminB12-Consumer"},{"key":"1147_CR542","doi-asserted-by":"publisher","first-page":"675780","DOI":"10.3389\/fgene.2021.675780","volume":"12","author":"JP Brabson","year":"2021","unstructured":"Brabson JP, Leesang T, Mohammad S, Cimmino L. Epigenetic Regulation of Genomic Stability by Vitamin C. Front Genet. 2021;12:675780.","journal-title":"Front Genet"},{"key":"1147_CR543","unstructured":"Office of Dietary Supplements NIoH. Vitamin C - Fact Sheet for Consumers 2021 [Available from: https:\/\/ods.od.nih.gov\/factsheets\/VitaminC-Consumer"},{"issue":"14","key":"1147_CR544","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1001\/jama.2011.1437","volume":"306","author":"EA Klein","year":"2011","unstructured":"Klein EA, Thompson IM Jr., Tangen CM, Crowley JJ, Lucia MS, Goodman PJ, et al. Vitamin E and the risk of prostate cancer: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA. 2011;306(14):1549\u201356.","journal-title":"JAMA"},{"issue":"1","key":"1147_CR545","doi-asserted-by":"publisher","first-page":"2211361","DOI":"10.1080\/15592294.2023.2211361","volume":"18","author":"A Keshawarz","year":"2023","unstructured":"Keshawarz A, Joehanes R, Ma J, Lee GY, Costeira R, Tsai PC, et al. Dietary and supplemental intake of vitamins C and E is associated with altered DNA methylation in an epigenome-wide association study meta-analysis. Epigenetics. 2023;18(1):2211361.","journal-title":"Epigenetics"},{"key":"1147_CR546","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/bs.acr.2017.07.002","volume":"136","author":"E Jab\u0142o\u0144ska","year":"2017","unstructured":"Jab\u0142o\u0144ska E, Reszka E. Selenium and Epigenetics in Cancer: Focus on DNA Methylation. Adv Cancer Res. 2017;136:193\u2013234.","journal-title":"Adv Cancer Res"},{"key":"1147_CR547","doi-asserted-by":"publisher","first-page":"1490740","DOI":"10.3389\/fonc.2024.1490740","volume":"14","author":"L He","year":"2024","unstructured":"He L, Zhang L, Peng Y, He Z. Selenium in cancer management: exploring the therapeutic potential. Front Oncol. 2024;14:1490740.","journal-title":"Front Oncol"},{"issue":"5","key":"1147_CR548","doi-asserted-by":"publisher","first-page":"33","DOI":"10.31080\/ASCB.2020.04.0223","volume":"4","author":"LC Costello","year":"2020","unstructured":"Costello LC, Franklin RB. Zinc: The Wonder Drug for the Treatment of Carcinomas. Acta Sci Cancer Biol. 2020;4(5):33\u20139.","journal-title":"Acta Sci Cancer Biol"},{"issue":"3","key":"1147_CR549","doi-asserted-by":"publisher","first-page":"612","DOI":"10.20892\/j.issn.2095-3941.2020.0106","volume":"17","author":"J Wang","year":"2020","unstructured":"Wang J, Zhao H, Xu Z, Cheng X. Zinc dysregulation in cancers and its potential as a therapeutic target. Cancer Biol Med. 2020;17(3):612\u201325.","journal-title":"Cancer Biol Med"},{"key":"1147_CR550","unstructured":"(ODS) USDoHHSNIoHOoDS. Zinc \u2013 Fact Sheet for Consumers 2022 [Available from: https:\/\/ods.od.nih.gov\/factsheets\/Zinc-Consumer"}],"container-title":["Nutrition &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12986-026-01147-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12986-026-01147-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12986-026-01147-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T14:55:05Z","timestamp":1787669705000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12986-026-01147-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,15]]},"references-count":550,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1147"],"URL":"https:\/\/doi.org\/10.1186\/s12986-026-01147-8","relation":{},"ISSN":["1743-7075"],"issn-type":[{"value":"1743-7075","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,15]]},"assertion":[{"value":"3 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Human ethics and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"We acknowledge that this essay was edited and its writing style refined with the help of ChatGPT (GPT-5, OpenAI\u2019s large-scale language generation model, used via the editGPT extension). The AI was not used to create the manuscript\u2019s content or references; it was employed solely to enhance the language. All AI-assisted text was carefully reviewed, edited, and rewritten by the authors, who assume full responsibility for the article\u2019s accuracy and substance.","order":2,"name":"Ethics","label":"Statement on the Use of Artificial Intelligence (AI)","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"96"}}